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Zusammenfassung 
 
In den letzten 20 Jahren entwickelte sich die Olefin-Metathese zu einer 
ausgezeichneten Methode um Kohlenstoff-Kohlenstoff Doppelbindungen zu 
manipulieren. Trotz des ernormen Fortschritts bezüglich Stabilität von Katalysatoren, 
deren hohe Aktivitäten und deren Toleranz gegenüber funktionellen Gruppen sind 
weitere Verbesserungen von grosser Bedeutung. Diese Dissertation ist dem Ziel 
gewidmet neuartige Katalysatoren  zu synthetisieren und deren Verhalten in der 
Ringschlussmethatese (RCM) zu untersuchen.  
Der erste Abschnitt dieser Arbeit, welcher im zweiten Kapitel beschrieben ist, 
konzentriert sich auf die Entwicklung von einer Reihe auf Ruthenium basierende 
Metathesekatalysatoren der Hoveyda-Blechert-Familie. Diese Katalysatoren bestehen 
aus N-heterozyklische Carbene mit einer substituierten Naphthyl-Seitenkette. Zum 
ersten Mal war eine chromatographische Trennung und Aufreinigung der syn- und 
anti-Isomere einiger Katalysatoren erfolgreich. 
Durch verschiedene kinetische Untersuchungsreihen an den isolierten Isomeren 
konnten entscheidende Unterschiede in der Aktivität und Stabilität zwischen anti- und 
syn-Konformeren des Katalysators festgestellt werden. 
Intensive Studien zur Auswirkung der Konzentration auf die Reaktionsrate von 
RCM-Reaktionen wurden zusätzlich durchgeführt mit dem Ergebnis, dass unter 
bestimmten Konditionen, sehr hohe Konzentrationen des Vorläufer-Diens zu RCM 
führen kann mit einer Vielfalt von Substraten mit extrem niedrig katalytischer 
Ladung. 
Im dritten Kapitel wird die Synthese und Charakterisierung einer neuen Familie von 
NHC mit mono- oder disubstituierten Seitenketten behandelt. Das Ziel dieser Arbeit 
war das Erlangen von Liganden, welche vorwiegend die anti –Konformation 
einnehmen. Dadurch wird erreicht, dass diese Komponenten vielseitiger in der 
Organischen Chemie und als Organokatalysatoren einsetzbar sind. Insbesonders 
können durch Inkorporation der Liganden diese Ru-Katalysatoren zu Metathese-
Reaktionen verwendet werden.  
Im vierten Kapitel wird zum Abschluss die Entwicklung jener katalytischen 
Methoden, um Alkenbromide durch RCM-Reaktionen zu erhalten, angestrebt. Dafür 
 vii 
werden katalytische Mengen von kommerziell erwerblichen Katalysatoren verwendet. 
Diese Produkte stellen ein grosses Interesse, nicht nur als Bausteine in der 
Organischen Synthese dar, sondern auch als Möglichkeit neuwertige milde 
synthetische Wege einzuschlagen. Eingeschlagene Versuche diese 
Reaktionsmechanismen zu klären werden in dieser Arbeit vorgestellt. 
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 1 
CHAPTER ONE 
 
1.1 Introduction to olefin metathesis 
 
In the last 50 years olefin metathesis (OM) experienced an amazing evolution 
becoming one of the most useful synthetic transformation for generating carbon-
carbon double bonds.1,2,3,4 This metal catalyzed reaction involves two olefins that, via 
a metallacyclobutane intermediate, undergo a disproportionation (Figure 1). 
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Figure 1. Olefin metathesis reaction 
 
This reaction can be applied in a great variety of synthetically useful 
permutations, including ring-closing metathesis (RCM), cross metathesis (CM), enyne 
metathesis, acyclic diene metathesis polymerization (ADMET) and ring-opening 
metathesis polymerization (ROMP) (Figure 2). A huge number of catalysts has been 
developed and tested for these transformations; however, ruthenium alkylidene 
complexes have become the most widely used in organic synthesis.  
 
n
RCM
ROMP
n
R1 R1 R1
R2CM
ENYNE
C2H4
ADMET
n
 
 
Figure 2. Some of the most commonly used olefin metathesis transformations. 
 
The success is mostly due to their excellent functional group tolerance combined 
with a high activity and remarkable stability toward air and moisture.1,2 The 
 2 
commercial availability of some of these catalysts, mainly Grubbs first and second-
generation (Figure 3), also played a key role in their rapid diffusion. 
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Figure 3. Grubbs first and second-generation catalysts. 
 
In the past few years, the application of ruthenium-based olefin metathesis 
catalysts has expanded to include the synthesis of molecules in organic, inorganic, 
biochemical, polymer, and materials chemistry.5 Quite a few studies on large-scale 
application were also developed but none has yet been implemented.6 
 
1.2 Nature and reactivity of carbenes 
 
In order to understand how an olefin metathesis catalyst works, it is important to 
study the nature of a carbene and its reactivity toward a metal center. Carbenes are 
neutral species containing a carbon atom with only six valence electrons. They are, in 
most of the cases, too reactive to be isolated and observed. Spectroscopic 
investigations of a number of carbenes of different structures have shown that they 
fall broadly into two groups: those that electron spin resonance spectroscopy (ESR) 
demonstrates have unpaired electrons and whose bond angles are between 130 and 
150°; and those that have bond angles of 100-110° but cannot be observed by ESR.  
The first are generally called triplet state carbene; the second are referred to as singlet 
state carbene. Many carbenes, like :CH2, can be found in either states (Figure 4). 
The bond angle between 100 and 150°, observed for most of the carbenes, 
suggests a trigonal (sp2) hybridization state. An sp2 hybridized carbene would have 
three, lower energy, sp2 orbitals and one, higher energy, p orbital in which to 
distribute its six electrons. There are two possible ways to do this. 
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Figure 4. Representation of singlet and triplet state carbenes. 
 
Either all of the electrons can be paired, with each pair occupying one of the sp2 
orbitals, or two of the electrons can remain unpaired, with one electron in the p 
orbitals and one in the remaining sp2 orbital (Figure 5). These two possibilities 
explain the existence of the two observed classes of carbenes. 
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Figure 5. Electronic structure of an sp2 hybridized carbene with 2 unpaired electrons 
(left) and two paired electrons (right). 
 
The existence of the two spin states explains the different behavior of triplet and 
singlet carbenes in ESR spectroscopy.  
Most of the carbenes are more stable in the triplet state because the energy to be 
gained by bringing the electron in the p orbital down into the sp2 orbital is insufficient 
to overcome the repulsion that exists between two electrons in a single orbital.  
Carbenes can be considered, in some aspects, as extremely reactive Lewis acids. 
This explains why they are able to react with very weak Lewis bases, like unactivated 
olefins or even simple alkanes (Figure 6). These reactions can be considered as 
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insertion reactions and, depending on the state of the carbene, can proceed with a 
concerted cycloaddition or a radical mechanism. 7,8 
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Figure 6. Two examples of reactions of carbene in organic synthesis. 
 
In all the cases in which the singlet state is the lower energy state, an electron-
rich substituent carrying lone pairs is present adjacent to the carbene center. These 
lone pairs can interact with the p orbital of the carbene to produce a new, lower-
energy orbital which can be occupied by the two electrons. This type of molecule is 
normally less electrophilic than other carbenes and, in particular cases, they can be 
quite nucleophilic (Figure 7). 9  
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Figure 7. Reaction between a nucleophilic carbene and formaldehyde. 
 
1.3 Interaction of carbenes with metals 
 
The first studies on the interaction of a carbene with a metal started in the 1960s. 
The pioneer of this chemistry was Ernst Otto Fischer who in 1964 presented the first 
important work aimed to prove that some particular types of carbenes were indeed 
able to generate a remarkably stable bond with a transition metal.10 His contribution 
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to this topic was so important that these types of carbenes nowadays are generally 
called Fischer carbenes (Figure 8). For this discovery and for more extensive work in 
the organometallic field (in particular for the discovery of Ferrocene) Fischer was 
awarded the Nobel prize in chemistry in 1973. 
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Figure 8. The general structure of a Fischer type carbene (left) and two classical 
examples (middle and right). 
 
Fischer carbenes are typically found with electron-rich, low oxidation state metal 
complexes (middle to late transition metals) containing π-acceptor ligands (such as 
CO). They feature a π-donor substituent on the methylene group such as alkoxy or 
alkylated amino groups. Looking at the orbital interaction, two main processes take 
place: the σ-donation from the carbene to an empty d-orbital of the metal and the 
retro-donation from a filled metal orbital into an empty p-orbital of the carbon (Figure 
9). There is competition between the retro-donation process and the donation of a lone 
pair from the heteroatom and this is consistent with the last resonance structure shown 
in Figure 9. This model explains, at least in part, the electrophilic-at-carbon nature of 
Fischer carbenes. 
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Figure 9. Resonance structures of a Fischer carbene (above) and an interpretation of a 
Fischer carbene-metal bond with molecular orbitals (below). 
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Metal complexes of Fischer carbenes have proven to be highly stable and very 
efficient and versatile starting material for a wide array of cycloaddition and 
cyclopropanation reactions.11 However, a major limit in their application in modern 
organic synthesis is the necessity to employ a stoichiometric amount of reagent. 
Efforts to solve this problem are underway and some limited success has been 
achieved.12 
Carbenes that are not stabilized with a π-donor substituent generate a totally 
different type of metal complexes. These species, commonly called Schrock carbenes, 
generally form stable complexes with electron poor, early transition metals in a high 
oxidation state. Bonding in such complexes can be viewed as the coupling of a triplet 
state metal and triplet carbene. These bonds are polarized towards carbon and 
therefore the methylene group presents strong nucleophilic character (Figure 10). 
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Figure 10. Interpretation of a metal-Schrock carbene bond with molecular orbital. 
 
Schrock carbenes are widely used in organometallic chemistry and metathesis is 
certainly one of the most important catalytic applications. 
Only in 1991, almost three decades after Fischer’s discoveries, the work of 
Arduengo brought to the development of the first stable free carbene (Figure 11).13  
 
NN
IAd  
Figure 11. The first stable free carbene developed from Arduengo. 
 
The core of the molecule constituted an N-heterocycle hence its name N-heterocyclic 
carbene (NHC). This species proved to be stable in the absence of oxygen and 
moisture and it could be handled easily, being a crystalline solid. NHCs feature a 
good σ-donor character, similarly to Fischer carbenes, but their π-acceptor character 
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is very weak. This results in an empty p-orbital on the carbene carbon that is partially 
stabilized by the lone pairs of the adjacent heteroatoms. As a result, the interaction 
between the metal and the NHC is usually represented as a single bond with a 
delocalized charge on the heterocyclic ring (Figure 12). 
 
NN RR
M  
Figure 12. Classical representation of a metal-NHC bond. 
 
After the discovery of Arduengo, NHCs started to attract a great interest as 
ligands in organometallic chemistry. Thanks to the pioneering work of Herrmann, 
followed by Grubbs, Nolan and many others, they now represent, in many 
applications, a valid alternative to tertiary phosphine. The main advantage, with 
respect to the classical phosphine ligands, consists in the greater stability towards 
heat, oxygen and moisture observed for NHC complexes.14  
Despite the great effort spent in the last decade, to date only a few types of NHCs 
are commercially available and largely employed in common organometallic 
chemistry. They are aryl-substituted imidazol-2-ylidenes (2,4,6-mesityl-substituted 
IMes and 2,6-isopropylphenyl-substituted IPr) and their saturated imidazolin-2-
ylidene counterparts (SIMes and SIPr) (Figure 13). In Chapter 3 some of the results 
obtained in the last years in our group concerning the development of new NHCs that 
feature naphthyl-substituted side chains will be presented. 
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Figure 13. The most common NHCs currently used. 
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1.3 Mechanism of olefin metathesis 
 
The discovery of olefin metathesis raised questions concerning the exact 
mechanism of this type of transformation. Initially, a number of ideas were 
postulated, none of which fully matched the experimental observations.15,16,17 Only in 
1971, starting from those early studies and in particular from the one developed from 
Calderon, Chauvin was able to propose a mechanism that appeared to be consistent 
with the experimental data.18 He was the first to hypothesize that in the key step of the 
metathetic process an unstabilized, very reactive metal-alkylidene complex had to be 
involved (Figure 14).19 In the proposed mechanism, after coordination of an olefin to 
the metal center (II) a [2+2] cycloaddition takes place, generating a 
metallacyclobutane (III). The intermediate can rapidly evolve releasing ethylene and 
generating a new metal alkylidene (IV) that can then undergo the same sequence of 
transformations reacting with a new olefin, eventually completing the 
disproportionation of two double bonds, as shown in Figure 14.  
 
M CH2
Catalyst
precursor
M CH2
R1
R1
M
R1
M
R1
2+2
cycloaddition
R2
M
R1
R2
M
R1 R2
2+2
cycloaddition
R1 R2
I
II
III
IV
V
VI
 
Figure 14. Proposed olefin metathesis mechanism. 
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All the steps of this process are reversible and only the presence of a driving force, 
such as the formation of volatile byproducts that can be released from the reaction 
environment, drive the equilibrium towards a specific product. 
Today this mechanism is commonly accepted and new theoretical20 as well as 
experimental21 evidences for the involvement of these intermediates in the catalytic 
cycle are continuously being reported.  
Less developed are the studies that aim to identify the way in which the olefin 
approaches the metal center. Evidence for a bottom-bound intermediate were obtained 
from Snapper employing Grubbs first generation (GI) and a strained tricyclic 
cyclobutene substrate (Figure 15, left).22 Later, Grubbs, employing ortho-
divinylbenzene as a test substrate and a Grubbs third generation catalyst (GIII), was 
able to prove with NMR and X-Ray crystallographic studies that, after the first cross-
metathetic step in the catalytic cycle, the remaining olefin coordinates to ruthenium in 
a cis position with respect to the NHC (Figure 15, right).21a  
A criticism that can be made of these two types of studies is associated with the 
use of model substrates that have a restricted conformational freedom, and therefore 
do not represent well, the class of substrates commonly used in olefin metathesis. 
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Figure 15. Side bound-intermediate (left) and bottom bound-intermediate (right). 
 
Computational studies performed by Goddard23 and Cavallo20a on Grubbs 
second-generation catalysts suggest that the preferred reaction pathway is governed 
by a delicate balance between electronic, steric and solvent effect. Polar solvents 
should push toward the side reaction pathway and can easily overturn an electronic 
preference for the bottom reaction pathway. This means that, with less bulky ligands 
and/or substrates, the side reaction pathway can be indeed competitive. If these 
prerequisites are not present, the bottom reaction pathway becomes strongly favored.  
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1.4 Historical evolution of olefin metathesis catalysts 
 
Olefin metathesis was initially observed in the 1950s during the research 
performed on Ziegler-Natta polymerization processes.24 In the early 1960s, industrial 
chemists at DuPont discovered that alumina-supported molybdenum species catalyzed 
the transformation of propene into 2-butenes and ethylene. Similar catalysts were also 
able to induce polymerization of cyclopentene and norbornene, generating completely 
new polymers.25 These observations were followed by several reports describing 
improved catalytic systems based on molybdenum and tungsten that catalyzed either 
the polymerization of cyclic olefins or the disproportionation of linear olefins.26 For 
more than 20 years, until the early 1970s, olefin metathesis catalysts were based on 
multi-component systems that consisted of early transition metal salts and alkylating 
reagents, generally based on aluminum. Although these systems were limited in 
substrate scope and required high reaction temperature, their catalytic activity was 
high and some important industrial application were implemented (e.g. the SHOP and 
Phillips triolefin processes).27 Only after the hypothesis formulated from Chauvin 
regarding the participation in the olefin metathesis reaction of a metal alkylidene 
moiety a great effort was concentrated in the isolation and characterization of well-
defined catalytic systems. In 1974 Schrock was able, for the first time, to isolate and 
characterize a tantalum complex containing a stable alkylidene (1, Figure 16), 
definitely proving the existence of this chemical entity and giving a fundamental 
support to the metathesis mechanism proposed by Chauvin.28  
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Figure 16. Evolution of well-defined metathesis catalysts. 
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Two years later, in 1976, Katz reported the first well-defined metal carbene that 
underwent olefin metathesis. The [(CO)5W(=CPh2)] complex 2 initiated metathesis, 
albeit at a low rate, of a variety of di- and tri-substituted cycloalkenes and E- and Z-2-
pentenes.29 In 1978 Tebbe et al. proposed the first homogeneous metathesis catalyst 
based on titanium and aluminum (3). Despite the low activity in metathesis some 
insight into the mechanism of the reaction were proposed in 1980. Using the same 
catalyst, Grubbs et al. were able to isolate, characterize and study the reactivity of a 
stable metallacyclobutane intermediate.30 This catalyst, today called Tebbe’s reagent, 
is still widely used for olefination reactions of esters. In the same period, Schrock and 
coworkers had started to investigate the behavior of high-oxidation state metal 
alkylidene complexes in the presence of olefins.31 In 1980 this resulted in the 
development of Nb/Ta-complexes 4 that catalyzed the metathesis of cis-2-pentene. 
Formation of new alkylidene complexes upon reaction of 4 with styrene presented 
another solid proof for Chauvin’s proposed olefin metathesis mechanism.32 
Encouraged by the good results obtained with poorly defined, high oxidation 
state tungsten-based systems and by the good results of complex 2, Schrock and other 
groups started to synthesize W- and Mo-alkylidene complexes and evaluate their 
activity as catalysts for olefin metathesis.33 The first stable, catalytically active W-
alkylidene complexes were reported throughout the 1980s by the groups of Schrock,34 
Osborn35 and Bassett36 (Figure 17, complex 5-7). 
 
W
PEt3
PEt3
Cl
Cl
O
5
Schrock
1980
W
Br
Br
O
O
6
Osborn
1983
+ GaBr3
W
Et2O
O
Cl
ArO
7
Basset
1985  
Figure 17. The first well-defined W-based metathesis catalysts 
 
Finally, in 1990, Schrock proposed a series of single-component imido-
alkylidene catalysts in which two bulky, electron poor alkoxide ligands contributed to 
increase the stability of the complexes (Figure 18). These compounds are still 
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nowadays among the most active catalysts known and a wide number of 
modifications were developed and employed in synthetic organic chemistry.37 
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Figure 18. General structure of one of the most active metathesis catalysts (8) and of 
its asymmetric version (9, 10). 
 
Asymmetric versions of these catalysts were also developed in 1993 by Schrock. 
The first generation of chiral catalysts featured, in place of the two bulky alkoxide 
groups, a bidentate, C2-symmetric chiral diolate ligand (9, Figure 15).38 More recently 
Schrock and Hoveyda were able to synthesize a second-generation of chiral catalysts 
in which the chelating diolate was substituted with an enantiomerically pure aryl 
alcohol and a functionalized pyrrole.  
 
N
H
N
N
Mo
Ph
O
N
iPriPr
Cl
TBSO
Cl
N
H
N
N
H
N
(+)-quebrachamine> 98 % conv., 84 % yield
96 % e.e. (e.r., 98:2)
(5:1, in situ)
C6H6, 22°C1 mol %
 
 
Figure 19. Asymmetric synthesis of Quebrachamine. 
 
These complexes are stereogenic at metal and proved to be extremely active and 
highly stereoselective. One of the more fascinating examples of their application in 
synthetic organic chemistry is the enantioselective synthesis of (+)-Quebrachamine 
(Figure 16).39,40 
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Despite the great improvement that Schrock catalysts experienced in the last 
decade, their high sensitivity to moisture and air, along with the complexity of their 
synthesis, are still major drawbacks.  
In parallel with the discovery and evolution of tungsten and molybdenum based 
catalysts, Grubbs explored the chemistry of ruthenium alkylidene based complexes. 
The first successful results were achieved, in terms of catalyst activity and stability, in 
1992 with the discovery of complex 11 (Figure 17). Although the activity of 11 was 
poor with respect to the Mo-based catalysts, it was significantly more versatile due to 
its remarkable functional group tolerance. In addition, it was not very air sensitive as 
a solid and displayed a good resistant to water, alcohols and acids.41 The synthesis of 
this complex though was still particularly difficult. In this sense a great advancement 
was achieved with the discovery of catalyst 12, today known as Grubbs first 
generation catalyst: not only was this catalyst around 20,000 time more active than 
11, but it could also be easily obtained via a short, high yielding synthetic pathway. 
Remarkably, the necessity to use potentially explosive diazo-compounds during the 
synthesis of this compound did not hamper the development of large scale processes 
and nowadays it can be produced in multi-kilogram scale.42 
After only three years from the discovery of 12, a new, revolutionary, advance 
was achieved in the Herrmann group. He was able, for the fist time, to replace the two 
phosphines present in complex 12 with imidazolin-2-ylidene ligands generating a 
completely new class of catalysts. Although these complexes showed little, if any, 
improvements in applications to ROMP and RCM,43 they opened the way to the use 
of NHCs as ligands not only for olefin metathesis catalysts but for a large plethora of 
other catalysts that today are key instruments in modern organic chemistry.  
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Figure 20. Some of the first Ru-based metathesis catalysts. 
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In 1999 Grubbs43,44 and Nolan45 were able to displace selectively only one 
phosphine from complex 12 using IMes and SIMes. These new catalysts (14 and 15, 
figure 18) were slightly less reactive than 12 at room temperature in ring-closing 
metathesis reactions but at higher temperatures the reactivity increased dramatically. 
In addition, complex 15 exhibited increased ring-closing activity towards sterically 
demanding substrates, being able to generate in moderate to excellent yield tri- and 
tetra-substituted olefins. 
As an alternative to Ru-benzylidene catalysts, NHC bearing Ru-3-
phenylindenylidene complexes,46 such as 16, were developed and are now widely 
used in natural product synthesis (Figure 21).47 The Ru-indenylidene complexes 
showed a higher thermal stability than their benzylidene counterparts and, at the same 
time, showed a good catalytic activity and selectivity. It is important to note that these 
complexes can be obtained using a simple and high yielding procedure that avoids the 
use of diazo-compounds. 
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Figure 21. Ru-based metathesis catalysts containing one phosphine. 
 
In 2000 Hoveyda48 and Blechert49 developed, in parallel, the first phosphine-free 
ruthenium-based metathesis catalyst. Starting from the second-generation Grubbs 
catalyst they were able to introduce a chelating benzylidene ligand generating 
complex 17 (Figure 21). This catalyst was found to be particularly stable but less 
active, generally requiring high temperature to be activated. This problem was 
partially solved in 2002 by Blechert and Grela. The first introduced a phenyl ring in 
position α to the isopropoxy group of 17, generating a strong steric repulsion that 
facilitates the dissociation of the ether moiety from the metal center (18, Figure 22);50 
the second introduced a strongly electron-withdrawing group on the benzylidene ring 
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of 17, reducing the propensity of the ether moiety to bind to the metal center (19, 
Figure 22).51 In both cases, the catalysts became active at room temperature. 
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Figure 22. Ru-based metathesis catalysts containing a chelating benzylidene. 
 
Another important attempt to induce faster activation of second-generation 
Grubbs-type catalyst was performed by the group of Piers. He was able to isolate a 
stable pre-catalyst containing a 14-electron metal center (20, Figure 23). This 
compound, now commercially available, has been used mainly to perform 
mechanistic studies at very low temperature, conditions under which conventional 
catalysts would be too unreactive.52 
Many other modifications of the catalysts were performed but their impact was 
not as relevant as the one previously reported. Great effort was also spent, with 
modest success, in generating complexes immobilized on different solid support, in 
order to obtain a recyclable catalyst that could be more easily used in industrial 
applications.53 
 
Ru
NN
PCy3
Cl
Cl
MesMes
B(C6F5)4
20
Piers
2004  
Figure 23. One of the more successful examples of fast activating Ru-based olefin 
metathesis catalysts. 
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The successful applicability of olefin metathesis to so many different fields of 
science and the incredible revolution that this reaction brought to modern organic 
chemistry were recognized in 2005 by the Royal Swedish Academy of Sciences that 
conferred the Nobel prize in chemistry to Yves Chauvin, Richard Schrock and Robert 
Grubbs.54 
 
1.5 Ring-closing metathesis (RCM): application in organic synthesis. 
 
As much as ROMP and ADMET had, in the last 15 years, a great impact on 
polymer chemistry, RCM imposed itself as the most flexible, easily applicable and 
atom economic method to generate unsaturated small, medium, and large rings in 
organic synthesis.55  
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Figure 24. Some examples of successful applications of RCM in the synthesis of 
complex natural products featuring ring of different size.56 
This innovation revolutionized in particular the field of complex natural products 
synthesis.57 Some examples of the significance of RCM in this field are shown in 
Figure 24. 
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Olefin metathesis, as shown by the mechanism proposed by Chauvin, is a process 
that is normally fully reversible. This implies that a driving force must to be present in 
order to obtain a single, defined product. For example, in ROM and ROMP the 
reaction is driven by the release of the ring strain. For RCM and CM the equilibrium 
is usually driven in the desired direction by progressive removal of one of the 
products from the reaction environment (generally ethene or propene, liberated as 
gas). Examples of RCM reactions in which non-volatile products are produced 
(styrene for example) are known and, for specific applications, important results have 
been obtained. 
As previously observed in Figure 2 a classical problem in RCM reactions is 
connected with the presence of a competitive reaction: ADMET. A plethora of factors 
has to be taken into account in order to understand which one of the two processes 
will be dominant:  
 
1) Small (5 and 6 atoms) and large (more than 15 atoms) rings normally can be 
easily obtained via RCM. For medium sized cycles (8-14 atoms) ring strain is 
a problem and often ADMET is dominant. 
2) Presence of substitutents that induce a strong Thorpe - Ingold effect favors 
RCM products.58 
3) Presence of one terminal electron poor olefin favors ADMET processes. α,β-
unsaturated ester are particularly problematic, as they also reduce the 
conformational freedom of the molecules favoring a linear arrangement in 
space. 
4) In the presence of an heteroatom that may chelate the metal, RCM is 
generally favored but the reaction rate is slower and higher temperature could 
be necessary.59 
5) High dilutions favors RCM but have a remarkably negative effect on the 
catalyst performance.60 
 
The concentration effect is one of the easier factors to manipulate ond has been 
widely studied, as demonstrated by the numerous reports that describe the importance 
of high dilution for the synthesis of macrocycles.61 Surprisingly almost no attempts of 
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testing the effect of high concentration on RCM reactions that generate medium and 
small rings have been reported in literature.62 One of the main focuses of this thesis 
has been directed to this topic and the results will be presented in Chapter 2. 
 
1.6 Ring-closing metathesis of heteroatom-substituted olefins 
 
The discovery of well defined, ruthenium-based metathesis catalysts, featuring 
greatly increased functional group tolerance, allowed, in the last ten years, a 
broadening of the scope of the olefin metathesis reaction. Nevertheless, some 
important limitations are still present, principally connected to substrates featuring 
directly functionalized olefins. Strongly electron-donating or electron-withdrawing 
groups are indeed able to drastically modify the reactivity of a double bond towards 
the metal.  
 
Electron rich olefins 
 
When the olefin substituent increases the electron density of the double bond, a 
fast reaction with the catalyst generates a Fisher-type carbene (21), too stable to 
further react in the catalytic cycle (Figure 25). This reaction is normally so fast, 
quantitative and irreversible that vinyl ethers have become common reagents for 
quenching metathesis catalysts. 
 
Ru
L
OMe
Cl
Cl
L
Ru
L
Ph
Cl
Cl
L
Ph
O
Me
21  
Figure 25. Reaction between a general metathesis catalyst and an electron rich olefin. 
 
By employing harsh conditions and using the more stable ruthenium-based catalysts 
now available, some groups succeeded in performing successful RCM of enol ethers 
and enamines. In general, substrate scope is however very limited, catalyst loading 
must be high, and only few turnovers can be achieved.63 
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Electron poor olefins 
 
When electron poor olefins are used, electron-deficient, poorly stable metal 
carbene species are formed. Moreover, the low propensity of these olefins to 
coordinate and react with the catalyst represents a major problem. In these cases 
chelation of an heteroatom of the substrate to the metal center often becomes 
competitive with coordination of the olefin and a drastic reduction of the reaction rate 
is observed. This behavior is particularly well documented in literature for α,β-
unsaturated carbonyl compounds (Figure 26).64  
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Figure 26. Possible deactivation of the catalyst via intramolecular heteroatom 
chelation. 
 
Various attempts to solve this problem were performed, and the use of a 
stoichiometric amount of Lewis-acid (usually bulky Ti-based molecules) that can pre-
chelate the carbonyl function proved to be quite successful.65 
Vinyl halides constitute another class of electron poor olefins of great synthetic 
interest that proved to be challenging substrates for RCM reactions. Pioneering work 
in this field was reported by Weinreb with vinyl chlorides. Even though a high 
catalyst loading was required (10% GII), Weinreb was able for the first time to 
generate a series of 5-, 6- and 7-membered vinyl chlorides in good overall yields.66  
Later on, Brown,67 Rutjes68 and Haufe69 demonstrated that substrate containing 
vinyl fluorides and trifluoromethyl-substituted olefins undergo RCM (Figure 27). 
However, the drastic reaction conditions employed represented a serious limit, often 
inducing partial decomposition of the starting material.  
Vinyl bromide substrates proved to be, to date, completely inactive with both 
Schrock-type and first or second-generation Grubbs-type catalysts.70 In Chapter 4 of 
this thesis a first, partial solution to these problems will be presented, demonstrating 
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how appropriate modifications of the starting vinyl halide can lead to efficient RCM 
of these substrates with a catalytic amount of a commercially available catalyst. 
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Figure 27. Some successful examples of products formed via RCM reaction of vinyl 
halides. 
 
Other electron poor olefins, substituted with sulfur or phosphorus atoms, have 
been used as RCM substrates with good results generating 5, 6 and 7 membered 
heterocycles.71 Particularly fascinating in this area is the work of Hoveyda, who by 
using enantiomerically enriched molybdenum based catalyst, was able to generate in 
average to good yields enantioenriched cyclic phosphinates and phosphine oxides.72 
 
1.7 Olefin metathesis in Dorta’s laboratory 
 
Early work developed in our laboratories has led to the synthesis of promising 
members of a new family of stable, saturated free NHC ligands that incorporate bulky 
naphthyl side chains. The introduction of the naphthyl moieties generates 
atropoisomeric ligands with C2-symmetric (anti) and Cs-symmetric (syn) 
conformations (Figure 28). 
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SiPr: R2, R6 = Isopropyl; R4 = H
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R1, R2 = Isopropyl; SIPer analogues  
 
Figure 28. Imidazolin-2-ylidenes with phenyl (left) and naphthyl (right) side chains. 
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The first applications of these types of ligands in Grubbs second-generation 
ruthenium type complexes proved to be quite successful, and some of the new 
catalysts appeared to be superior to the original SIMes-containing Grubbs second-
generation complex in simple RCM reactions leading to di-substituted olefins.73 
Already at this early stage the idea of separating the isomers to test their 
reactivity and stability was developed but, despite numerous attempts, the process was 
always unsuccessful, mainly due to fast decomposition of the catalysts. 
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Figure 29. Ellipsoid view (30% probability) and 1H NMR spectrum of decomposition 
product 22. 
 
The work was then extended and a screening of the substituents on the naphthyl 
side chains was performed.74 Bulky, cyclic or linear substituents in position 2 of the 
ring were fundamental for the activity of the catalyst; substituents in position 2 and 7 
improved the overall catalytic performance, particularly when substrates generating 
tri- and tetra-substituted olefins were used. Finally and in some way surprisingly, 
 22 
simply switching from a 2,7- to a 2,6-substitution on the naphthyl ring, a clear drop in 
catalytic performance was observed. 
A crystal structure obtained from the decomposition of one of these catalysts (22, 
Figure 29) helped to rationalize this trend: in the absence of a substituent in position 7 
of the naphthyl ring, the ligand can undergo intramolecular cyclometalation, 
generating an inactive species.  
 
H H H H H
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Ru
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H Ru
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H
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Figure 30. Plausible order of C-H activity for different side chains. 
 
The presence of substituent in position 7 clearly disfavors this decomposition pathway 
for steric reasons. Substituents in position 6 instead probably increase the electron-
density in position 8 and enhance the likelihood of a C–H activation; this leads to the 
least active catalyst (Figure 30). 
Mimics of the second-generation Hoveyda-type catalyst were also developed and 
tested and the reactivity of this new family of catalysts proved to be similar, or, in the 
best cases, slightly superior with respect to the original catalytic system.75 Again, 
separation of the two diasteroisomers was attempted but no significant results were 
obtained. 
 
1.8 Aim of the thesis (Summary) 
 
As already mentioned, in the last twenty years olefin metathesis has become one 
of the more important tools to manipulate carbon-carbon double bond. Despite the 
great advancement obtained in catalyst stability, activity and functional group 
tolerance, further improvement are still highly desirable. Following this lead, the 
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work described in this thesis is dedicated to the synthesis of novel catalysts and to the 
study of their behavior in ring-closing metathesis (RCM) reactions. 
The first part of the work, described in Chapter 2, focuses on the development of 
a series of new ruthenium-based metathesis catalysts of the Hoveyda-Blechert family 
incorporating N-heterocyclic carbenes featuring substituted naphthyl side chains. 
Chromatographic separation and purification of the syn and anti isomers of some of 
these catalysts was, for the first time, possible. Through a series of kinetic studies 
performed on the isolated isomers, a remarkable difference in activity/stability 
between the anti and the syn conformers of the catalyst was observed. 
Extensive studies on the effect of the concentration on the reaction rate of RCM 
reactions have also been performed, proving that, under particular conditions, very 
high concentration of the starting diene can lead to RCM of a variety of substrates 
with extremely low catalyst loading. 
In Chapter 3 the synthesis and characterization of a new family of NHC featuring 
mono- or di-substituted naphthyl side chains is presented. The goal of this work was 
to obtain ligands able to adopt predominantly the anti conformation. This will allow 
for a wider use of these compounds in organometallic chemistry and as 
organocatalysts in general, and for incorporation of the ligands in Ru-catalysts for 
olefin metathesis reactions in particular.76 
Finally in Chapter 4, the development of a catalytic method to access cyclic 
alkenyl bromides via the RCM reaction using a catalytic amount of a commercially 
available catalyst will be presented. These products are of great interest as building 
blocks in organic synthesis and new, mild synthetic pathways to access them are 
highly desirable. Preliminary attempts to clarify the mechanism of the reaction will be 
presented. 
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CHAPTER TWO 
 
 
Impact of NHC Ligand Conformation and Solvent Concentration on the 
Ruthenium-Catalyzed Ring-Closing Metathesis Reaction 
 
Michele Gatti, Ludovic Vieille-Petit, Xinjun Luan, Ronaldo Mariz, Emma Drinkel, 
Anthony Linden, and Reto Dorta* 
 
(J. Am. Chem. Soc. 2009, 131, 9498) 
_____________________________________________________________________ 
 
Ring-closing metathesis (RCM) reactions promoted by transition metal catalysts 
have gained enormous importance in synthetic organic chemistry.1 Especially 
valuable was the introduction of ruthenium-based N-heterocyclic carbene complexes 
such as Grubbs’ II (GII) a decade ago.1 Since then, major research efforts have been 
directed toward optimizing the ligand sphere around the ruthenium center and have 
led, inter alia, to derivatives shown in Figure 2.1.2 Overall though, activities of these 
catalysts in RCM, while sufficient for laboratory-scale applications, are still relatively 
low for applications in larger-scale reactions. 
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Our entry into this fascinating field of research began via the identification of 
saturated NHCs that feature substituted naphthyl side chains.3 The ligands are present 
as a mixture of anti and syn conformers, and preliminary data with two of these 
NHCs, (2,7)- SIPrNap and (2)-SICyNap, outlined their high catalytic activity in the 
RCM of GII type precatalysts (used as isomeric mixtures).3c The substitution pattern 
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on the naphthyl side chains confers a high degree of conformational stability,3a,4 and 
we were therefore intrigued by the prospect of metathesis-active NHC-ruthenium 
complexes that are only distinguished by the relative orientation of their side chains.5 
 
Scheme 1. Preparation and Separation of Catalysts 3 and 4 
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To enhance the possibility of separating such complexes and at the same time 
ensure high catalytic activity, we decided to prepare phosphine-free ruthenium 
precatalysts that are analogues to Blechert’s catalyst (BleII).2b Complex 3 was 
prepared from an anti/syn mixture (ca. 1:1) of 1 by metathesis with o-isopropoxy-m-
phenylstyrene (Scheme 1). Careful chromatographic workup of the isomeric mixture 
led to the isolation of the two complexes anti-3 (first compound eluted) and syn-3 in 
63% overall yield. When the same reaction was performed with an anti/syn (4:1) 
mixture of 2, only the first isomer, namely anti-4, was isolated from the column (62% 
yield).6 The assignment of the respective isomers was verified through X-ray 
structural studies of complexes anti-3 and anti-4 (Figure 2.3). 
RCM activities (27 °C, 0.1 M substrate/CD2Cl2) of complexes anti-3, syn-3, and 
anti-4 were then benchmarked against Blechert’s SIMes-derived catalyst (BleII) 
using a series of substrates (5-15, Figure 2.4) and following their conversion by 1H 
NMR spectroscopy. Selected kinetic data are shown in Figure 2.4 (see the Supporting 
Information for more details). As anticipated based on our earlier studies on GII 
derivatives, the modification of the NHC structure has a beneficial effect on the 
reactivity profile and the following overall order of activity can be deduced: anti-3 > 
anti-4 > syn-3 > BleII.  
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Figure 1. Ball-and-stick drawing of anti-3 (left) and anti-4 (right) 
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Somewhat surprising is the fact that differences in activity favoring (2,7)-
SIPrNap and (2)-SICyNap over SIMes increase with bulkier substrates that give tri- 
and tetrasubstituted cyclic olefins or with dienes that produce six-membered 
cycloolefins.7 Here, both anti-3 and anti-4 clearly outperform syn-3 and in particular 
BleII, and the overall reactivity profile puts them among the most active RCM 
catalysts known. 
While the higher reactivity of the new catalysts as well as the clear differences 
between anti-3 and syn-3 looked very interesting, we were puzzled by the fact that the 
BleII catalyst seemed to perform better than originally reported by Blechert et al.2b A 
closer inspection of their report shows that the reaction conditions used, except for 
substrate concentration (and catalyst loading), were identical. This prompted us to 
examine the dependence of reaction concentration on RCM activity. To do so, we 
chose the overall most active precatalyst (anti-3, 0.1 mol %) and moderately bulky 
substrate 7. Figure 2.4 (below right) shows that reaction rates indeed increase 
dramatically with increasing substrate-to-solvent concentrations. Using Blechert’s 
dilution (0.01 M substrate/CD2Cl2) or a 0.04 M concentration does not lead to full 
conversion of 7, while a high concentration (0.8 M) ensured complete conversion 
after only 21 min. More significantly, a reaction run in an open vessel without any 
solvent gave quantitative yields of the product within 2 min, without generating any 
byproducts that arise from ADMET.8,9 
As a result, neat reactions with other substrates at lower catalyst loadings were 
performed with anti-3 (Table 1). In some cases, namely for the tosylamide-derived 
substrates, the products were solids at room temperature and impeded simple, neat 
reaction runs. Here, a concentrated hexane solution of anti-3 was added to the neat 
substrates giving pure solid products with almost the same efficiency as that of the 
neat reactions. 
Overall, catalyst loadings could be significantly lowered compared to the runs 
performed in solution. Although not optimized, between 50 and 250 ppm of 
precatalyst anti-3 at room temperature suffice for virtually complete conversion to 
give ring-closed disubstituted and trisubstituted five- and six-membered rings. 
Generation of ethylene gas is not necessary for the reaction to proceed (entries 13-15). 
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Figure 2. Substrates (above, catalyst loadings for 5-8, 10-14: 0.1 mol %; For 15: 0.2 
mol %; For 9: 2 mol %), kinetic data for RCM of 7, 9, and 11, and concentration 
dependence for conversion of 7 with anti-3 (below). 
 
In the case of the representative enyne substrate 10, a concentrated CH2Cl2 
solution already ensures unprecedented levels of activity (entries 9,10). Also notable 
is the very low catalyst loading (0.2 mol %) needed to obtain the tetrasubstituted 
olefin from 9 (entry 8). This product is normally only produced with heating and 
substantially higher catalyst loadings. Turnover numbers reaching 20,000 (entries 
2,10,12) and turnover frequencies of 240,000 per hour (entries 1,11,13) for complete 
conversion certainly approach values needed for larger-scale industrial applications of 
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the RCM reaction.10 
 
Table 1. RCM (25°C) with anti-3 at low catalysts loadings 
 
 
In conclusion, we have identified ruthenium metathesis catalysts that show 
improved reactivity profiles for the RCM and where clear differences exist between 
the respective conformers of the NHC ligand. While testing these new catalysts, we 
discovered that substantially higher reaction rates could be obtained when more 
concentrated substrate/solvent mixtures were employed. This ultimately led to the 
RCM forming five- and six-membered rings of a variety of substrates with catalyst 
loadings of just 50-250 ppm of anti-3. This simple and practical way for improving 
the reactivity and the lifetime of anti-3 seems to be applicable to other ruthenium 
metathesis catalysts and should extend their usefulness in chemical synthesis. The 
intriguing reactivity differences between anti-3 and syn-3 are now the subject of a 
mechanistic study that will be extended to metathesis reactions using chiral 
derivatives of the ligands described here.11 
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2.1 Supplementary Data 
 
In the attempt to improve the results obtained with catalyst 3 and 4 we decided to 
synthesize and test a family of catalysts featuring different substituents in position 2 
of the naphthyl side chains (Figure 3).  
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Figure 3. Second-generation Hoveyda-Blechert type catalysts. 
 
All the desired compounds were obtained in moderate to good yields using a new 
one-pot procedure starting from the corresponding free carbenes and GI. The in situ 
generated GII-type catalyst was, without any purification, directly reacted with an 
excess of the desired modified styrene and with CuCl to furnish the crude desired 
BleII-type analogues (see supporting information for details). The previously 
developed purification procedure was also improved and this led to a higher purity of 
the final compound and to a much easier separation of the isomers  (anti-16 and syn-
16 were obtained in good yield in an almost 1:1 ratio). Moreover, the isolation of 
compound syn-4, previously observed in the crude reaction mixture but never isolated 
due to its instability during the work up procedure, was now possible. 
The assignment of the conformation of compound anti-16 was verified through 
X-ray structure study and the thermal ellipsoid drawings are reported in Figure 4.  
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Figure 4. Thermal ellipsoid drawing (30 % probability) of anti-17. Hydrogen atoms 
were omitted for clarity. 
 
As a first test we decided to compare the anti and the syn isomers of catalysts 4 
and 16 to understand if, as previously observed with catalyst 3, the syn form was 
indeed less active/stable than the anti configured NHC-containing catalysts in RCM. 
Substrates 7 and 8 were chosen for the kinetic studies, as they are known to be 
challenging substrates for RCM reaction at low catalyst loading and at room 
temperature. This ensured longer reaction time and, as a consequence, meaningful 
kinetic curves.  
The obtained results are reported in Figure 5 and clearly confirmed the trend 
previously observed. Moreover the analysis of the kinetic data collected showed that 
there was only a small difference between the reactivity of catalyst 4, that features 
rigid cyclic substitutions on the naphthyl side chains, and 16, that feature flexible 
linear alkyl chains (both for the syn and anti isomers, Figure 5).  
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Figure 5. Kinetic studies of syn and anti isomers of catalyst 4 and 17 in RCM 
reaction of substrates 7 and 8. 
 
A quite significant difference was instead observed when the catalytic 
performances of the syn isomers of catalysts 4 and 17 were confronted with the results 
obtained with syn-3 (Figure 6).  
 
 
Figure 6. Confront of the catalytic performance of the syn isomers of catalysts 3, 4 
and 17. 
 
 
All the catalysts presented a similar fast activation period but, in a second phase 
of the reaction, catalyst syn-3 proved to be more stable and able to perform RCM for a 
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longer overall period of time. It is possible to speculate that the higher stability 
observed with catalyst 3 could be connected with the presence of a substituent in 
position 7 of the naphthyl side chains12 but to verify this hypothesis more through 
kinetic studies with catalysts incorporating a wide range of naphthyl-based NHC 
ligands must be performed. 
In the attempt to create a catalyst displaying at the same time high activity and 
good stability we decided to substitute one of the two naphthyl side chains with a 
bulky di-substituted aryl moiety. The obtained compound was no more present in 
solution as a mixture of diastereoisomers (syn and anti) but as a racemic mixture of 
enantiomers (Figure 7). 
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Figure 7. Structure of compound 18 (above); comparison of the catalytic performance 
of the anti isomers of catalysts 3, 4, 16, 17, and 18 (below). 
 
To evaluate the catalytic activity of 18 we collected kinetic data using again 
substrates 7 and 8. In figure 7 are reported the obtained results, compared with the one 
recorded using the other catalysts. We were pleased to observe that indeed catalysts 
18 present good activity. These observations, together with the easier synthesis and 
purification, make 18 and its congeners featuring similar NHC design an appealing 
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candidate for future catalyst development and for future applications in organic 
synthesis. 
 
2.2 Experimental Section 
 
General procedures. All reactions were carried out using standard Schlenk or 
glovebox (Mecaplex or Innovative Technology) techniques under nitrogen. All 
reagents were used as received unless otherwise noted. Solvents were purchased in 
the best quality available, degassed by purging thoroughly with nitrogen and dried 
over molecular sieves of appropriate size. Alternatively, they were purged with argon 
and passed through alumina columns in a solvent purification system (Innovative 
Technology). Solvents for NMR spectroscopy were degassed with nitrogen and dried 
over molecular sieves. NMR spectra were collected on AV2 400 or AV2 500 MHz 
Bruker spectrometers. Chemical shifts are given in ppm. The spectra were calibrated 
to the residual 1H and 13C of the solvent. Multiplicities are abbreviated as follows: 
singlet (s), doublet (d), triplet (t), quartet (q), doublet-doublet (dd), quintet (quint), 
septet (sept), multiplet (m), and broad (br). High-resolution electrospray ionization 
mass spectrometry was performed on a FinniganMAT 900 (Finnigan MAT95, San 
Jose, CA; USA) double-focusing magnetic sector mass spectrometer (geometry BE). 
GC- MS analysis was done on a Finnigan Voyager GC8000 Top. Elemental analysis 
was done on a Leco CHN-932 analyzer. X-ray crystallography was performed on a 
Nonius KappaCCDarea-detector diffractometer using graphite-monochromated Mo K 
radiation (= 0.71073 Å) and an Oxford Cryosystems Cryostream 700 cooler. 
Compounds 6,13 7,14 8,15 9,16 10,17 11,18 12,19 13,20 14,21 and 15,22 were prepared 
according to literature procedures. 
 
Synthesis of the catalyst 
 
Synthesis of catalyst 3 
 
In a glovebox, a ca. 1:1 anti/syn mixture of complex 1 (0.100 g, 0.097 mmol) and 
CuCl (0.011 g, 0.110 mmol) were placed in a Schlenk tube and methylene chloride (4 
 41 
ml) was added. Styrene e (0.046 g, 0.180 mmol), dissolved in methylene chloride (4.0 
ml), was then added and the resulting bright violet solution was stirred at 45°C for 90 
min. During this time the color moves to brown and, when the reaction is completed, 
to dark green. The solvent was evaporated and the crude catalyst was purified by 
column chromatography (Hexane – CH2Cl2 6:4 to 1:1) to afford the two conformers 
anti-3 (0.042 g, 0.048 mmol) and syn-3 (0.021 g, 0.024 mmol) in 63% overall yield. 
 
Data for anti-3 are as follows: 
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1H NMR (CD2Cl2, 400 MHz): δ 16.3 (s, 1H), 8.2 (br, 4H), 7.85 (d, J = 8.4 Hz, 2H), 
7.64 (d, J = 8.4 Hz, 2H), 7.44 (d, J = 7.3 Hz, 2H), 7.27 (m, 6H), 6.82 (t, J = 7.5 Hz, 
1H), 6.65 (dd, J = 7.55 – 1.5 Hz, 1H), 4.44 (s, 4H), 4.22 (sept, J = 6.3 Hz, 1H), 4.15 
(br, 2H), 3.13 (sept, J = 7.0 Hz, 2H), 1.4 (m, 24H), 0.67 (d, J= 6.2 Hz, 3H), 0.62 (d, J 
= 6.2 Hz, 2H). 13C NMR (CD2Cl2, 100 MHz): δ 294.2, 213.4, 149.5, 148.1, 146.8 
(br), 139.7, 133.3, 132.3, 131.8, 130.1, 129.8, 128.9, 128.1, 127.9, 126.8 (br), 123.8, 
123.7, 122.4 (br), 121.5, 77.8, 34.9, 32.1, 29.5, 26.2, 24.0, 23.6, 23.2, 23.1, 20.59, 
20.6, 14.4. MS (ESI) calculated for C51H58N2O1Cl2Ru1: 887.0. Found 851.5 [M-Cl]+. 
HRMS (ESI) calculated for 12C51H5814N2O135Cl2104Ru: 888.9950. Found 818.3850 
[M-2Cl]+. Elemental analysis calculated for C51H58N2O1Cl2Ru1: C 69.06, H 6.59, N 
3.16; found C 69.37, H 6.74, N 2.89. 
 
Data for syn-3 are as follows: 
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1H NMR (CD2Cl2, 400 MHz): δ 16.3 (s, 1H), 8.2 (br, 4H), 7.85 (d, J = 8.4 Hz, 2H), 
7.64 (d, J = 8.4 Hz, 2H), 7.44 (d, J = 7.3 Hz, 2H), 7.27 (m, 6H), 6.82 (t, J = 7.5 Hz, 
1H), 6.65 (dd, J = 7.55 – 1.5 Hz, 1H), 4.44 (s, 4H), 4.22 (sept, J = 6.3 Hz, 2H), 4.15 
(br, 1H), 3.13 (sept, J = 7.0 Hz, 2H), 1.4 (m, 24H), 0.67 (d, J= 6.2 Hz, 3H), 0.62 (d, 
J= 6.2 Hz, 2H). 13C NMR (CD2Cl2, 400 MHz): 295.1, 213.6, 149.6, 148.0, 147.4, 
146.7 (br), 139.8, 133.4, 132.4, 131.8, 129.8, 129.4, 128.9, 128.1, 125.9 (br), 123.9, 
123.7, 123.5 (br), 121.5, 77.9, 35.3, 30.3, 29.6, 26.1, 24.5, 23.9, 22.9, 22.3, 20.3, 12.3. 
MS (ESI) calculated for C51H58N2O1Cl2Ru1: 887.0. Found 851.5 [M-Cl]+. HRMS 
(ESI) found 851.3272 [M-Cl]+. Elemental analysis calculated for C51H58N2O1Cl2Ru1: 
C 69.06, H 6.59, N 3.16; found C 69.00, H 6.69, N 3.11. 
 
Synthesis of catalyst 4 
 
In a glovebox, a ca. 4:1 anti/syn mixture of complex 2 (100 mg, 0.099 mmol) and 
CuCl (30 mg, 0.300 mmol) were placed in a Schlenk tube and methylene chloride (5 
ml) was added. Styrene e (51 mg, 0.200 mmol) in methylene chloride (5.0 ml) was 
then added and the resulting bright violet solution was stirred at 45° C for 30 min. 
During this time the color changes to brown and, when the reaction is completed, to 
dark green. The solvent was evaporated and the crude catalyst was purified by column 
chromatography (Hexane – CH2Cl2 6:4 to 1:1) to afford the desired product anti-4 (54 
mg, 0.061 mmol) in 62%. 
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1H NMR (CD2Cl2, 400 MHz): δ 16.22 (s, 1H), 8.43 (br, 2H), 8.03 (d, J = 8.3 Hz, 2H), 
7.92 (d, J = 8.0 Hz, 2H), 7.65 (m, 4H), 7.50 (t, J = 7.1 Hz, 2H), 7.24 (m, 5H), 7.14 
(dd, J = 5.52 – 1.6 Hz, 1H), 6.72 (t, J = 7.5 Hz, 1H), 6.38 (dd, J = 7.6 – 1.6 Hz, 1H), 
4.44 (m, 4H), 4.2 (sept, J = 6.2 Hz, 1H), 6.34 (m, 2H), 2.0 – 1.2 (m, 20H), 0.62 (d, J = 
6.2 Hz, 3H), 0.58 (d, J = 6.2 Hz, 3H). 13C NMR (CDCl3, 100 MHz): δ 295.7, 214.8, 
149.3, 147.3, 145.3, 139.7, 133.2, 133.1, 131.9, 131.2, 131.1, 129.6, 129.3, 128.4, 
127.9, 127.6, 127.3, 126.2, 125.5, 123.1, 121.6, 54.7, 40.0, 32.7, 27.8, 26.9, 26.8, 
20.5, 20.4. MS (ESI) calculated for C51H54N2O1Cl2Ru1: 882.3. Found 846.8 [M-Cl]+. 
HRMS (ESI) calculated for 12C51H5414N2O135Cl296Ru1: 841.30007. Found 841.30004 
[M-Cl]+. Elemental analysis calculated for C51H54N2O1Cl2Ru1: C 69.37, H 6.16, N 
3.17; found C 69.01, H 6.27, N 3.16. 
 
Comments and spectra of crude mixtures of 3 and 4 
 
Column chromatography of 3 and 4 leads to some degradation of the complexes. This 
is the reason why the syn-isomer of complex 4 could not be recovered and the initial 
anti/syn mixture of 3 is not maintained (1:1 going to 2:1). 1H NMR spectra of crude 
mixtures of 3 and 4 before column chromatography are shown below to illustrate this 
point. 
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Figure S1. 1H NMR spectrum (C6D6, 10°C) of a crude mixture of anti/syn-3. 
Zoomed-in regions show benzylidene signals and H8-protons of the naphthyl side 
chains. 
 
 
 
 
Figure S2. 1H NMR spectra (C6D6, 10°C) of a crude mixture of anti/syn-4 (above, 
before column chromatography) and of anti-4 (below, after column chromatography). 
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Zoomed-in regions show benzylidene signals and H8-protons of the naphthyl side 
chains. 
 
Synthesis of the styrene precursor 
 
The synthesis of e follows a combination of standard synthetic procedures. However, 
the synthetic pathway to e shown below is more scalable than other procedures 
insofar as it does not need any chromatographic workup. 
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Scheme S1. Procedure for the synthesis of the styrene derivative 
 
2-Bromo-6-phenylphenol (b): The procedure reported from Mu23 was used with 
some modification. Br2 (2.9 ml, 56.40 mmol) was added drop wise to a solution of 
Me2NH (7.5 ml of a 7.9 M solution in water, 58.0 mmol) and NaOH (4.50 g, 113.00 
mmol) in 50 ml of water cooled to -20°C. The mixture was stirred for 30 minutes at 
this temperature and extracted with toluene (70 ml). The organic layer was separated 
and dried with MgSO4 to give a yellow solution of Me2NBr which was added to a 
solution of 2-phenyl-phenol (a, 8.50 g, 51.70 mmol) in toluene (250 ml) cooled to - 
20°C. The mixture was stirred for 1 hour at room temperature and the formation of a 
white solid was observed. After completion of the reaction, a solution of HCl (5%) 
was added (50 ml) and the organic layer was extracted with water (300 ml). After 
evaporation of the solvent, a yellow oil was obtained. This was filtered through silica 
gel (30 g, Hexane : CH2Cl2 1:1) to afford a colorless oil that, dissolved in hexane and 
cooled to -20°C overnight, forms white needle crystals (10.90 g, 85 % yield). The 
analytical data were consistent with the ones reported in literature.23 
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3-Bromo-2-Isopropoxybiphenyl (c): Compound b (10.00 g, 40.10 mmol) was 
dissolved in acetone and NaOH (1.70 g, 42.20 mmol) was added as a solid. The 
solution was refluxed until almost complete dissolution of the base was observed and 
then 2- bromopropane (9.5 ml, 100.0 mmol) was added in portions with a syringe. 
The obtained solution was refluxed until completion of the reaction (around 18 h). It 
was cooled to room temperature and water (100 ml) was added followed by diethyl 
ether (200 ml). The organic layer was washed with brine (100 ml), separated, dried 
over MgSO4, filtered, and concentrated to give a yellow oil that was filtered through 
silica (30 g, Hexane: CH2Cl2 20:1) to afford 10.2 g of the desired compound c. 1H 
NMR (CDCl3, 400 MHz): δ 7.55 (m, 3H), 7.42 (m, 2H), 7.35 (m, 1H), 7.27 (d, J = 7.8 
Hz, 1H), 7.05 (t, J = 7.8 Hz, 1H), 3.95 (sept, J = 7.6 Hz, 1H), 1.05 (d, J = 7.6 Hz, 1H). 
13C NMR (CDCl3, 100.6 MHz): 152.6, 138.9, 137.8, 132.7, 130.5, 129.4, 128.4, 
127.6, 124.9, 119.6, 76.4, 22.25. MS (EI) m/z calculated for C15H15OBr (M+) 291.2, 
observed 292.2 [M+1]. 
 
2-Isopropoxybiphenyl-3-carbaldehyde (d): Compound c (5.35 g, 18.40 mmol) was 
dissolved in 100 ml of THF and cooled to -78°C. n-BuLi in hexane (20.20 mmol) was 
then added dropwise. The obtained solution was stirred for two hours at this 
temperature and then DMF (7.1 ml, 92.00 mmol) was slowly added via syringe. The 
reaction was stirred for 10 minutes and subsequently quenched by the addition of 
water (100 ml) followed by diethyl ether (200 ml). The organic layer was washed 
with brine, separated, dried over MgSO4, filtered, and then concentrated to give a 
yellow oil. This was filtered through silica gel (40 g, Hexane : CH2Cl2 to only 
CH2Cl2) to give the desired product d (3.52 g, 79.8 %). The analytical data were 
consistent with the ones reported in literature.24 
 
2-Isopropoxy-3-vinylbiphenyl (e): To a suspension of methyl-triphenylphosphonium 
bromide (6.30 g, 17.60 mmol) in 150 ml of THF was added NaOtBu (1.97 g, 20.60 
mmol) as a solid in small portions. The obtained bright yellow mixture was stirred for 
1 h at room temperature under nitrogen and then it was cooled to -78°C. d (3.50 g, 
14.70 mmol) was added dropwise dissolved in 10 ml of THF. The reaction was 
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allowed to warm to room temperature, then quenched with water, followed by diethyl 
ether (100 ml). The organic layer was washed with brine, separated, dried over 
MgSO4, filtered, and concentrated to give a colorless oil. Hexane (50 ml) was added 
and the immediate formation of a precipitate was observed. The supernatant hexane 
solution was decanted and the precipitate was washed twice with hexane (100 ml). 
Hexane fractions were then collected and dried to give a colorless oil. After filtering 
on a pad of silica gel (20 g, Hexane : CH2Cl2 9:1), the desired product e was obtained 
(3.44 g, 99 %). The analytical data were consistent with the one reported in 
literature.25 
 
Procedures for metathesis reactions 
 
Comments 
 
-) Due to the low catalyst loading used, catalytic runs can be rather sensitive to 
impurities present in the substrates. For example, we find that ethyl acetate should be 
avoided as an eluent for the chromatographic purification of the substrates. Neat runs 
with substrates obtained in that manner were found to be less efficient. 
 
-) The dependence of reaction concentration on the RCM activity is most probably not 
limited to Blechert-type precatalysts. In our first RCM study,26 the time needed for 
GII to convert substrate 6 (RT, CH2Cl2) into the ring-closed product was taken from 
the literature (90 min for ca. 98% conversion at 0.01M).27 In our more recent report,12 
we performed kinetic studies with 6 and GII and found that less than 20 minutes were 
needed for the reaction to go to >98% conversion (at 0.1M). 
 
-) 1H NMR analysis of neat reaction runs with GII (see manuscript) contain 1-2% of 
an unidentified product that is neither the starting nor the final compound. 
 
General procedure for kinetic study  
 
A screw capped NMR tube was loaded in a glove box with the desired amount of 
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precatalyst dissolved in CH2Cl2 (stock solutions were always freshly prepared adding 
10 ml of dry CH2Cl2 to 0.008 mmol of catalyst) and the solvent was dried. The diene 
(0.08 mmol) dissolved in CD2Cl2 (0.8 ml) was then added via syringe. Data points 
were collected after an appropriate period of time. The conversion was determined by 
comparing the ratio of the integrals of the methylene protons in the starting material 
with those in the product. 
 
General procedure for neat reactions 
 
A 1.5 ml screw capped scintillation vial was charged with the desired amount of 
precatalyst dissolved in CH2Cl2 and the solvent was removed in vacuum. A stirring 
bar was introduced into the vial and the desired amount of diene was added via 
syringe. Immediately, the color of the solution turns from transparent to pink and 
evolution of gas is observed. The reaction was followed by GC-MS analysis. When 
the reaction was completed an NMR of the crude mixture was recorded to determine 
the final conversion and the eventual presence of oligomers. The crude residue was 
then filtered on silica gel. For compounds in which the desired metathesis product 
was a solid (6, 8, 9 and 13) only moderate yields were observed (between 50 and 60 
%) using this procedure. 
 
General procedure for reaction in hexane solution 
 
A 1.5 ml screw capped scintillation vial was charged with the desired amount of 
precatalyst dissolved in CH2Cl2 and the solvent was removed in vacuum. Hexane was 
then added and the resulting solution was added, via syringe, to a scintillation vial 
containing the desired amount of diene and a stirring bar. After a few seconds, 
formation of a white suspension was observed. Reaction conversion was followed by 
GC-MS (samples of the hexane solution were collected and the consumption of the 
starting material was observed). When the reaction was complete, diethyl ether was 
added and the solution was transferred into a round bottom flask. The solvent was 
evaporated and an NMR of the product was recorded to determine the final 
conversion and the eventual presence of oligomers. 
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Kinetic Data 
 
Kinetic data for substrates 10, 12-14 have been run with anti-3 only (27°C, 0.1M 
CD2Cl2). With a catalyst loading of 0.1 mol%, reaction times were 1 min (10), 6 min 
(12) and 4 min (13). 
 
Reaction curves 
 
 
Figure S3. RCM of 5, using 0.1 mol% of the respective catalysts (27°C, 0.1M, 
CD2Cl2). 
 
 
Figure S4. RCM of 6, using 0.1 mol% of the respective catalysts (27°C, 0.1M 
CD2Cl2). 
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Figure S5. RCM of 7, using 0.1 mol% of the respective catalysts (27°C, 0.1M 
CD2Cl2). 
 
 
Figure S6. RCM of 8, using 0.1 mol% of the respective catalysts (27°C, 0.1M 
CD2Cl2). 
 
 51 
 
Figure S7. RCM of 9, using 2 mol% of the respective catalysts (30°C, 0.1M CD2Cl2). 
 
 
Figure S8. RCM of 11, using 0.1 mol% of the respective catalysts (27°C, 0.1M 
CD2Cl2). 
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Figure S9. RCM of 14, using 0.1 mol% of anti-3 (27°C, 0.1M CD2Cl2). 
 
 
Figure S10. RCM of 15, using 0.2 mol% of the respective catalysts (27°C, 0.1M 
CD2Cl2). 
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Figure S11. RCM of 7, using 0.1 mol% of anti-3 at different solvent concentrations 
(CD2Cl2) . For runs at 0.4M and 0.8M, ethylene formed during the reaction is released 
by piercing the screw-cap septum of the NMR tube every 3-5 minutes (the same 
procedure when applied for 0.1M has practically no effect on the outcome). 
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2.4 Additional experimental data 
 
General procedure for the improved one-pot synthesis of the catalyst: 
 
In a glovebox the desired carbene (1 eq) was dissolved in toluene and GI was added 
(1 eq). The obtained dark violet solution was stirred for 24 h and then the conversion 
was checked via 31P NMR. If the conversion was not complete after this time another 
0.2 eq of carbene were added and the mixture was stirred until from 31P NMR almost 
full conversion was obtained. The solvent was then evaporated and the obtained dark 
red foam was dried in high vacuum for 3 h. CuCl (3 eq), the desired styrene 
compound (3 eq) and dry CH2Cl2 (a 0.2 M solution was used) were then added and 
the obtained suspension was refluxed (43°C) for 1.5 h under nitrogen. The color of 
the reaction mixture became brown and then, upon completion of the reaction, dark 
green. The solvent was evaporated and the flask was transferred into the glovebox. 
The green foam was dissolved in 2 ml of CH2Cl2 and directly charged into a silica gel 
filter (1x15 cm). The solid obtained after chromatography was usually dissolved in 
the minimal amount of hexane (or Hexane-CH2Cl2) and then crystallized at -35 °C to 
eliminate the impurity residue. 
 
Catalyst syn-4: 
 
N
N
Ru O
Ph
Cy
ClCl
Cy
 
 
Chromatography: Hexane to Hexane-CH2Cl2 to elute the styrene in excess; Hexane-
CH2Cl2 to elute the first isomer (anti) and then only CH2Cl2 to obtain the second 
isomer (sin). Microcrystalline product obtained from fraction two cooling for 3 days 
at -35°C a concentrated solution of the catalyst in pentane. 1H NMR (C6D6, 400 
MHz): δ 16.55 (s, 1H), 8.82 (d, J = 8.6 Hz, 2H), 7.93 (d, J = 8.7 Hz, 2H), 7.75 (m, 
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4H), 7.62 (d, J = 8.6 Hz, 3H), 7.39 (m, 1H), 6.95-6.85 (m, 4H), 6.68 (m, 1H), 6.48 (m, 
1H), 4.45 (hept, J = 6.2 Hz, 1H), 4.00-3-65 (m, 6H), 2.20-0.90 (m, 20H), 0.85 (d, J = 
7.8 Hz, 6H). 13C NMR (C6D3, 100 MHz): δ 292.8, 292.7, 215.3, 149.9, 148.3, 140.2, 
134.0, 133.1, 131.9, 130.9, 130.2, 129.8, 129.7, 129.5, 128.8, 128.7, 128.6, 128.0, 
127.9, 127.5, 126.8, 125.8, 124.2, 123.6, 121.5, 78.0, 75.1, 31.2, 30.8, 28.7, 27.5, 
27.4, 27.2, 26.8, 22.5, 20.7. Elemental analysis calculated for C51H54N2O1Cl2Ru1: C 
69.37, H 6.16, N 3.17; found C 68.16, H 6.49, N 2.63. 
 
Catalyst 16: 
 
N
N
Ru O
Ph
Cy
ClCl
iPriPr
 
 
Chromatography: Hexane to Hexane-CH2Cl2 to elute the styrene in excess. Only 
CH2Cl2 to elute the product. 1H NMR (CD2Cl2, 400 MHz): δ 16.50 (s, 1H), 8.61 (d, J 
= 8.2 Hz, 1H), 7.96 (d, J = 8.6 Hz, 1H), 7.84 (d, J = 8.1 Hz, 1H), 7.65 (m, 3H), 7.45 
(m, 3H), 7.32-7.18 (m, 6H), 6.87-6.74 (m, 2H), 4.50-4.20 (m, 5H), 3.82 (s, broad, 
1H), 3.48 (s, broad, 1H), 3.32 (s, broad, 1H) 2.0-0.8 (m, 22H), 0.70-0.50 (m, 6H). 13C 
NMR (CDCl3, 100 MHz): δ 295.1, 294.9, 214.0, 149.4, 149.1, 147.5, 145.9, 139.7, 
133.3, 133.2, 131.4, 131.2, 130.3, 129.7, 129.4, 129.1, 128.3, 128.2, 127.7, 127.4, 
126.5, 126.0, 125.2, 125.0, 124.9, 123.1, 121.6, 55.4, 53.8, 40.7, 37.2, 34.9, 34.7, 
34.3, 32.1, 31.8, 28.7, 28.5, 27.9, 27.1, 26.9, 26.7, 25.5, 24.0, 23.9, 22.8, 22.5, 22.3, 
20.9, 20.5, 20.3, 14.3, 14.2. HRMS (ESI) calculated for C47H54N2O1Cl2Ru1: 
834.2656. Found 799.2977 [M-Cl]+. Elemental analysis calculated for 
C47H54N2O1Cl2Ru1: C 67.61, H 6.52, N 3.36; found C 64.89, H 6.27, N 3.16. 
 
Catalyst 17 
 
 
Chromatography: Hexane to Hexane-CH2Cl2 8:1 to elute the styrene in excess. 
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Hexane-CH2Cl2 1:1 to elute the first isomer (anti). Only CH2Cl2 was used to elute the 
second isomer.  
 
anti-17 
 
N
N
Ru O
Ph
R
ClCl
R
R =
 
 
Crystals suitable for X-Ray diffraction were obtained by slow evaporation of a 
mixture of catalyst in Hexane-CH2Cl2. 1H NMR (C6D6, 400 MHz): δ 16.50 (s, 1H), 
8.68 (d, J = 8.7 Hz, 2H), 7.87 (d, J = 8.7 Hz, 2H), 7.78 (d, J = 8.2 Hz, 2H), 7.70 (t, J = 
7.2 Hz, 2H), 7.60 (d, J = 8.6 Hz, 2H), 7.35 (m, 4H), 6.95 (m, 4H), 6.60 (m, 1H), 6.50 
(m, 1H), 4.45 (m, 1H), 4.00 (m, 6H), 2.20-0.80 (m, 34H). 13C NMR (C6D6, 100 
MHz): δ 291.6, 291.5, 217.9, 150.5, 148.4, 140.5, 140.1, 134.0, 132.8, 132.6, 132.2, 
130.1, 129.8, 129.4, 128.9, 128.0, 127.7, 127.5, 126.7, 126.2, 126.0, 123.6, 121.1, 
78.3, 76.6, 54.9, 40.3, 39.0, 32.3, 27.6, 23.4, 22.6, 22.5, 21.8, 20.8, 20.7, 15.5, 15.4, 
14.7. HRMS (ESI) calculated for C51H58N2O1Cl2Ru: 914.3282. Found 879.3598 [M-
Cl]+. Elemental analysis calculated for C51H58N2O1Cl2Ru1*H2O: C 68.22, H 6.91, N 
3.00; found C 68.42, H 6.89, N 3.01. 
 
syn-17 
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N
N
Ru O
Ph
R
ClCl
R
R =
 
 
 
1H NMR (C6D6, 400 MHz): δ 16.7 (s, 1H), 8.98 (d, J = 8.6 Hz, 2H), 7.91 (d, J = 8.5 
Hz, 2H), 7.78 (m, 4H), 7.62 (d, J = 8.7 Hz, 2H), 7.38 (m, 4H), 6.98 (m, 4H), 6.68 (m, 
1H), 6.52 (m, 1H), 4.43 (m, 1H), 4.04 (s, broad 4H), 3.80 (s, broad, 2H), 2.00-0.80 
(m, 34H). 13C NMR (C6D6, 100 MHz): δ 292.2, 292.0, 216.2, 150.5, 148.3, 140.1, 
134.0, 132.8, 132.2, 129.8, 129.5, 128.8, 128.0, 127.5, 127.0, 126.3, 123.6, 121.2, 
78.4, 54.9, 40.2, 39.8, 38.3, 22.5, 21.8, 20.7, 15.5, 15.3. HRMS (ESI) calculated for 
C51H58N2O1Cl2Ru: 914.3282. Found 879.3598 [M-Cl]+. Elemental analysis calculated 
for C51H58N2O1Cl2Ru1: C 69.57, H 6.83, N 3.06; found C 69.00, H 6.74, N 3.04. 
 
Catalyst  anti-18 
 
N
N
Ru O
Ph
R
ClCl
R
R =
 
 
1H NMR (C6D6, 400 MHz): δ 16.55 (s, 1H), 8.65 (s, broad, 2H), 7.85 (d, J = 8.7 Hz, 
2H), 7.70 (m, 4H), 7.53 (d, J = 8.6 Hz, 2H), 7.35 (t, J = 5.6 Hz, 2H), 7.17 (2H, 
overlapped with solvent signal) 6.85 (m, 4H), 6.55 (m, 1H), 6.42 (m, 1H), 4.37 (hept, 
J = 6.2 Hz, 1H), 4.15-3.70 (m, 6H), 2.20-1.60 (m, 20H), 0.75 (d, J = 7.8 Hz, 6H). 13C 
NMR (C6D6, 100 MHz): δ 293.2, 293.1, 216.3, 150.1, 150.0, 148.4, 140.1, 133.8, 
133.1, 132.2, 132.0, 130.1, 130.0, 129.5, 128.9, 128.8, 128.7, 127.6, 126.6, 126.3, 
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126.0, 123.6, 121.3, 78.1, 76.5, 39.5, 28.1, 27.0, 22.6, 20.7, 20.6. Elemental analysis 
calculated for C55H62N2O1Cl2Ru1: C 70.35, H 6.65, N 2.98; found C 70.17, H 6.63, N 
2.98. 
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3.1 Abstract 
 
Eight new N-heterocyclic carbenes (NHCs) featuring substituted naphthyl side chains 
were synthesized. These molecules are present in solution as a stable mixture of anti 
and syn conformers. Through careful tuning of the substituents on position 2 and 2,7 
of the naphthyl side chains, it was possible to synthesize molecules that display a 
strong preference for the anti conformation (up to 95:5). This will greatly facilitate 
their optimized use as single isomeric ligands in metal-catalysis and as 
organocatalysts on their own. 
 
3.2 Introduction    
 
The affirmation of N-heterocyclic carbenes as ligands for transition metals 
catalysts and as organic catalysts proved to be an important innovation in the field of 
catalysis.1,2 Especially useful in this respect (so far) have been N-heterocyclic 
carbenes with five-membered heterocyclic structures first reported by Arduengo et al., 
such as imidazol-2-ylidene A and the saturated heterocyclic imidazolidin-2-ylidene 
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derivatives B.3,4 
 
N N
Me
MeMe Me
Me
Me
A
N N
B  
 
Whereas dozens of structural variations of NHCs A and B exist nowadays, the 
overwhelming majority incorporates the unsaturated central N-heterocycle of A. The 
reason for this lies in the surprisingly different stabilities of unsaturated and saturated 
NHCs. While dimerization of aromatically stabilized N-heterocyclic carbenes of type 
A is thermodynamically unfavorable even for small N-substituents like R = Me,5,6 
formation of the enetetramine dimer of B occurs readily. This renders saturated NHCs 
considerably less amenable to catalysis and restricts access to stable modifications of 
this ligand class, as the substituents at the nitrogen atoms need to be very bulky. The 
demarcation line separating stable from unstable carbenes may be established and lies 
somewhere between tBu/iPr for N-alkyl substituents and Mes/Ph for aromatic side 
chains.7,8,9 
In catalysis, work in the last decade has shown that monodentate NHCs with 
bulky, aryl-substituted side chains are the overall most successful design. As such, 
2,4,6-mesityl-substituted IMes and 2,6-isopropylphenyl-substituted IPr and their 
saturated imidazolin-2-ylidene counterparts (SIMes and SIPr) still remain the only 
ligands that represent a truly viable alternative to phosphines, in terms of both 
versatility and reactivity.  
Our entry in this fascinating field of research began with the design and the 
synthesis of stable saturated free carbenes that feature substituted naphthyl side 
chains.10 We reasoned that this architecture would mimic well the original SIMes and 
SIPr ligand systems, offering at the same time a scaffold that is less hindered in 
proximity to the potential metal binding site and that can be functionalized more 
readily with a wide range of substituents, tuning both its steric and electronic 
properties. The substitution pattern confers to these molecules a high degree of 
conformational stability, generating in solution a mixture of anti and syn conformers 
(Figure 1). 
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Figure 1. Imidazolin-2-ylidenes with phenyl (left) and naphthyl (right) side chains. 
 
Detailed NMR study on the fluxional behavior of this class of carbenes showed 
that, even at high temperature, interconversion between the conformers is not possible 
if sterically demanding substituents are present in position 2 of the naphthyl side 
chains (R1 in Figure 3.1).11 This encouraged us to attempt the separation of the syn 
and anti isomers for some of these molecules but this process, up to now, has been 
successful only when the NHC was incorporated into a stable metal complex. Recent 
studies performed in our laboratory also indicated that, for some type of metal-
catalyzed transformations, organometallic catalysts containing NHCs in the anti 
isomeric form perform better then the ones in the syn form.12 
These reasons prompted us to attempt the synthesis of molecules displaying a 
conformational preference for only one of the two isomers. Herein, we describe the 
synthesis of a series of new saturated NHCs that incorporate alkylated naphthyl side 
chains. With the aim of minimizing the formation of the syn isomer, we selected a 
bulky, linear alkyl substitutent as well as more rigid, cyclic alkyl derivatives of 
various sizes 
 
3.3 Results and Discussion 
 
Synthesis of free NHCs began with the preparation of mono and dialkylated 
naphthalene rings. Compounds 1a-d were obtained starting from 2-bromonaphthalene 
and the desired alkyl halide via an iron-catalyzed Csp2-Csp3 coupling adapting a 
procedure reported recently by Cahiez et al. (Scheme 2).13 After initial formation of 
the mono-Grignard derivative of naphthalene, the solution/suspension was added to 
the respective alkylbromide solution in THF containing the (FeCl3)2(TMEDA)3 
catalyst (4.6 mol% Fe).  
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Scheme 1. General synthesis of new 2- and 2,7-substituted naphthalenes. 
 
1a R = 4-heptyl 
1b R = cyclopentyl
1c R = cycloheptyl
1d R = cyclooctyl
RMgBr
iii)
Reaction conditions: i) Mg, THF, I2 (cat.), r.t. ii) Mg, THF, I2 (cat.), reflux 2h; 
iii) (FeCl3)2(TMEDA)3 (cat.), THF, RBr
RRMgBrBrMg 1e R = cyclopentyl1f  R = cyclohexyl
1g R = cycloheptyl
1h R = cyclooctyl
i)
Br
BrBr ii) iii)
y = 92 %
y = 64 %
y = 89 %
y = 72 %
y = 35 %
y = 46 %
y = 31 %
y = 37 %
 
 
After appropriate aqueous workup, elimination of naphthalene, the main byproduct of 
the reaction, was easily achieved via sublimation under high vacuum. The reaction 
proceeded in all cases with good yields, apparently unaffected by the increasing 
bulkiness of the alkyl halide employed (Scheme 1). 
Compounds 1e-h were obtained in a similar manner, starting from 2,7-
dibromonaphthalene.14 Generation of the di-Grignard reagent, required for the 
subsequent coupling reaction, proceeded without problems when heating a THF 
solution at reflux temperature for several hours. The resulting di-Grignard compound 
can be used directly as a heavy suspension in THF or it can be isolated under nitrogen 
as a white stable powder after evaporation of the solvent. The di-Grignard is then 
slowly added (as powder or as suspension) to the mixture of catalyst (7 mol% Fe) and 
alkyl bromide, resulting in a rapid color change of the reaction to dark brown/black 
and this color was maintained upon completion of the reaction. After standard 
aqueous work up,15 the final purification of the product was performed via bulb-to-
bulb high vacuum distillation (Kugelrohr) to separate the desired product from the 
monoalkylated naphthalene compound (the main secondary product of the reaction) 
and from naphthalene. This purification method allowed to easily scale-up the 
reaction to (at least) 10 grams. The isolated yields were generally not very high (35 to 
45 %), but the reaction procedure proved to be robust and suitable for a wide range of 
commercially available bromoalkanes. Indeed and to the best of our knowledge, these 
are the first examples reported in the literature of an iron-catalyzed double Kumada-
type Csp2-Csp3 coupling. 
Bromination of the alkylnaphthalenes (Scheme 2) was achieved in all cases with 
excellent yield and with perfect regioselectivity for position 1 of the naphthalene 
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when performing the reaction at low temperature (-78 °C) using equimolar amounts 
of Br2 with CH2Cl2 as the solvent.16 The control of the temperature is particularly 
important for 2-alkylnaphthalenes; when the reaction is performed at 0 °C, a mixture 
of regioisomers is obtained whose separation by column chromatography is not 
trivial.17 Quenching of the reaction involved addition of a diluted aqueous solution of 
NaOH to the reaction solution at -78 °C, as the more commonly used Na2S2O3 agent 
was found to sometimes interfere with the subsequent metal-catalyzed reaction step. 
This double Buchwald-Hartwig coupling with ethylenediamine in the presence of 
Pd2(dba)3 (mol%), (±)-BINAP (10 mol%) and NaOtBu (eq) generated diamines 3a-h 
in good yield and high purity after chromatographic purification. 
 
Scheme 2. General synthesis of the free NHCs featuring naphthyl side chains. 
 
R1
H
i)
N N
R1
R1
BF4
4a-4h 5a-5h
iv)
Reaction conditions: i) Br2, CH2Cl2, -78°C; ii) ethylenediamine, Pd2(dba)3, rac-BINAP, 
NaOtBu, toluene, 110°C; iii) NH4BF4, HCO2H (cat.), HC(OEt)3, 100°C, iv) NaH, 
KOtBu (cat.), THF.
R2
R2
R2
N N
R1
R1
R2
R2
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R1
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Finally, following the procedure originally reported by Grubbs et al.,18 ring-
closing of the respective diamines in the presence of triethyl orthoformate as 
reagent/solvent and NH4BF4 furnished the desired imidazolinium salts 4a-h in 
generally good yields. Table 1 reports the yields for the ring formation step and the 
ratio of conformers (syn respectively anti) observed. To have a more general 
overview, data concerning naphthyl-based NHC salts already reported by our group 
are also shown. 
Tendentially, yields are slightly lower when starting with diamines that contain 
very bulky substituents in position 2 of the naphthalene moiety (Table 1, entries 1-7) 
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and with precursor molecules with 2,7-dialkylated precursors (Table 1, entires 8-13), 
probably reflecting an increasingly difficult approach of the nucleophile in the 
reaction sequence. 
Concerning the syn/anti-ratio of the NHC salts, we note that when small alkyl 
groups and linear, flexible alkyl chains are present in positions 2 or 2,7 of the 
naphthalene rings (entries 1-3 and 8-9 in Table 1), the two possible conformers were 
formed in almost equal amounts. The same trend was observed when a small, cyclic 
ring was present in position 2 or 2,7 (entry 4 and 10 in Table 1). Increasing 
progressively the bulkiness of the cyclic alkyl substituents (entries 5-7 in Table 1) 
favors the formation of the anti conformer. When large cyclic alkyl groups are present 
in both positions 2 and 7, the syn conformer becomes strongly disfavored and, in the 
best case (entry 11), a 95:5 anti-syn ratio is obtained. 
 
Table 1. Yields and syn-anti ratio for compounds 4a-4h and previously reported 
imidazolinium salts containing naphthalene wingtips. 
 
(2)-SIHeptNap.HBF4 (4a)
imidazolinium salt syn-anti ratioa
(2)-SICypentNap.HBF4 (4b)
(2)-SICyheptNap.HBF4 (4c)
(2)-SICyoctNap.HBF4 (4d)
(2,7)-SICypentNap.HBF4 (4e)
(2,7)-SICyNap.HBF4 (4f)
(2,7)-SICyheptNap.HBF4 (4g)
(2,7)-SICyoctNap.HBF4 (4h)
(2)-SIMeNap.HBF4b
(2,7)-SIPrNap.HBF4b
(2)-SICyNap.HBF4b
50 : 50
22 : 78
17 : 83
50 : 50
5 : 95
15 : 85
10 : 90
50 : 50
50 : 50
27 : 72
50 : 50
43 : 57
(2)-SIPrNap.HBF4b
yield (%)
75
58
60
35
50
48
29
88
56
78
60
75
entry
5
6
7
10
11
12
13
1
9
4
2
3
(2,7)-SIMeNap.HBF4b 50 : 50808
a The ratios were deduced from NMR analysis. b These 
compounds have been reported before (ref. 10)  
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Finally and not surprisingly given our precedent studies, the NHC salts 4a-h 
could be cleanly converted to free monomeric NHCs 5a-h (Scheme 3), via 
deprotonation of the imidazolinium proton in THF with NaH in the presence of a 
catalytic amount of potassium tert-butoxide. 1H NMR spectroscopy at 300 K of 
carbenes 5a-h revealed two sets of signals corresponding, within error, to the ratio of 
anti/syn isomers found in the starting imidazolinium salts. This in turn means that a 
sufficiently high barrier to rotation between the conformers exists and that no 
interconversion occurs during and after the deprotonation step. 
 
 
 
 
 
 74 
 
Figure 2. Ellipsoid drawings (30 % probability) of 4c (top), 4f (middle) and 4g 
(bottom). Hydrogen atoms (except for imidazolinium and backbone hydrogen atoms) 
and counterion (BF4-) were omitted for clarity.  
 
Figure 3. Thermal ellipsoid drawing (30 % probability) of 5b. Hydrogen atoms 
(except for backbone hydrogen atoms) were omitted for clarity. 
All of the new imidazolinium salts (4a-h) and free N-heterocyclic carbenes (5a-
h) were fully characterized and include single crystal X-ray diffraction studies of 
compounds 4c, 4f and 4g and free carbene 5b. Thermal ellipsoid drawings of the salts 
are shown in Figure 2 and a representation of 5b can be found in Figure 3. Bond 
lengths and angles of the central five-membered heterocycles of all known 
imidazolinium salts that incorporate naphthyl side chains are given in Tables 2 and 3. 
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These tables also include the respective values for 5b, our previously reported 
NHCs and the other two known structures in the literature, namely SIMes and SItBu.  
 
Table 2. Selected bond lengths of NHC salts with naphthyl wingtips. 
 
anti-(2)-SICyheptNap.HBF4 (4c)
Imidazolinium salt C2—N1(3)
syn-(2,7)-SIPrNap.HCla
anti-(2,7)-SICyheptNap.HBF4 (4g)
syn-(2)-SIPrNapa
anti-(2,7)-SIPrNapa
SIMesb
SItBuc
syn-(2)-SIMeNap.HBF4a
syn-(2,7)-SIMeNapa
anti-(2,7)-SICyNap.HBF4 (4f)
1.311(3), 1.311(3)
anti-(2)-SICyNap.HBF4a
syn-(2)-SICypentNap (5b)
C4—C5 N1(3)—C5(4) N1(3)—CAr
1.522(5) 1.485(3), 1.485(3) 1.440(3), 1.440(3)
1.313(5), 1.306(5) 1.536(6) 1.479(5), 1.470(5) 1.448(5), 1.448(5)
1.308(3), 1.315(3) 1.536(3) 1.484(3), 1.479(3) 1.444(3), 1.454(3)
1.318(4), 1.307(4) 1.528(4) 1.483(4), 1.481(4) 1.442(4), 1.442(4)
1.304(3), 1.310(3) 1.542(3) 1.487(2), 1.491(3) 1.440(2), 1.439(3)
1.308(4), 1.301(4) 1.544(4) 1.496(4), 1.490(4) 1.439(4), 1.455(4)
1.351(2), 1.3498(19) 1.514(2) 1.4814(19), 1.486(2) 1.4266(19), 1.433(2)
1.348(2), 1.351(2) 1.520(2) 1.483(2), 1.484(2) 1.423(2), 1.432(2)
1.344(4), 1.348(4) 1.516(4) 1.480(4), 1.480(4) 1.435(4), 1.433(4)
1.337(3), 1.354(3) 1.519(4) 1.471(3), 1.473(3) 1.432(4), 1.430(3)
1.352(5), 1.345(5) 1.505(6) 1.475(5), 1.487(5) 1.427(5), 1.437(5)
1.348(1), 1.347(1) 1.512(2) 1.475(1), 1.476(1) 1.480(1), 1.480(1)
Free carbenes
 
a For details, see ref. 10. b For details, see ref. 4. c For details, see ref. 8a. 
 
Table 3. Selected bond angles of NHC salts with naphthyl wingtips and of known free 
NHCs. 
 
anti-(2)-SICyheptNap.HBF4 (4c)
imidazolinium salt
syn-(2,7)-SIPrNap.HCla
anti-(2,7)-SICyheptNap.HBF4 (4g)
syn-(2)-SIPrNapa
anti-(2,7)-SIPrNapa
SIMesb
SItBuc
syn-(2)-SIMeNap.HBF4a
syn-(2,7)-SIMeNapa
anti-(2,7)-SICyNap.HBF4 (4f)
anti-(2)-SICyNap.HBF4a
syn-(2)-SICypentNap (5b)
N1—C2—N3 C5(4)—N1(3)—C2 N1(3)—C5(4)—C4(5) C2—N1(3)—CAr
113.1(3) 110.5(2), 110.5(2) 102.95(12), 102.95(12) 128.0(2), 128.0(2)
113.4(4) 110.3(3), 110.6(3) 102.5(3), 102.9(3) 125.2(3), 124.8(3)
113.58(19) 110.41(17), 110.25(17) 102.63(17), 102.98(17) 127.31(18), 126.28(19)
113.5(3) 109.8(2), 109.7(2) 102.1(2), 102.9(2) 124.6(3), 124.8(3)
114.72(18) 109.98(16), 109.50(17) 102.64(16), 102.73(15) 124.91(16), 123.93(17)
114.8(3) 109.5(2), 110.3(2) 102.8(2), 102.4(2) 124.6(2), 124.0(2)
104.77(14) 114.52(13), 114.38(13) 101.25(13), 100.94(12) 124.48(14), 122.38(14)
105.10(14) 114.64(13), 114.35(14) 101.17(13), 101.29(13) 124.13(13), 122.60(14)
104.8(2) 115.5(2), 115.3(2) 101.8(2), 101.9(2) 123.6(2), 124.4(2)
104.5(2) 115.9(2), 115.8(2) 102.3(2), 101.5(2) 125.0(2), 123.9(2)
104.7(3) 115.0(3), 114.6(3) 101.6(4), 101.9(4) 122.9(3), 122.5(3)
106.44(9) 112.51(8), 112.91(8) 101.34(9), 100.96(9) 123.37(9), 123.10(8)
Free carbenes
 
a For details, see ref. 10. b For details, see ref. 4. c For details, see ref. 8a. 
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The average length of the C2–N1(3) bonds in these free carbenes increase only very 
slightly from the average values found in the imidazolinium salts and indicate a 
partial double bond character of these bonds. 
The remaining distances of the five-membered N-heterocycle in both the salts 
and the free carbenes identify these as single bonds. The most apparent change in 
bond angles between imidazolinium salts and free carbenes can be found when 
looking at the N–C–N angles, which are opened in the salts relative to the free 
carbene species. 
 
3.4 Conclusions 
 
A new, regioselective and scalable procedure for the synthesis of 2,7-
disubstituted naphthyl rings was developed and relies on an Iron-catalyzed coupling 
procedure involving alkylbromides and the corresponding Grignard derivatives of the 
naphthalene moieties. These units were then selectively brominated at low 
temperature to give the corresponding 1-bromonaphthalene in quantitative yield. 
Subsequent Buchwald-Hartwig coupling with ethylene diamine and ring-closing gave 
eight new imidazolinium salts. Final deprotonation proceeded smoothly and permitted 
to considerably extend the family of known, stable NHC ligands featuring a saturated 
central N-heterocyclic backbone. Interestingly, through carefully tuning and enlarging 
the substituents on positions 2 or 2,7 of the naphthyl side chains, NHC molecules 
were generated that display a very strong preference to assume only the anti 
conformation. The subtle steric differences of these new structures should allow a 
more thorough investigation of their behavior when used as organocatalysts or as 
monodentate ligands in metal complexes and pertinent research on stoichiometric and 
catalytic activities of these species will be published in due course.  
 
3.5 Supplementary data 
 
All the NHCs presented in this paper were symmetrically substituted in position 
N,N’. Attempt to synthesize unsymmetric compounds were also successfully 
performed (Scheme 3). The main idea in this new type of carbene was to avoid the 
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formation of two diastereoisomers in solution (syn and anti) by simply exchanging 
one of the side chains with a properly substituted phenyl ring (moving from a C2 
symmetric molecule to a Cs symmetric one).  
 
Scheme 3. Synthesis of an unsymmetrically substituted free carbene. 
 
NH2NH
iPr
iPr
HNNH
iPr
iPr
Cy
BrH3N Br
a) b)
NN
iPr
iPr
Cy
BF4
NN
iPr
iPr
Cy
d)c)
Conditions: (a) 2,6 di-isopropylaniline, Toluene, KOH-H2O, reflux. (b) 1-Bromo-2-
cyclohexylnaphthalene, rac-BINAP, Pd2dba3, tBuONa. (c) NH4BF4, (EtO)3CH, 
HCOOH cat, 110 °C, 78 %. (d) NaH, tBuOK cat, THF.
3i
4i 5i
2i
 
 
The synthesis of the desired compound started from 2i, which was synthesized as 
previously described in literature.19 The obtained di-amine was then transformed in 3i 
via standard C-N Buchwald-Hartwig coupling.  
 
C1
C2
N2N1
C3
 
Figure 4. Thermal ellipsoid drawing (30 % probability) of 5i. Hydrogen atoms 
(except for backbone hydrogen atoms) were omitted for clarity. 
 78 
Ring closure and generation of the free carbene 5i also proceeded in high yield using 
the same reaction condition employed above. Characterization of the final compound 
includes crystal X-ray diffraction analysis. Thermal ellipsoid drawings of 5i can be 
found in Figure 4. 
The high stability displayed from this compound, together with the simple and 
high yielding synthesis, make 5i a good candidate for further studies and application 
in organometallic chemistry. 
 
 
3.6 Experimental section 
 
General. All reactions were carried out using standard Schlenk or glovebox 
(Mecaplex or Innovative Technology) techniques under nitrogen atmosphere. All 
reagents were used as received unless otherwise noted. Solvent were purchased in the 
best quality available, degassed by purging thoroughly with nitrogen and dried over 
molecular sieves of appropriate size. Alternatively, they were purged with argon and 
passed through alumina columns in a solvent purification system (Innovative 
Technology). Solvent for NMR spectroscopy were degassed with nitrogen and dried 
over molecular sieves. NMR spectra were measured on an AV2 400 or AV2 500 MHz 
Bruker spectrometer. Chemical shifts are given in ppm. The spectra are calibrated 
with respect to the residual 1H and 13C signals of the solvent. Multiplicities are 
abbreviated as follows: singlet (s), doublet (d), triplet (t), quartet (q), doublet of 
doublet (dd), quintet (quint), septet (sept), multiplet (m), and broad (br). High-
resolution electrospray ionization mass spectrosmetry was performed on a 
FinniganMAT 900 (Finnigan MAT95, San Jose, CA; USA) double-focusing magnetic 
sector mass spectrometer (geometry BE).  GC-MS analysis was done on a Finnigan 
Voyager GC8000 Top. 4-bromo-heptane, bromocyclopentane, bromocycloheptane 
and bromocyclooctane were purchased from ABCR or Acros and used as reveived. 
 
(FeCl3)2(TMEDA)3. A partial modification of the original procedure described by 
Cahiez et al.x was employed. In a glovebox, a one-liter flask was filled with 500 ml of 
THF and then FeCl3 (9.73 g, 60 mmol) was added slowly as a solid (caution: reaction 
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is exothermic and the solvent starts to boil). After 10 min, TMEDA (10.46 g, 90 
mmol) was added dropwise and the color changed rapidly to brown-red. This mixture 
was stirred for 1 hour at room temperature; in this period of time only a very small 
amount of precipitate was formed. The solvent was then completely evaporated and 
100 ml of pentane were added. The walls and the bottom of the flask were scratched 
until an orange suspension was obtained and then it was stirred for 1 hour. The 
solvent was decanted and the remaining solid was washed other 2 times with 100 ml 
of pentane. After 12 hours under high vacuum the desired product was obtained as a 
yellow powder (19.5 g, 95 % yield). 
 
2,7-Dibromonaphthalene. A three-liter 3-neck round-bottomed flask equipped with 
a mechanistic stirrer was charged with PPh3 (720.00 g, 2.75 mol) and 1 liter of dry 
acetonitrile. The mixture was stirred at 70 °C until an homogeneous solution was 
obtained and then it was cooled to 0°C to form an uniform, fine suspension to which 
Br2 (120 ml) was added dropwise in 1 h. 2,7-dihydroxynaphthalene (200.00 g, 1.25 
mol) was added solid in portion at room temperature and the mixture was heated at 
70°C until an homogeneous solution was formed. At this point the flask was fitted 
with a distillation head and it was heated until almost all the solvent was distilled. The 
dark red residue was heated to 270 °C and then maintained at this temperature for 1 h 
during which time a strong HBr evolution was observed (it was trapped by means of 
beaker filled with NaOH solution). The dark oil was allowed to cool to 100 °C, 
poured into EtOH (1 l) and then allowed to sit overnight. The crude product was 
isolated by filtration and then recrystallized from ethanol. The final gray solid was 
dried completely and then purified by filtering through siliga gel (hexane as eluent) to 
get the title product as white solid (148 g, 49 % yield). 
 
General procedure for the iron-catalyzed C-C coupling:  
 
2-(4-heptyl)naphthalene (1a). In a 250 mL 3-necked flask, equipped with condenser, 
addition funnel and N2 inlet, were added magnesium (1.18 g, 48.3 mmol) and I2 (one 
crystal) under N2. In the addition funnel were charged 2-bromonaphthalene (10.00 g, 
48.30 mmol) and THF (70 ml). A small amount of this solution was added to the flask 
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and warmed with the heat gun until the color became light brown. The reaction 
mixture was then heated to 60˚C (oil bath) and the remaining 2-bromonaphthalene 
solution was added dropwise. At the end of the addition, the mixture was further 
refluxed for 1h. In the meanwhile, in a 250 ml Schlenk flask containing 60 ml of dry 
THF where charged 4-bromoheptane (6.66 g, 37.20 mmol) and (FeCl3)2(TMEDA)3 
(0.75 g, 1.12 mmol). To this flask was then added dropwise the Grignard reagent 
previously generated; the resulting black mixture was stirred for 30 min at room 
temperature. The reaction was quenched with aqueous HCl (1 M solution) and 
extracted with Et2O (2x150 ml). After evaporation of the solvent, the crude product 
was heated at 90 °C under high vacuum to eliminate the excess of alkyl bromide and 
naphthalene. The desired product was isolated after flash chromatography (eluent: 
hexane) as colorless oil (7.30 g, 92 % yield). 1H NMR (CDCl3, 400 MHz): δ 7.83 (m, 
3H), 7.61 (s, 1H), 7.52-7.42 (m, 2H), 7.37 (m, 1H), 2.76 (m, 1H), 1.77-1.64 (m, 4H), 
1.30-1.15 (m, 4H), 0.91 (t, J = 7.3 Hz, 6H). 13C NMR (CDCl3, 100 MHz): δ 144.0, 
133.9, 132.5, 128.1, 127.9, 127.8, 126.6, 126.3, 126.0, 125.2, 45.9, 39.4, 21.1, 14.4. 
HRMS (EI) m/z calcd for C17H22: 226.1722. Found: 226.1722. 
 
2-cyclopentylnaphthalene (1b). Following the general procedure [2-
bromonaphthalene (10.00 g, 48.30 mmol, 60 ml THF), Mg (1.18 g, 48.30 mmol), 
catalyst  (0.75 g, 1.12 mmol), bromocyclopentane (5.54 g, 37.20 mmol, 30 ml THF)], 
the desired product was obtained after flash chromatography (eluent: hexane) as 
colorless oil (4.70 g, 64 % yield). 1H NMR (CDCl3, 400 MHz): δ 7.78 (m, 3H), 7.67 
(s, 1H), 7.43 (m, 3H), 3.21 (m, 1H), 2.20 (m, 2H), 1.95-1.60 (m, 6H). 13C NMR 
(CDCl3, 100 MHz): δ 144.3, 133.9, 132.3, 128.1, 127.9, 127.8, 126.4, 126.1, 125.3, 
125.1, 46.3, 34.8, 25.9.  HRMS (EI) m/z calcd for C15H16: 196.1252. Found. 196.1255.  
 
2-cycloheptylnaphthalene (1c). Following the general procedure [2-
bromonaphthalene (10.00 g, 48.30 mmol, 100 ml THF), Mg (1.18 g, 48.30 mmol), 
catalyst  (0.75 g, 1.12 mmol), bromocycloheptane (6.59 g, 48.30 mmol, 50 ml THF)], 
the desired product was obtained after flash chromatography (eluent: hexane) as 
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colorless oil (7.40 g, 89 % yield). 1H NMR (CDCl3, 400 MHz): δ 7.78 (m, 3H), 7.62 
(s, 1H), 7.40 (m, 3H), 2.84 (m, 1H), 2.05-1.40 (m, 12H). 13C NMR (CDCl3, 100 
MHz): δ 147.7, 134.0, 132.2, 128.1, 127.9, 127.8, 126.4, 126.0, 125.2, 124.6, 47.4, 
37.0, 28.3, 27.6.  HRMS (EI) m/z calcd for C17H20: 224.1565. Found: 224.1565. 
 
2-cyclooctylnaphthalene (1d). Following the general procedure [2-
bromonaphthalene (15.00 g, 72.40 mmol, 80 ml THF), Mg (1.76 g, 72.40 mmol), 
catalyst  (1.12 g, 1.67 mmol), bromocyclooctane (10.60 g, 55.70 mmol, 40 ml THF)], 
the desired product was obtained after flash chromatography (eluent: hexane) as white 
solid (9.50 g, 72 % yield). 1H NMR (CDCl3, 400 MHz): δ 7.75 (m, 3H), 7.60 (s, 1H), 
7.39 (m, 3H), 2.92 (m, 1H), 1.95-1.45 (m, 14H). 13C NMR (CDCl3, 100 MHz): δ 
148.1, 133.9, 132.2, 128.1, 127.9, 127.7, 126.7, 126.0, 125.2, 124.8, 45.0, 34.8, 27.3, 
26.7, 26.3. HRMS (EI): m/z : calcd for C18H22: 238.1722; Found: 238.1725. 
 
General procedure for the iron-catalyzed double C-C coupling: 
 
2,7-dicyclopentylnapthalene (1e). In a 500 mL 3-necked flask, equipped with 
condenser, addition funnel and N2 inlet, were added magnesium (2.40 g, 100.00 mmol) 
and I2 (one crystal) under N2. In the addition funnel were charged 2,7-
dibromonaphtalene (13.00 g, 45.40 mmol) and THF (250 ml). A small amount of this 
solution was added into the flask and warmed with the heat gun until the color became 
light brown. The reaction mixture was then heated to 60˚C (oil bath) and the remaining 
solution was added dropwise. At the end of the addition, the mixture was refluxed for 
another 2 hours. The obtained red-orange suspension was cooled and then 
cannulated,20 into a 500 ml schlenk flask containing bromocyclopentane (13.50 g, 
90.80 mmol) and (FeCl3)2(TMEDA)3 (0.92 g, 1.57 mmol) in dry THF (100 ml). After 
the addition, the resulting black mixture was stirred for 1 hour at room temperature. 
The reaction was then quenched with aqueous HCl (1 M solution) and extracted with 
Et2O. After evaporation of the solvent, the obtained yellow oil was plugged through a 
silica gel pad (eluent: hexane) to remove metal contaminants and give a 4:1 mixture of 
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desired product and mono-substituted alkylnaphthalene. The latter could be 
eliminated by Kugelrohr distillation (120-125 °C, 0.01 mbar). The desired product 
was obtained as a white solid (4.19 g, 35 % yield). 1H NMR (CDCl3, 400 MHz): δ 
7.71 (d, J = 8.5 Hz, 2H), 7.59 (s, 2H), 7.33 (d, J = 8.5 Hz, 2H), 3.12 (m, 2H), 2.20-
2.00 (m, 4H), 1.81-1.60 (m, 12H). 13C NMR (CDCl3, 100 MHz): δ 144.25, 133.97, 
130.89, 127.7, 125.7, 124.7, 46.4, 34.8, 25.9. HRMS (EI) m/z calcd for C20H24: 
264.1878. Found: 264.1880. 
 
2,7-dicyclohexylnapthalene (1f). Following the general procedure [2,7-
dibromonaphthalene (30.00 g, 105.00 mmol, 500 ml THF), Mg (5.61 g, 231.00 mmol), 
catalyst  (2.12 g, 3.15 mmol), bromocyclohexane (34.00 g, 210.00 mmol, 200 ml 
THF)], the desired product was obtained as a white solid (13.70 g, 45 % yield). 1H 
NMR (CDCl3, 400 MHz): δ 7.71 (d, J = 7.8 Hz, 2H), 7.54 (s, 2H), 7.28 (d, J = 7.8 Hz, 
2H), 2.64 (m, 2H), 2.00-1.82 (m, 10H), 1.61-1.23 (m, 10H). 13C NMR (CDCl3, 100 
MHz): δ 145.7, 134.1, 131.0, 127.6, 125.6, 124.4, 44.9, 34.7, 27.2, 26.5. HRMS (EI) 
m/z calcd for C22H26: 292.2191. Found: 292.2191. 
 
2,7-dicycloheptylnapthalene (1g). Following the general procedure [2,7-
dibromonaphthalene (10.00 g, 35.00 mmol, 400 ml THF), Mg (2.50 g, 102.88 mmol), 
catalyst  (1.20 g, 1.78 mmol), bromocycloheptane (12.40 g, 70.02 mmol, 100 ml 
THF)], the desired product was obtained as a white solid (3.50 g, 31 % yield). 1H 
NMR (CDCl3, 400 MHz): δ 7.72 (d, J = 7.8 Hz, 2H), 7.52 (s, 2H), 7.27 (d, J = 7.8 Hz, 
2H), 2.84 (m, 2H), 2.10-1.50 (m, 24H). 13C NMR (CDCl3, 100 MHz): δ 147.6, 134.1, 
130.6, 127.7, 125.5, 124.2, 47.3, 37.0, 28.3, 27.5.  HRMS (EI) m/z calcd for C24H32: 
320.2504. Found: 320.2500. 
 
2,7-dicyclooctylnapthalene (1h). Following the general procedure [2,7-
dibromonaphthalene (12.00 g, 42.00 mmol, 200 ml THF), Mg (2.55 g, 105.00 mmol), 
catalyst  (0.85 g, 1.26 mmol), bromocyclooctane (16.00 g, 84.00 mmol, 100 ml THF)], 
the desired product was obtained as a white solid (6.10 g, 42 % yield). 1H NMR 
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(CDCl3, 400 MHz): δ 7.68 (d, J = 8.5 Hz, 2H), 7.52 (s, 2H), 7.27 (d, J = 7.8 Hz, 2H), 
2.89 (m, 2H), 1.95-1.50 (m, 28H). 13C NMR (CDCl3, 100 MHz): δ 148.0, 134.1, 
130.6, 127.7, 125.8, 124.5, 45.0, 34.8, 27.3, 26.7, 26.3. HRMS (EI) m/z calcd for 
C26H36: 348.2817. Found: 348.2813. 
 
General procedure for the bromination of 2- and 2,7-alkyl substituted naphthalene: 
 
1-bromo-2-(4-heptyl)naphthalene (2a). Compound 1a (5.00 g, 23.55 mmol) was 
dissolved in 100 ml of dry CH2Cl2 in a Schlenk flask and the solution was cooled to -
78°C. At this temperature a solution of Br2 (3.76 g, 23.55 mmol) in CH2Cl2 (50 ml) 
was slowly added. The reaction was left stirring at the same temperature for 5 hours 
and was subsequently quenched with aqueous NaOH (1M solution, 100 ml). The 
organic phase was separated, washed with 200 ml of water, dried with MgSO4, 
filtered and concentrated under vacuum to afford a orange oil. After purification on a 
silica gel pad (eluent: hexane) to eliminate residual Br2, the desired product was 
obtained as a colorless oil (6.80 g, 99 % yield). 1H NMR (CDCl3, 400 MHz): δ 8.35 
(d, J = 8.5 Hz, 1H), 7.78 (m, 2H), 7.57 (t, J = 8.3 Hz, 1H), 7.47 (t, J = 8.0 Hz, 1H), 
7.33 (d, J = 8.5 Hz, 1H), 3.63 (m, 1H), 1.77-1.51 (m, 4H), 1.34-1.08 (m, 4H), 0.85 (t, 
J = 7.4 Hz, 6H). 13C NMR (CDCl3, 100 MHz): δ 143.5, 133.5, 132.8, 128.3, 128.2, 
128.0, 127.4, 126.0, 125.3, 125.2, 44.2, 39.1, 20.7, 14.5. HRMS (EI) m/z calcd for 
C17H21Br 304.0827. Found: 304.0830. 
 
1-bromo-2-cyclopentylnaphthalene (2b). Following the general procedure using 1b 
(4.20 g, 21.40 mmol, 80 ml CH2Cl2) and Br2 (3.42 g, 21.40 mmol, 80 ml CH2Cl2), the 
desired product was obtained as a nearly colorless oil (5.75 g, 98 % yield). 1H NMR 
(CDCl3, 400 MHz): δ 8.36 (d, J = 8.5 Hz, 1H), 7.78 (m, 2H), 7.56 (m, 1H), 7.45 (m, 
2H), 3.72 (hept, J = 8 Hz, 1H), 2.2 (m, 2H), 1.95-1.60 (m, 6H). 13C NMR (CDCl3, 100 
MHz): δ 143.6, 133.5, 132.8, 128.2, 128.0, 127.9, 127.5, 126.0, 125.1, 124.2, 46.0, 
34.1, 26.2.  HRMS (EI) m/z calcd for C15H15Br: 274.0357. Found: 274.0352. 
 
1-bromo-2-cycloheptylnaphthalene (2c). Following the general procedure using 1c 
(5.70 g, 25.60 mmol, 50 ml CH2Cl2) and Br2 (4.09 g, 25.29 mmol, 80 ml CH2Cl2), the 
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desired product was obtained as a colorless oil (7.60 g, 99 % yield). 1H NMR (CDCl3, 
400 MHz): δ 8.36 (d, J = 8.5 Hz, 1H), 7.78 (m, 2H), 7.58 (m, 1H), 7.48 (m, 1H), 7.40 
(d, J = 8.5 Hz, 1H), 3.52 (m, 1H), 2.05-1.50 (m, 12H). 13C NMR (CDCl3, 100 MHz): 
δ 146.5, 133.3, 132.7, 128.2, 128.1, 128.0, 127.4, 125.9, 125.5, 122.8, 46.2, 35.8, 
28.2, 27.9.  HRMS (EI) m/z calcd for C17H19Br: 302.0673. Found: 302.0673. 
 
1-bromo-2-cyclooctylnaphthalene (2d). Following the general procedure using 1d 
(5.00 g, 21.00 mmol, 80 ml CH2Cl2) and Br2 (3.35 g, 21.00 mmol, 80 ml CH2Cl2), the 
desired product was obtained as a transparent oil (6.65 g, 99 % yield). 1H NMR 
(CDCl3, 400 MHz): δ 8.32 (d, J = 8.4 Hz 2H), 7.75 (m, 1H), 7.55 (m, 1H), 7.44 (m, 
1H), 7.37 (d, J = 8.4 Hz 3H), 3.68 (m, 1H), 1.90-1.52 (m, 14H). 13C NMR (CDCl3, 
125 MHz): δ 147.33, 133.31, 132.75, 128.17, 128.09, 128.08, 127.44, 125.94, 122.87, 
43.58, 34.56, 27.18, 26.88, 26.59. HRMS (EI): m/z : calcd for C18H21Br: 316.0827. 
Found: 316.0823. 
 
1-bromo-2,7-dicyclopentylnaphthalene (2e). Following the general procedure using 
1e (2.13 g, 8.06 mmol, 20 ml CH2Cl2) and Br2 (1.29 g, 8.06 mmol, 20 ml CH2Cl2), the 
desired product was obtained as a colorless oil (2.70 g, 98 % yield). 1H NMR (CDCl3, 
400 MHz): δ 8.14 (s, 1H), 7.68 (d, J = 8.5 Hz, 2H), 7.34 (m, 2H), 3.80 (m, 1H), 3.20 
(m, 1H), 2.20-1.5 (m, 16H). 13C NMR (CDCl3, 100 MHz): δ 146.0, 143.6, 132.8, 
132.1, 128.2, 127.7, 126.2, 125.2, 124.3, 123.9, 46.7, 46.0, 35.0, 34.1, 26.2, 26.0. 
HRMS (EI) m/z calcd for C22H27Br: 342.0983. Found: 342.0980. 
 
1-bromo-2,7-dicyclohexylnaphthalene (2f). Following the general procedure using 
1f (2.20 g, 7.52 mmol, 60 ml CH2Cl2) and Br2 (1.26 g, 7.90 mmol, 20 ml CH2Cl2), the 
desired product was obtained as a light yellow oil (2.75 g, 98 % yield). 1H NMR 
(CDCl3, 400 MHz): δ 8.11 (s, 1H), 7.68 (m, 2H), 7.34 (m, 2H), 3.35 (m, 1H), 2.71 (m, 
1H), 2.00-1.2 (m, 20H). 13C NMR (CDCl3, 100 MHz): δ 147.4, 144.3, 132.8, 132.1, 
128.1, 127.6, 126.1, 124.9, 124.3, 123.5, 45.3, 44.7, 34.7, 33.4, 27.2, 27.1, 26.5, 26.4.   
HRMS (EI) m/z calcd for C22H27Br: 370.1296. Found: 370.1297. 
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1-bromo-2,7-dicycloheptylnaphthalene (2g). Following the general procedure using 
1g (1.20g, 3.74 mmol, 40 ml CH2Cl2) and Br2 (0.59 g, 3.70 mmol, 40 ml CH2Cl2), the 
desired product was obtained as light yellow oil (1.50 g, 99 % yield). 1H NMR 
(CDCl3, 400 MHz): δ 8.08 (s, 1H), 7.68 (m, 2H), 7.34 (m, 2H), 3.51 (m, 1H), 2.85 (m, 
1H), 2.08-1.5 (m, 24H). 13C NMR (CDCl3, 100 MHz): δ 149.1, 147.0, 132.9, 132.0, 
128.3, 127.8, 126.0, 124.7, 122.9, 47.7, 37.1, 35.9, 28.3, 28,2 27.9, 27.6. HRMS (EI) 
m/z calcd for C24H31Br: 398.1609. Found: 398.1610. 
 
1-bromo-2,7-dicyclooctylnaphthalene (2h). Following the general procedure using 
1h (9.40 g, 27.00 mmol, 300 ml CH2Cl2) and Br2 (4.31 g, 27.00 mmol, 200 ml 
CH2Cl2), the desired product was obtained as colorless oil (11.40 g, 99 % yield). 1H 
NMR (CDCl3, 400 MHz): δ 8.12 (s, 1H), 7.68 (d, J = 8.4 Hz, 2H), 7.32 (m, 2H), 3.71 
(m, 1H), 2.98 (m, 1H), 2.00-1.5 (m, 28H). 13C NMR (CDCl3, 100 MHz): δ 149.8, 
147.2, 132.8, 131.8, 128.3, 127.7, 126.3, 125.0, 124.9, 122.7, 45.4, 35.0, 34.6, 27.2, 
27.1, 26.9, 26.7, 26.6 HRMS (EI) m/z calcd for C26H35Br: 426.1922. Found: 426.1916. 
 
 
General procedure for the C-N Buchwald-Hartwig coupling: 
 
N,N’-Bis(2-(4-heptyl)naphthalene-1yl)ethane-1,2-diamine (3a). In a glove box, a 
Schlenk flask was charged with rac-BINAP (0.27 g, 0.42 mmol), Pd(dba)2 (0.23 g, 
0.387 mmol) NaOtBu (1.15 g, 11.60 mmol) and toluene (50 ml). The resulting violet 
suspension was stirred at room temperature for 10 minutes and then 2a (2.60 g, 8.52 
mmol) was added. After another 5 minutes ethylenediamine (0.23 g, 3.87 mmol) was 
added, the flask was taken out of the glovebox, connected to a condenser and the 
suspension was refluxed for 18 hours. The mixture was cooled to room temperature 
and then passed through a celite filter to eliminate the inorganic salts. After 
evaporation of the solvent the obtained oil was purified by silica gel chromatography 
(eluent: hexane-CH2Cl2 3:1) to yield the desired product as yellow oil (1.25 g, 63 % 
yield). 1H NMR (CDCl3, 400 MHz): δ 8.31 (d, J = 8.5 Hz, 2H), 7.79 (d, J = 8.1 Hz, 
2H), 7.58 (d, J = 8.6 Hz, 2H), 7.48-7.38 (m, 4H), 7.33 (d, J = 8.3 Hz, 2H), 4.05-3.85 
(s, broad, 2H), 3.43 (s, 4 H), 3.18 (m, 2H), 1.75-1.55 (m, 10H), 1.32-1.12 (m, 12H), 
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0.85 (t, J = 7.4 Hz, 6H). 13C NMR (CDCl3, 100 MHz): δ 135.0, 133.2, 129.7, 128.4, 
125.8, 125.3, 124.9, 124.2, 123.9, 52.0, 39.5, 34.9, 31.8, 27.1, 25.5, 22.9, 21.4, 14.6.  
HRMS (ESI) m/z calcd for C30H48N2: 508.3896. Found: 509.3893  [M+1]. 
 
N,N’-Bis(2-cyclopentylnaphthalene-1yl)ethane-1,2-diamine (3b). Following the 
general procedure [rac-BINAP (0.41 g, 0.65 mmol), Pd(dba)2 (0.31 g, 0.54 mmol), 
NaOtBu (1.57 g, 16.40 mmol), Toluene (140 ml), 2b (3.00 g, 10.90 mmol), 
ethylenediamine (0.32 g, 5.34 mmol)], the desired product was obtained after silica 
gel chromatography (eluent: hexane-EtOAc 10:1) as a yellow oil (2.20 g, 92 % yield). 
1H NMR (CDCl3, 400 MHz): δ 8.28 (d, J = 8.5 Hz, 2H), 7.81 (d, J = 7.9 Hz, 2H), 7.58 
(d, J = 8.5 Hz, 2H), 7.52-7.39 (m, 6H), 3.95 (s, 2H), 3.55 (m, 2H), 3.45 (s, 4H), 2.12 
(m, 4H), 2.00-1.70 (m, 12H). 13C NMR (CDCl3, 100 MHz): δ 142.0, 135.2, 133.4, 
129.5, 128.5, 125.9, 125.3, 125.2, 124.0, 123.4, 52.3, 40.1, 35.1, 26.4. HRMS (ESI) 
m/z calcd for C32H36N2: 448.2878. Found: 449.2945 [M+1]. 
 
N,N’-Bis(2-cycloheptylnaphthalene-1yl)ethane-1,2-diamine (3c). Following the 
general procedure [rac-BINAP (0.12 g, 0.19 mmol), Pd(dba)2 (0.095 g, 0.16 mmol), 
NaOtBu (0.48 g, 5.00 mmol), Toluene (50 ml), 2c (1.00 g, 3.30 mmol), 
ethylenediamine (0.097 g, 1.62 mmol)], the desired product was obtained after silica 
gel chromatography (eluent: hexane-EtOAc 10:1) as a yellow foam (0.71 g, 87 % 
yield). 1H NMR (CDCl3, 400 MHz): δ 8.28 (d, J = 8.5 Hz, 2H), 7.81 (d, J = 7.9 Hz, 
2H), 7.58 (d, J = 8.5 Hz, 2H), 7.52-7.39 (m, 6H), 3.90 (s, 2H), 3.45 (s, 4H), 3.35 (m, 
2H), 2.00-1.50 (m, 24H). 13C NMR (CDCl3, 100 MHz): δ 140.2, 139.1, 133.3, 129.8, 
128.5, 125.9, 125.7, 125.2, 124.2, 123.6, 52.4, 40.7, 36.9, 28.2, 28.1. HRMS (EI) m/z 
calcd for C36H44N2: 504.3504. Found: 504.3511. 
 
N,N’-Bis(2-cyclooctylnaphthalene-1yl)ethane-1,2-diamine (3d). Following the 
general procedure [rac-BINAP (0.34 g, 0.55 mmol), Pd(dba)2 (0.26 g, 0.45 mmol), 
NaOtBu (1.31 g, 13.60 mmol), Toluene (100 ml), 2d (3.17 g, 10.0 mmol), 
ethylenediamine (0.27 g, 4.55 mmol)], the desired product was obtained after silica 
gel chromatography (eluent: hexane-EtOAc 10:1) as an off-white powder (1.60 g, 66 
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% yield). 1H NMR (CDCl3, 400 MHz): δ 8.28 (s, broad, 2H), 7.78 (d, J = 8 Hz, 1H), 
7.58 (d, J = 8.9 Hz, 2H), 7.48-7.33 (m, 6H), 4.20-3.50 (s, broad, 2H), 3.52 (m, 6H), 
1.90-1.42 (m, 14H). 13C NMR (CDCl3, 100 MHz): δ 140.15, 140.02, 133.25, 129.84, 
128.49, 126.09, 125.92, 125.25, 124.25, 123.67, 52.40, 38.04, 35.62, 27.04, 26.93, 
26.87. HRMS (ESI) m/z calcd for C38H48N2: 532.3895. Found: 533.3890 [M+1]. 
 
N,N’-Bis(2,7-dicyclopentylnaphthalene-1yl)ethane-1,2-diamine (3e). Following the 
general procedure [rac-BINAP (0.41 g, 0.65 mmol), Pd(dba)2 (0.31 g, 0.54 mmol), 
NaOtBu (1.57 g, 16.44 mmol), Toluene (140 ml), 2e (3.00 g, 10.91 mmol), 
ethylenediamine (0.32 g, 5.34 mmol)], the desired product was obtained after silica 
gel chromatography (eluent: hexane-EtOAc 20:1 to 10:1) as a yellow oil (2.20 g, 92 
% yield). 1H NMR (CDCl3, 400 MHz): δ 8.10 (s, 2H), 7.72 (d, J = 8.4 Hz, 2H), 7.52 
(d, J = 8.6 Hz 2H), 7.33 (d, J = 8.5 Hz, 4 H), 3.90 (s, broad 2H), 3.50 (m, 2H), 3.42 (s, 
4H), 3.13 (m, 2H), 2.15-1.60 (m, 32H). 13C NMR (CDCl3, 100 MHz): δ 144.1, 141.7, 
135.1, 132.0, 129.4, 128.4, 125.6, 124.3, 123.6, 120.7, 52.1, 46.7, 40.1, 35.1, 35.0, 
26.3, 25.9. HRMS (EI) m/z calcd for C42H52N2: 584.4130. Found: 585.4207 [M+1]. 
 
N,N’-Bis(2,7-dicyclohexylnaphthalene-1yl)ethane-1,2-diamine (3f). Following the 
general procedure [rac-BINAP (0.24 g, 0.39 mmol), Pd(dba)2 (0.20 g, 0.35 mmol), 
NaOtBu (0.99  g, 10.32 mmol), Toluene (50 ml), 2f (2.90 g, 7.81 mmol), 
ethylenediamine (0.21 g, 3.55 mmol)], the desired product was obtained after silica 
gel chromatography (eluent: hexane-CH2Cl2 3:1 to 2:1) as a crystalline white solid 
(2.00 g, 88 % yield). 1H NMR (CDCl3, 400 MHz): δ 8.08 (s, 2H), 7.72 (d, J = 8.4 Hz, 
2H), 7.52 (d, J = 8.5 Hz 2H), 7.33 (m, 4 H), 3.90 (s, broad 2H), 3.42 (s, 4H), 3.12 (m, 
2H), 2.63 (m, 2H), 1.95-1.10 (m, 40H). 13C NMR (CDCl3, 100 MHz): δ 145.6, 141.0, 
136.7, 132.0, 129.7, 128.3, 125.5, 124.4, 123.6, 120.4, 52.2, 45.3, 39.1, 34.8, 34.5, 
27.4, 27.1, 26.5, 26.4. HRMS (EI) m/z calcd for C46H60N2: 640.4756. Found: 641.4825 
[M+1]. 
 
N,N’-Bis(2,7-dicycloheptylnaphthalene-1yl)ethane-1,2-diamine (3g). Following 
the general procedure [rac-BINAP (0.25 g, 0.40 mmol), Pd(dba)2 (0.17 g, 0.30 
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mmol), NaOtBu (1.07 g, 11.10 mmol), Toluene (150 ml), 2g (2.90 g, 7.26 mmol), 
ethylenediamine (0.21 g, 3.46 mmol)], the desired product was obtained after silica 
gel chromatography (eluent: Hexane to Hexane-CH2Cl2 1:1) as a crystalline white 
solid (2.11 g, 88 %). 1H NMR (Acetone d621, 400 MHz): δ 8.17 (s, 2H), 7.69 (d, J = 
8.0 Hz, 2H), 7.48 (d, J = 8.5 Hz 2H), 7.33 (m, 4 H), 3.76 (s, 4H), 3.45 (m, 2H), 2.69 
(m, 2H), 2.20-1.40 (m, 48H). 13C NMR (Acetone d6, 100 MHz): δ 147.1, 140.6, 139.1, 
132.2, 130.3, 128.5, 125.3, 124.8, 123.6, 120.8, 68.9, 68.8, 52.1, 47.8, 40.3, 37.2, 
37.0, 28.2, 28.1, 27.4. HRMS (EI) m/z calcd for C50H68N2: 696.5382. Found: 697.5455 
[M+1]. 
 
N,N’-Bis(2,7-dicyclooctylnaphthalene-1yl)ethane-1,2-diamine (3h). Following the 
general procedure [rac-BINAP (0.44 g, 0.70 mmol), Pd(dba)2 (0.34 g, 0.58 mmol), 
NaOtBu (1.69 g, 17.64 mmol), Toluene (150 ml), 2b (5.00 g, 15.72 mmol), 
ethylenediamine (0.34 g, 5.70 mmol)], the desired product was obtained after silica 
gel chromatography (eluent: Hexane-EtOAc 15:1 to 10:1) as a yellow solid (3.50 g, 
81 % yield). 1H NMR (CDCl3, 400 MHz): δ 8.08 (s, 2H), 7.72 (d, J = 8.3 Hz, 2H), 
7.52 (d, J = 8.5 Hz 2H), 7.38 (m, 4 H), 3.92 (s, broad 2H), 3.45 (s, 6H), 2.89 (m, 2H), 
1.95-1.10 (m, 56H). 13C NMR (CDCl3, 100 MHz): δ 147.8, 139.9, 139.8, 131.7, 
129.9, 128.4, 125.8, 125.1, 123.8, 120.5, 52.3, 45.5, 38.0, 35.6, 34.7, 27.3, 27.0, 26.9, 
26.8, 26.4, 26.3. HRMS (EI) m/z calcd for C54H76N2: 752.6008. Found: 752.6005. 
 
Synthesis of imidazolinium salts: 
 
1,3-Bis(2-(4-heptyl)naphthalen-1-yl)-imidazolinium tetrafluoroborate (4a). To a 
Schlenk tube containing 3a (1.10 g, 2.16 mmol) and NH4BF4 (0.36 g, 3.46 mmol), 
was added (EtO)3CH (20 ml). To this suspension was added formic acid (3 drops) and 
the mixture was heated at 110˚C for 2 hours. After this time a small amount of white 
solid was present in the suspension. The solvent was distilled out and the obtained 
brown foam was purified by silica gel chromatography (eluent:  Hexane to CH2Cl2 to 
CH2Cl2-MeOH 40:1). To the obtained light yellow oil were added ether (3 ml) and 
pentane (10 ml) to induce the precipitation of a white powder that, from NMR 
analysis, proved to be the desired compound (1.31 g, 75 % yield). From NMR 
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analysis a 43:57 mixture of two isomers was detected. 1H NMR (CDCl3, 400 MHz): δ 
8.16 (d, J = 8.4 Hz, 1H), 8.03 (d, J = 8.7 Hz, 2H), 7.97-7.84 (m, 4H), 7.78-760 (m, 
4H), 7.52 (d,  J = 8.7 Hz, 1H), 7.47 (d, J = 8.7 Hz, 1H), 5.30-4.65 (m, 4H), 3.22-2.97 
(m, 2H), 2.05-140 (m, 10H), 1.30-0.70 (m, 18H). (Due to the existence of two 
atropisomers, 13C NMR spectrum appeared complex) 13C NMR (CDCl3, 100 MHz): δ 
159.8, 159.5, 143.0, 142.1, 133.03, 133.02, 132.2, 132.1, 130.0, 129.7, 129.5, 129.4, 
129.1, 128.9, 128.2, 128.0, 127.6, 127.4, 124.4, 123.9, 121.3, 120.6, 54.8, 54.7, 41.23, 
41.21, 39.8, 39.1, 39.0, 38.5, 22.0, 21.7, 21.6, 21.5, 14.7, 14.62, 14.60, 14.5. 19F NMR 
(CDCl3, 376 MHz): δ -148.34, -148.31. HRMS (ESI) m/z calcd for C37H47BF4N2: 
606.3768. Found: 519.3798 [M-BF4]. 
 
1,3-Bis(2-cyclopentylnaphthalen-1-yl)-imidazolinium tetrafluoroborate (4b). To a 
Schlenk tube under nitrogen containing 3b (2.20 g, 4.90 mmol) and NH4BF4 (0.64 g, 
5.88 mmol), were added (EtO)3CH (20 ml) and formic acid (3 drops). The mixture 
was then heated at 110˚C for 5 hours. After this the resulting suspension was cooled 
to room temperature and filtered to eliminate most of the (EtO)3CH. The obtained 
yellow solid was dissolved in CH2Cl2 and filtered through celite to eliminate the 
excess of NH4BF4. The filtrate was concentrated under vacuum until a yellow oil was 
obtained. Toluene (70 ml) was then added and the obtained mixture was sonicated for 
15 minutes at room temperature and then heated at 75°C until a homogeneous yellow 
suspension was formed. It was cooled to ca. 50°C and filtered. The obtained solid was 
washed with 10 ml of Et2O and dried under high vacuum overnight (1.75 g, 65 % 
yield). From NMR analysis a 50:50 mixture of syn-anti isomer was observed. 1H 
NMR (DMSO-d6, 400 MHz): δ 9.58 – 9.52 (s, 1H), 8.30 (d, J = 8.5 Hz, 1H), 8.18 (d, 
J = 8.7 Hz, 2H), 8.1 (m, 3H), 7.83 (m, 1H), 7.78 (m, 1H), 7.70 (m, 4H), 4.95-4.65 (m, 
4H), 3.60 (m, 1H), 3.40 (m, 1H), 2.28 (m, 2H), 2.10-1.50 (m, 16H). (Due to the 
existence of two atropisomers, 13C NMR spectrum appeared complex) 13C NMR 
(DMSO-d6, 100 MHz): δ 161.6, 161.4, 142.3, 142.2, 132.4, 132.3, 131.1, 131.0, 
129.3, 129.1, 128.7, 128.6, 128.5, 128.3, 128.2, 128.1, 126.8, 125.1, 125.0, 122.0, 
121.4, 53.7, 53.6, 40.1 (overlapped with solvent, determined by 2D-HSQC), 39.7 
(overlapped with solvent, determined by 2D-HSQC), 36.0, 35.5, 34.7, 33.8, 26.1, 
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25.9, 25.8, 25.7. 19F NMR (DMSO-d6, 376 MHz): -148.30, -148.35. HRMS (ESI) m/z 
calcd for C33H35BF4N2: 546.2829. Found:  459.2795 [M-BF4]. 
 
1,3-Bis(2-cycloheptylnaphthalen-1-yl)-imidazolinium tetrafluoroborate (4c). To a 
Schlenk tube under nitrogen containing 3c (0.71 g, 1.41 mmol) and NH4BF4 (0.16 g, 
1.55 mmol), were added (EtO)3CH (7 ml) and formic acid (2 drops). The mixture was 
then heated at 120˚C for 3 hours. The resulting suspension was cooled to room 
temperature and filtered to eliminate most of the (EtO)3CH. The obtained yellow solid 
was dissolved in CH2Cl2 and filtered through celite to eliminate the excess of 
NH4BF4. The solution was then concentrated under vacuum and, upon addition of 
Et2O, a white powder precipitated. The solvent was decanted and the solid was 
washed with cold Et2O (2 × 20 ml) and with cold CH2Cl2 (1 × 10 ml). The desired 
product was dried under high vacuum for 12 hours (0.49 g, 58 % yield). From NMR 
analysis 22 % of the syn isomer was detected. 1H NMR (DMSO-d6, 400 MHz): δ 9.68 
– 9.56 (s, 1H), 8.23 -8.04 (m, 6H), 7.88 – 7.68 (m, 6H), 7.87 (s, 2H), 5.05-4.65 (m, 
4H), 3.10-3.00 (m, 2H), 2.10-1.50 (m, 24H). (Due to the existence of two 
atropisomers, 13C NMR spectrum appeared complex) 13C NMR (DMSO-d6, 100 
MHz): δ 162.6, 162.0, 145.7, 145.3, 132.8, 132.7, 131.7, 131.6, 129.6, 129.5, 129.2, 
129.1, 128.7, 127.3, 127.2, 126.8, 126.5, 125.9, 125.8, 122.2, 122.0, 54.3, 54.1, 41.8, 
41.1, 36.6, 36.2, 35.9, 35.6, 28.2, 29.0, 27.9, 27.7, 27.6, 27.4, 27.3. 19F NMR (DMSO-
d6, 376 MHz): -148.28, -148.33. HRMS (ESI) m/z calcd for C37H43BF4N2: 602.3455. 
Found: 515.3418 [M-BF4]. 
 
1,3-Bis(2-cyclooctylnaphthalen-1-yl)-imidazolinium tetrafluoroborate (4d). To a 
Schlenk tube under nitrogen containing 3d (1.50 g, 2.81 mmol) and NH4BF4 (0.36 g, 
3.38 mmol), were added (EtO)3CH (30 ml) and formic acid (3 drops). The mixture 
was heated at 100˚C for 2 hours. The suspension was then cooled to room temperature 
and filtered to eliminate most of the (EtO)3CH. The obtained solid was washed with 
30 ml of Et2O, then dissolved in CH2Cl2 (200 ml) and slowly filtered through celite. 
The solvent was then reduced to ~ 5 ml and Et2O (60 ml) was added inducing the 
precipitation of a white powder. The solid was isolated by decantation and dried 
under high vacuum (1.53 g, 86 % yield). From NMR analysis, two isomers are 
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present in a 83:17 (anti-syn) ratio. Due to overlap of most of the signals of the 
respective isomers only the ones related to the major isomer will be presented. 1H 
NMR (DMSO-d6, 400 MHz): δ 9.64 (s, 1H), 8.18 (d, J = 8.8 Hz, 2H), 8.12 (d, J = 7.6 
Hz, 2H), 8.01 (d, J = 8.4 Hz, 2H), 7.80-7.67 (m, 6H), 5.75 (s, 4H), 5.10-4.65 (m, 4H), 
3.20 (m, 2H), 2.15-1.50 (m, 28H). (Due to the existence of two atropisomers, 13C 
NMR spectrum appeared complex)  13C NMR (DMSO-d6, 100 MHz): δ 161.45, 
161.43, 146.06, 145.04, 132.30, 132.20, 131.21, 129.08, 128.98, 128.72, 128.61, 
128.20, 126.82, 126.70, 126.28, 125.75, 125.65, 125.58, 121.54, 121.26, 53.80, 53.63, 
34.82, 34.15, 33.16, 27.09, 26.86, 26.15, 26.11, 26.02, 25.92, 25.69, 25.45, 25.28, 
25.14. 19F NMR (DMSO-d6, 376 MHz): -143.51, -143.56. HRMS (ESI) m/z calcd for 
C39H47BF4N2: 630.3768. Found: 543.3727 [M-BF4]. 
 
1,3-Bis(2,7-dicyclopentylnaphthalen-1-yl)-imidazolinium tetrafluoroborate (4e). 
To a Schlenk tube under nitrogen, containing 3e (1.60 g, 2.74 mmol) and NH4BF4 
(0.45 g, 4.10 mmol), were added (EtO)3CH (30 ml) and formic acid (2 drops). The 
mixture was then heated at 110˚C for 4 hour. After this it was cooled to room 
temperature and filtered to eliminate most of the (EtO)3CH. The obtained yellow solid 
was dissolved in CH2Cl2 and filtered through celite to eliminate the excess of 
NH4BF4. The solution was then concentrated in vacuum and, upon addition of Et2O, a 
white powder precipitate. The solvent was decanted and the solid was washed with 
Et2O (3 × 10 ml). The desired product was then dried in high vacuum for 12 h (0.73 g, 
39 % yield). Crystals suitable for X-Ray analysis were obtained through slow 
evaporation of a toluene-CH2Cl2 solution of the product. 1H NMR (DMSO-d6, 400 
MHz): δ 9.49 (s 1H), 8.13 (d, J = 8.7 Hz, 2H), 8.07 (d, J = 8.6 Hz, 2H), 7.87 (s, 2H), 
7.65 (m, 4H), 5.10-4.60 (m, 4H), 2.90 (m, 4H), 2.10-1.10 (m, 32H). 13C NMR 
(DMSO-d6, 100 MHz): δ 160.9, 148.1, 143.0, 131.1, 130.5, 129.2, 128.7, 126.9, 
126.0, 124.2, 118.8, 64.9, 53.6, 44.8, 33.9, 33.6, 33.4, 33.1, 26.4, 26.3, 26.2, 25.5, 
25.4, 15.1. 19F NMR (DMSO-d6, 376 MHz): -143.53, -143.58. HRMS (ESI) m/z calcd 
for C43H51BF4N2: 682.4081. Found: 595.4047 [M-BF4]. 
 
1,3-Bis(2,7-dicyclohexylnaphthalen-1-yl)-imidazolinium tetrafluoroborate (4f). 
To a Schlenk tube containing 3f (0.96 g, 1.50 mmol) and NH4BF4 (0.19 g, 1.80 
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mmol), were added (EtO)3CH (20 ml) and formic acid (3 drops). The mixture was 
then heated at 110˚C for 1 hour. After this the suspension was cooled to room 
temperature and filtered to eliminate most of the (EtO)3CH. The obtained yellow solid 
was dissolved in CH2Cl2 and filtered through celite to eliminate the excess of 
NH4BF4. The solution was then concentrated under vacuum and, upon addition of 
Et2O, a white powder precipitated. The solvent was decanted and the solid was 
washed with Et2O (3 × 10 ml). The desired product was then dried under high vacuum 
for 12 hours (0.55 g, 50 % yield). Crystals suitable for X-Ray analysis were obtained 
through slow evaporation of a Toluene/CH2Cl2 solution of the product. 1H NMR 
(DMSO-d6, 400 MHz): δ 9.49 (s 1H), 8.13 (d, J = 8.7 Hz, 2H), 8.07 (d, J = 8.6 Hz, 
2H), 7.87 (s, 2H), 7.65 (m, 4H), 5.10-4.60 (m, 4H), 2.90 (m, 4H), 2.10-1.10 (m, 40H). 
13C NMR (DMSO-d6, 100 MHz): δ 160.9, 148.1, 143.0, 131.1, 130.5, 129.2, 128.7, 
126.9, 126.0, 124.2, 118.8, 64.9, 53.6, 44.8, 33.9, 33.6, 33.4, 33.1, 26.4, 26.3, 26.2, 
25.5, 25.4, 15.1. 19F NMR (DMSO-d6, 376 MHz): -143.53, -143-58. HRMS (ESI) m/z 
calcd for C47H59BF4N2: 738.4707. Found: 651.4668 [M-BF4]. 
 
1,3-Bis(2,7-dicycloheptylnaphthalen-1-yl)-imidazolinium tetrafluoroborate (4g). 
Following the same procedure used to synthesize compound 4a [3g (1.04 g, 1.50 
mmol), NH4BF4 (0.19 g, 1.80 mmol), formic acid (cat.), (EtO)3CH (25 ml)], the 
desired product was obtained after silica gel chromatography (CH2Cl2 to CH2Cl2-
MeOH 30:1 as eluent) as a white solid (0.57 g, 48 % yield). From NMR analysis 10 
% of the syn isomer was detected. Crystals suitable for X-Ray analysis were obtained 
by heating a suspension of the product in toluene-CH2Cl2 until complete dissolution 
and slowly cooling the sample to room temperature. 1H NMR (CDCl3, 500 MHz): δ 
7.94 (d, J = 8.4 Hz, 2H), 7.87 (d, J = 8.4 Hz, 2H), 7.71 (s, 1H), 7.62 (s, 2H), 7.54 (m, 
2H), 7.45  (d, J = 8.2 Hz, 2H), 5.22-4.71 (m, 4H), 2.98 (m, 4H), 2.10-1.40 (m, 48H). 
13C NMR (CDCl3, 125 MHz): δ 158.3, 151.6, 145.0, 131.8, 131.5, 129.6, 129.5, 
126.6, 125.4, 124.1, 117.8, 54.7, 48.4, 42.6, 37.8, 37.2, 37.1, 37.0, 36.7, 28.5, 28.3, 
28.1, 28.0, 27.4, 27.3. 19F NMR (DMSO-d6, 376 MHz): δ -143.49, -143.54. HRMS 
(EI) m/z calcd for C51H67BF4N2: 707.5304. Found: 707.5305. 
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1,3-Bis(2,7-dicyclooctylnaphthalen-1-yl)-imidazolinium tetrafluoroborate (4h). 
To a Schlenk tube containing 3h (0.41 g, 0.54 mmol) and NH4BF4 (0.006 g, 0.60 
mmol), were added (EtO)3CH (6 ml) and formic acid (2 drops). The mixture was then 
heated to 110˚C for 4 hours and to 90˚C overnight. The suspension was cooled to 
room temperature and filtered to eliminate most of the (EtO)3CH. The obtained 
yellow solid was dissolved in CH2Cl2 and filtered through celite to eliminate the 
excess of NH4BF4. The solution was then concentrated under vacuum and, upon 
addition of Et2O, a white solid precipitated. The solution was decanted and the solid 
was washed with Et2O (3 × 10 ml). The desired product was then dried under high 
vacuum for 12 hours (0.13 g, 29 % yield). From 1H-NMR analysis the two isomers 
were present in a ratio of 9:1 (anti/syn). Due to overlap of most of the signals of the 
two isomers only the ones related to the major isomer are reported. 1H NMR (DMSO-
d6, 500 MHz): δ 7.99 (d, J = 8.3 Hz, 2H), 7.92 (d, J = 8.7 Hz, 2H), 7.76 (s, 1H), 7.64 
(s, 2H), 7.58 (d, J = 8.7 Hz, 2H), 7.52 (d, J = 8.5 Hz, 2H), 5.22-4.75 (m, 4H), 3.10 (s, 
4H), 2.20-1.50 (m, 56H). 13C NMR (DMSO-d6, 125 MHz): δ 158.4, 152.3, 145.0, 
131.6, 131.5, 129.8, 129.4, 127.1, 125.8, 124.6, 118.0, 54.8, 46.7, 41.7, 35.4, 35.0, 
34.2, 33.9, 28.2, 27.7, 27.5, 27.0, 26.4, 26.3, 26.1, 25.9, 24.7. 19F NMR (DMSO-d6, 
376 MHz): -152.63, -152.69. HRMS (ESI) m/z calcd for C55H75BF4N2: 850.5959. 
Found: 763.5917 [M-BF4]. 
 
General procedure for the synthesis of free carbenes: 
 
1,3-Bis(2-(4-heptyl)naphthalen-1-yl)-imidazolin-2-ylidene (5a). To a suspension of 
4a (0.50 g, 0.82 mmol) in dry THF (50 ml) under nitrogen, NaH (55 to 65 % 
suspension in mineral oil, 0.043 g, 1.07 mmol) and a catalytic amount of KOtBu were 
added. The resulting mixture was stirred at room temperature for 15 h. It was then 
slowly filtered through celite to eliminate the inorganic salts. After evaporation of the 
solvent, the desired product was obtained as a slightly orange solid (0.42 g, 99 % 
yield). From NMR analysis two distinct isomers were present in a ratio of 
approximately 55:45. 1H NMR (C6D6, 400 MHz): δ 8.38-8.26 (m, 2H), 7.75-7.64 (m, 
4H), 7.57-7.44 (m, 2H), 7.43-7.27 (m, 4H), 3.85-3.51 (m, 6H), 1.91-1.13 (m, 16H), 
1.05- 0.73 (m, 12H). 13C NMR (C6D6, 100 MHz): δ 247.2, 247.1, 142.5, 142.2, 138.6, 
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138.5, 134.1, 133.0, 132.7, 129.0, 128.9, 127.2, 126.9, 126.1, 126.0, 125.4, 125.3, 
124.6, 124.5, 53.4, 54.2, 40.2, 40.0, 39.9, 39.8, 39.7 38.9, 22.4, 22.3, 21.7, 21.6, 15.4, 
15.2, 15.1. 
 
1,3-Bis(2-cyclopentylnaphthalen-1-yl)-imidazolin-2-ylidene (5b). Following the 
general procedure [4b (0.18 g, 0.27 mmol), NaH (0.013 g, 0.33 mmol), KOtBu (cat.), 
THF (40 ml)], the desired compound was obtained as an off-white solid (0.11 g, 90 % 
yield). From NMR analysis two isomers in a 50:50 ratio can be identified. Crystals 
suitable for X-Ray analysis were obtained through slow diffusion of pentane into a 
concentrated solution of the product in benzene. 1H NMR (C6D6, 500 MHz): δ 8.32 (d, 
J = 8.3 Hz, 1H), 8.20 (d, J = 8.3 Hz, 1H), 7.68 (m, 4H), 7.52-7.42 (m, 2H), 7.40-7.28 
(m, 4H), 3.85-3.40 (m, 6H), 2.35 (m, 2H), 2.17-2.00 (m, 2H), 1.95-1.5 (m, 12H). 13C 
NMR (C6D6, 125 MHz): δ 246.4, 246.2, 142.2, 142.1, 138.2, 138.1, 134.0, 132.7, 
132.6, 128.9, 128.8, 128.7, 128.5, 127.3, 127.0, 126.0, 125.9, 125.7, 125.6, 124.4, 
124.0, 54.1, 54.0, 41.7, 41.3, 36.3, 36.1, 35.7, 35.2, 27.4, 27.0, 26.9, 26.7. 
 
1,3-Bis(2-cycloheptylnaphthalen-1-yl)-imidazolin-2-ylidene (5c). Following the 
general procedure starting [4c (0.10 g, 0.17 mmol), NaH (0.008 g, 0.20 mmol), 
KOtBu (cat.), THF (50 ml)], the desired compound was obtained as an off-white solid 
(0.09 g, 99 % yield). From NMR analysis 16 % of the syn isomer can be identified 
(due to strong overlap between most of the signals of the two isomers only the ones 
related to the major isomer are reported). 1H NMR (C6D6, 400 MHz): δ 8.30 (d, J = 
8.5 Hz, 2H), 7.73 (d, J = 8.5 Hz, 2H), 7.67 (d, J = 8.5 Hz, 2H), 7.58 (t, J = 7.5 Hz, 
2H), 7.50-7.30 (m, 4H), 3.75-3.42 (m, 4H), 2.25 (m, 2H), 2.00-1.50 (m, 24H). 13C 
NMR (C6D6, 100 MHz): δ 245.7, 145.8, 136.3, 133.9, 132.7, 128.9, 128.7, 126.9, 
126.1, 125.9, 124.4, 54.1, 41.5, 38.0, 37.2, 36.8, 29.3, 29.0, 28.4, 28.3. 
 
1,3-Bis(2-cyclooctylnaphthalen-1-yl)-imidazolin-2-ylidene (5d). In a glove box, to 
a suspension of 4d (0.40 g, 0.63 mmol) in THF (50 ml), NaH (55 to 65 % suspension 
in mineral oil, 0.029 g, 0.76 mmol) and a catalytic amount of KOtBu were added. The 
obtained mixture was heated to reflux with a heat gun for a few minutes to initiate the 
reaction and then reaction was stirred at room temperature for 3 h. It was then slowly 
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filtered through celite to eliminate the inorganic salts. After evaporation of the 
solvent, 5 ml of Et2O were added to the sticky pink solid and the resulting suspension 
was stirred for 5 minutes. The solvent was decanted and the pink solid was dried in 
high vacuum (0.31 g, 90 % yield). From NMR analysis 17 % of the syn isomer was 
detected. (Due to overlap of most of the signals for both isomers, only the ones related 
to the major isomer are reported). 1H NMR (C6D6, 400 MHz): δ 8.32 (d, J = 8.2 Hz, 
2H), 7.74 (d, J = 8.3 Hz, 2H), 7.68 (d, J = 8.4 Hz, 2H), 7.59 (m, 2H), 7.37 (m, 2H), 
3.80-3.40 (m, 6H), 2.22-1.4 (m, 28H). 13C NMR (C6D6, 100 MHz): δ 245.8, 146.7, 
136.1, 133.9, 132.6, 128.9, 126.9, 126.7, 125.9, 124.6, 54.2, 38.6, 36.4, 36.1, 28.3, 
28.1, 27.1, 26.5. 
 
1,3-Bis(2,7-cyclopentylnaphthalen-1-yl)-imidazolin-2-ylidene (5e). Following the 
general procedure [4e (0.08 g, 0.11 mmol), NaH (0.006 g, 0.17 mmol), KOtBu (cat.), 
THF (20 ml)], the desired compound was obtained as an off-white solid (0.06 g, 92 % 
yield). From NMR analysis a 1:1 mixture of isomers was observed. 1H NMR (C6D6, 
500 MHz): δ 8.20 (s, 1H), 8.11 (s, 8.10), 7.74 (m, 4H), 7.38 (m, 4H), 3.97-3.18 (m, 
8H), 2.40-1.60 (m, 32H). 13C NMR (C6D6, 125 MHz): δ 246.1, 245.7, 145.0, 144.9, 
142.4, 142.2, 138.0, 137.9, 132.8, 132.7, 132.6, 129.1, 129.0, 128.7, 125.9, 125.7, 
124.9, 122.0, 121.5, 54.0, 53.9, 47.6, 47.5, 41.3, 36.2, 36.1, 35.9, 35.8, 35.6, 35.5, 
35.3, 35.2, 27.4, 27.3, 27.0, 26.5, 26.4, 26.3. 
 
1,3-Bis(2,7-cyclohexylnaphthalen-1-yl)-imidazolin-2-ylidene (5f). Following the 
general procedure [4f (0.40 g, 0.54 mmol), NaH (0.025 g, 0.65 mmol), KOtBu (cat.), 
THF (50 ml)], the desired compound was obtained as a pink solid (0.35 g, 99 % 
yield). From NMR analysis only trace amounts of the syn isomer can be detected (less 
then 5 %). 1H NMR (C6D6, 400 MHz): δ 8.22 (s, 2H), 7.82 (d, J = 8.4 Hz, 2H), 7.74 
(d, J = 8.5 Hz 2H), 7.47 (d, J = 8.5 Hz 2H), 7.42 (m, 2H), 3.9-3.35 (m, 6H), 2.96 (m, 
2H), 2.38-1.30 (m, 40H). 13C NMR (C6D6, 100 MHz): δ 245.7, 146.7, 143.9, 137.2, 
132.9, 132.8, 129.2, 128.1, 125.3, 125.1, 121.6, 68.2, 54.1, 46.8, 40.5, 35.7, 35.2, 
35.1, 34.9, 28.4, 27.8, 27.7, 27.6, 27.2, 26.9, 26.2.  
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1,3-Bis(2,7-cycloheptylnaphthalen-1-yl)-imidazolin-2-ylidene (5g). Following the 
general procedure [4g (0.10 g, 0.12 mmol), NaH (0.006 g, 0.15 mmol), KOtBu (cat.), 
THF (30 ml)], the desired product was obtained as a yellow-orange solid (0.09 g, 91 
% yield). From NMR analysis, 5 % of the syn isomer can be detected. 1H NMR (C6D6, 
500 MHz): δ 8.13 (s, 2H), 7.76 (d, J = 8.4 Hz, 2H), 7.68 (d, J = 8.5 Hz, 2H), 7.38 (m, 
4H), 3.80 (m, 2H), 3.52 (m, 2H), 3.40  (m, 2H), 3.06 (m, 2H), 2.42-1.3 (m, 48H). 13C 
NMR (C6D6, 125 MHz): δ 246.2, 148.6, 145.8, 136.1, 132.6, 132.5, 129.5, 128.7, 
125.5, 125.1, 121.0, 54.2, 49.2, 42.4, 38.2, 37.7, 37.6, 37.3, 29.3, 29.0, 28.7, 28.6, 
28.4, 28.1, 28.0, 27.8.  
 
1,3-Bis(2,7-cyclooctylnaphthalen-1-yl)-imidazolin-2-ylidene (5h). Following the 
general procedure [4b (0.10 g, 0.12 mmol), NaH (0.006 g, 0.14 mmol), KOtBu (cat.), 
THF (30 ml)], the desired product was obtained as a white solid (0.063 g, 70 % yield). 
From NMR analysis 5 % of the syn isomer can be detected. 1H NMR (C6D6, 400 
MHz): δ 8.23 (s, 2H), 7.89 (d, J = 8.4 Hz, 2H), 7.80 (d, J = 8.6 Hz, 2H), 7.55(d, J = 
8.6 Hz, 2H), 7.50 (dd, J = 8.4, 1.2 Hz, 2H), 3.97 (br, 2H), 3.77 (br, 2H), 3.57  (br, 
2H), 3.27 (br, 2H), 2.40-1.73 (m, 56H). 13C NMR (C6D6, 100 MHz): δ 246.6, 149.1, 
146.1, 136.2, 132.6, 132.5, 129.4, 128.2, 126.0, 125.5, 121.1, 54.1, 47.2, 40.7, 36.2, 
35.4, 34.3, 28.7, 27.9, 27.7, 27.6, 27.0, 26.9, 26.7, 26.6, 26.2, 25.9. 
 
3.7 Additional experimental data 
 
N-(2,6-diisopropylbenzene)-N’-(2-cyclohexylnaphthalen-1-yl)-ethane-1,2-diamine 
(3i). In a glove box, a Schlenk flask was charged with rac-BINAP (0.42 g, 0.68 
mmol), Pd2(dba)3 (0.41 g, 0.45 mmol) NaOtBu (1.74 g, 18.16 mmol) and toluene (100 
ml). The resulting violet suspension was stirred at room temperature for 10 minutes 
and then 1-bromo-2-cyclohexyl naphthalene (2.89 g, 9.98 mmol) was added. After 
another 5 minutes 2i (2.00 g, 9.08 mmol) was added, the flask was taken out of the 
glovebox, connected to a condenser and the suspension was refluxed for 18 hours. 
The mixture was cooled to room temperature and then passed through a celite filter to 
eliminate the inorganic salts. After evaporation of the solvent the obtained oil was 
purified by silica gel chromatography (eluent: hexane-CH2Cl2 4:1 to 1:1) to yield the 
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desired product as a white solid (1.50 g, 38 % yield). 1H NMR (CDCl3, 400 MHz): δ 
8.28 (d, J = 8.2 Hz, 1H), 7.82 (d, J = 8.1 Hz, 1H), 7.60 (d, J = 8.0 Hz, 1H), 7.53-7.42 
(m, 3H), 7.18-7.10 (m, 3H), 3.80-3.60 (s, broad, 2H), 3.45-3.37 (m, 4 H), 3.27 (t, J = 
6 Hz, 2H), 3.14 (m, 1H) 1.95-1.30 (m, 22H). 13C NMR (CDCl3, 100 MHz): δ 142.9, 
136.6, 133.3, 129.6, 128.4, 125.7, 125.3, 125.2, 124.2, 123.8, 123.7, 123.5 52.5, 52.3, 
39.0, 34.5, 28.0, 27.4, 26.5, 24.5.  HRMS (ESI) m/z calcd for C30H40N2: 428.3191. 
Found: 429.3263 [M+1]. 
 
1-(2,6-diisopropylbenzen-1-yl)-3-((2-cyclohexyl)naphthalene1-yl)-imidazolinium  
tetrafluoroborate (4i). To a Schlenk tube containing 3i (0.61 g, 1.42 mmol) and 
NH4BF4 (0.21 g, 1.99 mmol), was added (EtO)3CH (15 ml). To this suspension was 
added formic acid (3 drops) and the mixture was heated at 110˚C for 2 hours. After 
this time a lot of sticky yellow solid was present. The suspension was cooled to RT 
and filtered. The filtrate was washed with 100 ml of Et2O and dried. It was then 
purified by silica gel chromatography (eluent:  Hexane to CH2Cl2 to CH2Cl2-MeOH 
5:1) to give the desired product as a white powder (0.47 g, 63 % yield). 1H NMR 
(DMSO-d6, 400 MHz): δ 9.52 (s 1H), 8.18 (d, J = 8.8 Hz, 1H), 8.10 (d, J = 8.1 Hz, 
1H), 7.92 (d, J = 8.4 Hz, 1H), 7.79 (t, J = 6.8 Hz, 1H), 7.75 (d, J = 8.7 Hz, 1H), 7.68 
(t, J = 7.3 Hz, 1H), 7.57 (m, 1H), 7.45 (d, J = 7.7 Hz, 2H), 4.85-4.45 (m, 4H), 3.35 
(m, 2H), 3.12 (m, 1H), 2.91 (m, 1H), 1.95-1.2 (m, 22H). 13C NMR (DMSO-d6, 100 
MHz): δ 161.9, 146.1, 146.0, 143.1, 132.4, 131.2, 130.9, 130.0, 129.3, 128.9, 128.7, 
128.5, 128.2, 127.2, 126.8, 125.1, 124.9, 124.8, 121.1, 54.0, 53.1, 33.9, 32.5, 28.2, 
26.2, 26.0, 25.2, 25.0, 24.8, 23.5, 23.0. 19F NMR (DMSO-d6, 376 MHz): δ -148.29, -
148.35. HRMS (ESI) m/z calcd for C31H39BF4N2: 526.3142. Found: 439.3109 [M-
BF4]. 
 
1,3-Bis(2-(4-heptyl)naphthalen-1-yl)-imidazolin-2-ylidene (5i). To a suspension of 
5a (0.45 g, 0.85 mmol) in dry THF (50 ml) under nitrogen, NaH (55 to 65 % 
suspension in mineral oil, 0.027 g, 1.11 mmol) and a catalytic amount of KOtBu were 
added. The resulting mixture was stirred at room temperature for 15 h. It was then 
slowly filtered through celite to eliminate the inorganic salts. After evaporation of the 
solvent, the desired product was obtained as a slightly pink solid (0.37 g, 98 % yield). 
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1H NMR (C6D6, 400 MHz): δ 8.21 (d, J = 8.2 Hz, 2H), 7.74 (m, 2H), 7.49 (m, 2H), 
7.35 (m, 2H), 7.25 (d, J = 7.8 Hz, 2H), 3.68-3.29 (m, 7H), 2.25 (d, J = 5.1 Hz, 2H), 
1.98-1.30 (m, 21H). 13C NMR (C6D6, 100 MHz): δ 245.5, 147.8, 147.7, 143.3, 139.8, 
137.5, 134.1, 132.9, 127.0, 125.9, 125.6, 124.5, 125.7, 124.2, 54.3, 53.9, 40.1, 34.8, 
34.5, 29.5, 29.2, 28.1, 27.8, 27.0, 25.7, 25.6, 24.4, 23.9. 
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CHAPTER FOUR 
 
 
Efficient Ring-Closing Metathesis of Alkenyl Bromides: The Importance 
of Protecting the Catalyst during the Olefin Approach. 
 
Michele Gatti, Emma Drinkel, Linglin Wu, Ivano Pusterla, Fiona Gaggia, Reto Dorta* 
 
(J. Am. Chem. Soc. 2010, 132, 15179) 
 
Abstract: We present the first productive ring-closing metathesis reaction that leads 
to the construction of cyclic alkenyl bromides. Efficient catalysis employing 
commercially available Grubbs II catalyst is possible through appropriate 
modification of the starting bromoalkene moiety. 
_____________________________________________________________________ 
 
The advent of alkylidene-based ruthenium metathesis catalysts featuring high 
functional group tolerance greatly contributed to the affirmation of alkene metathesis 
as one of the most important tools to manipulate a C-C double bond.1 In particular 
RCM (ring-closing metathesis) has been widely explored and applied in the synthesis 
of complex natural products.2 Less developed, but highly desirable, are versions of 
this reaction in which one of the two olefins bears heteroatom substituents. To date, a 
number of dienes containing enol ethers and enamines have been studied,3 but good 
results in RCM were only obtained with high catalyst loadings and the applicability is 
restricted to a limited number of substrates. The synthesis of cyclic alkenyl halides, 
which could subsequently undergo an array of coupling reactions, represents another 
appealing version of the RCM reaction. Pioneering work in this field has been 
reported by the Weinreb group,4a,b who have shown that cyclic chloroalkenes could 
indeed be generated, albeit high catalyst loadings were again necessary for acceptable 
reactivity (10 mol %). This methodology has more recently been employed by Grubbs 
and Stoltz et al. in the successful synthesis of a specific natural compound.4c,d 
Unfortunately, the more useful alkenyl bromide substrates are known to be 
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completely inactive with both Schrock- type as well as first- and second-generation 
Grubbs-type catalysts.5,6 
In this report, we describe our effort toward the synthesis of carbo- and 
heterocyclic five-, six-, and seven-membered alkenyl halides via the RCM reaction of 
the corresponding dienes. Specifically, we show how appropriate protection of the 
starting alkenyl halide group not only leads to efficient RCM of alkenyl chlorides but 
also enables the unprecedented and highly efficient construction of cyclic 
bromoalkenes. 
Initial exploratory studies were carried out with malonate-derived alkenyl 
bromide 1. As previously reported,4a,5 both GI (Grubbs I) and GII (Grubbs II) were 
completely ineffective for the RCM of 1 as were HovII (Hoveyda-Grubbs II) and 
BleII (Blechert II).7 To possibly gain insight into what prevents catalytic turnover 
with 1, we mixed equimolar amounts of 1 and GII in C6D6 and compared results with 
a mixture of GII and the analogous substrate (2) that lacks the second terminal olefin 
unit (Figure 1). Rather unexpectedly, NMR spectroscopy of this latter mixture did not 
show appreciable amounts of decomposition of GII (and of 2) over a period of 2 
days, whereas substrate 1 was able to completely destroy the precatalyst. During the 
course of the reaction, a color change to red-brown was observed with concomitant 
formation of a white precipitate which when analyzed turned out to be clean 
SIMes·HBr.8,9 Another byproduct identified in solution and in nearly stoichiometric 
quantity (>90% against an internal standard) after the reaction was styrene.  
 
Br
EtO2C
EtO2C GII (0.9 equiv)
1
C6D6
Complete decomposition of GII
+ Styrene (> 90%)
+ SIMES HBr
Br
EtO2C
EtO2C
2
No reaction 
observed
GII (0.9 equiv)
C6D6
RT
RT
 
Figure 1. Stoichiometric reactivity of model substrates 1 and 2. 
 
While the overall mechanism by which GII decomposes is speculative at this point, 
the generation of styrene (and the lack of reactivity between 2 and GII) strongly 
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points to a reaction scenario where initial cross metathesis of the unsubstituted olefin 
in 1 with the benzylidene moiety of GII preceeds decomposition of the catalyst.10 
This in turn would mean that the alkenyl bromide unit only reacts irreversibly with 
the active ruthenium species when it is forced into close proximity to the metal 
center.11 Given these unexpectedly insightful stoichiometric studies, we reasoned that, 
by simply introducing one or two substituents to the terminal position of the 
bromoalkene, we could reduce its ability to destroy the catalyst and be able to 
catalytically generate cyclic bromoalkenes via RCM.12,13 
 
Table 1. Influence of Olefin Substitution on Catalytic Activitya 
 
1 (1)
entry mol %GII
T 
(°C)
yield 
(%)c
4 (5)
5 (6)
solvent
benzene 60 0
t (h)
24
Br
R1
R2EtO2C
EtO2C BrEtO2C
EtO2C
GII
R1 R2
Ph benzene 60 >98 (90)0.5
Ph
benzene 60 024H H
2 (3) benzene 60 024Me Me
3 (4) benzene 60 7024Me H
2
2
2
2
2
1,3,4,5,6 5a
R1
R2
H
H
a All the reactions were performed with a 0.1 M substrate
concentration. The substrate was added via syringe to a solution of
catalyst preheated in an oil bath for 2 min. b For a screening of different 
solvents and catalysts, see the Supporting infomation. c Yields based on
NMR analysis. Isolated yiled in parenthesis.  
 
As a first attempt, we tested a substrate featuring a geminal dimethyl substitution 
(Table 1, entry 2) that proved to be unreactive in RCM, most probably due to the low 
propensity of a tetrasubstituted olefin to approach the metal center and bind to it. In 
contrast, the introduction of a single substituent Z to the bromine atom turned out to 
be highly beneficial. In the presence of a methyl group (Table 1, entry 3) formation of 
a substantial amount of product was observed from NMR analysis;14 when a substrate 
featuring a Z-configured terminal phenyl group was employed, full conversion was 
observed and product 5a was obtained in 90% isolated yield using 2 mol % of GII 
(Table 1, entry 4). Mechanistically most relevant and in line with the idea of correctly 
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protecting the alkenyl bromide during its approach to the metal, incorporation of a 
terminal phenyl group E to the halide (Table 1, entry 5) did not lead to any product 
formation under otherwise identical reaction conditions.15 
  
Table 2. RCM Reactions Generating Cyclic Alkenyl Bromides and Chlorides 
1 Br
Ph
EtO2C
EtO2C
EtO2C
EtO2C Br 0.5 90Benzene2
5 5a
entrya yield (%)csolvent t (h)substrateb product GII (mol %)
Br
PhNTs NTs Br 1.5 64Benzene22
7 7a
Br
PhNTs NTs Br 1.5 76Benzene23
8 8a
Ph
4 Br
Ph
EtO2C
EtO2C
EtO2C
EtO2C Br 0.5 96Benzene2
9 9a
5 Br
Ph
EtO2C
EtO2C 2 92Benzene0.5
10 10a
75Benzene0.1
0.5 96Benzene2
2
BrEtO2C
EtO2C
Ph
O
Ph
Br
6 0.5 94Benzene2
11 11a
Br
PhO
Ph
N Br
7 1.5 95Benzene2
12 12a
Br
PhN
TsTs
N Br
8 2 95Benzene2
13 13a
Br
PhN
TsTs
Ph Ph
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entrya yield (%)csolvent t (h)substrateb product GII (mol %)
N Cl
9 2 97Benzene2
14 14a
Cl
PhN
TsTs
Ph Ph
N Cl
10 4 815
15 15a
Cl
PhN
TsTs
Ph Ph
CH2Cl2d
Cl
Ph
EtO2C
EtO2C
ClEtO2C
EtO2C11 14 925 CH2Cl2d
16 16a
N
Ph
Ph
Ts
Cl
Ph NTs
Cl
PhPh
NTs
Br
Br
PhN
Ts
Ph
12 24 0d5 CH2Cl2d
Ph
17 17a
18 18a
13 3 765 CH2Cl2d
N
Ph
Ph
Ts
br
Ph NTs
Br
PhPh
19 19a
14 3 675 CH2Cl2d
N Br
Br
Ph
N
TsTs
20 12a
15 5 Trace2 Benzene
Br
Ph
EtO2C
EtO2C
BrEtO2C
EtO2C
20 12a
16 5 Trace2 Benzene
a All The reaction were performed using 0.16 mmold of substrate with a 0.1 M substrate
concentration except entries 12-14 (0.01 M). b Shelf lives of all compounds at -25 °C are at 
least 5 months without decomposition. c Isolated yield after column chromatography. d
Reactions performed in benzene gave slightly lower yields. The main producto of the
reaction was compound 13a.  
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The scope of the reaction was then explored with a wider range of bromoalkene 
derivatives, and the results are summarized in Table 2. Overall, five-membered and 
especially six-membered rings were generated in good to excellent isolated yields 
within short reaction times. Indeed, less than 2 mol % of GII seem to suffice for 
efficient ring closing as evidenced from data collected for substrate 10 (Table 2, entry 
5). Vastly improved results as compared to data in the literature4a were obtained 
when applying the same concept to the construction of representative cyclic alkenyl 
chlorides 9a and 14a (Table 2, entries 4 and 9). Likewise, the synthesis of six-
membered tetrasubstituted cyclic chloroalkenes 15a and 16a proceeded with 
remarkable ease and in high yield when employing a higher catalyst loading (Table 2, 
entries 10 and 11).16 Unfortunately, an attempt to generate the analogous tetra-
substituted cyclic alkenyl bromide gave only trace amounts of product. For the 
synthesis of seven- membered rings (substrates 17-19), the disposition of the 
substituents proved to be important and efficient catalysis was only possible with 
substrates 18 and 19, where a stronger Thorp-Ingold effect is to be expected (Table 2, 
entries 13 and 14).17 Indeed, when trying to ring-close substrate 17, relatively clean 
conversion (50% isolated yield) to the six-membered product 13a was observed, 
meaning that an unusually efficient olefin isomerization step occurs before the 
expected metathetical ring closure.18  
 
Ru
NHC
Cl
Cl
Ph
Ru
NHC
Cl
Cl
Ru
NHC
Cl
Cl
Ph Br
Br
Ph Br
Only the less indered olefin 
undergoes initial CM
Coordination mode of the 
vinyl halide (end-on or side-on)
still unknown
Protected, Z-configured olefin
approaches the catalyst
without decomposing it
(Z)
A relatively stable benzylidene 
as the active species
Ph
Ph Br(Z)
 
Figure 2. Proposed catalytic cycle for the RCM of bromoalkenes. 
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The last two entries in Table 2 (15 and 16) again underline the importance of 
correctly substituting the starting alkenyl bromide and the strikingly different 
reactivity of the resulting diene, as both E-configured olefins 19 and 20 did not 
generate the desired RCM products.19 
In conclusion, we have developed a catalytic method (Figure 2) to access cyclic 
alkenyl bromides via the ruthenium-catalyzed ring-closing metathesis reaction using 
synthetically useful catalyst loadings of GII (Grubbs II). The starting diene 
compounds are easily accessible and should make the present protocol attractive as a 
methodology for the construction of more elaborate molecular structures. 
The concept of sterically protecting double bonds that would otherwise 
irreversibly react and deactivate metathesis-active catalysts should not be applicable 
to only alkenyl halides, and studies aimed at developing this idea further are currently 
underway. 
 
4.1 Experimental section 
 
General procedure: All reactions were carried out under nitrogen atmosphere using 
standard Schlenk-lines or glovebox (Mecaplex or Innovative Technology). Solvents 
(THF, CH2Cl2, pentane and Et2O) were purged through alumina columns in a solvent 
purification system (Innovation Technology). Toluene was distilled from Na or 
Na/benzophenone. Benzene (HPLC quality) was degassed and stored in a glovebox 
over molecular sieves. Dry DMF was purchased from ACROS and stored in a 
glovebox. Solvent for NMR spectroscopy were degassed with nitrogen and dried over 
molecular sieves. NMR spectra were collected on an AV2 400 or AV2 500 MHz 
Bruker spectrometer. Chemical shift are given in ppm. The spectra are calibrated to 
the residual 1H and 13C  signals of the solvent. Multiplicities are abbreviated as 
follows: singlet (s), doublet (d), triplet (t), quartet (q), doublet-doublet (dd), quintet 
(quint), septet (sept), multiplet (m), and broad (br).  High-resolution electrospray 
ionization mass spectrosmetry was performed on a FinniganMAT 900 (Finnigan 
MAT95, San Jose, CA; USA) double-focusing magnetic sector mass spectrometer 
(geometry BE).  GC-MS analysis was done on a Finnigan Voyager GC8000 Top. 
Infrared spectroscopy was performed on a Jasco FT/IR-4100. All commercially 
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available products were used as received except for 2,3-dibromopropene (Sigma 
Aldrich, Technical grade 85%) that was fractionally distilled.  
 
Screening of reaction conditions 
 
1 (1)
entry precatalyst(mol %) T (°C) yield (%)b
4 (3)
5 (4)
6 (5)
8 (5)
9 (5)
GII
GII
HovII
BleII
GII
GII
GII
solvent
Benzene
Benzene
Benzene
Benzene
Benzene
Toluene
CH2Cl2
60
60
60
60
27
60
60
70
100 (90)
70 (61)
100 (87)
< 5
100 (73)
100 (85)
a All the reactions were performed with a 0.1 M substrate concentration. The
substrate was added via siringe to a solution of catalyst preheated in an oil
bath for 2 minutes. b Yields based on NMR analysis. Isolated yields in
brackets. c Substrate mixed with catalyst at room temperature and then heated 
at 65°C
t (h)
24
0.5
24
0.5
24
0.5
0.5
Br
R1
R2EtO2C
EtO2C
Br
EtO2C CO2Et
Precatalyst
R1 R2
Me Me GII Benzene 60 024
Me H
Ph H
GII Benzene 60 024H H
Ph H
Ph H
Ph H
10 (5)
12 (5)
13 (5)
7 (5) GI Benzene 60 < 524Ph H
Ph H
Ph H
BleII Benzene 27 < 524Ph H
11 (5)
14 (5)
GII Benzene 60 100 (80)c24Ph H
Table 1. Preliminary screening of the reaction conditionsa
2 (1) HovII Benzene 60 024H H
3 (1) BleII Benzene 60 024H H
(2)
(2)
(2)
(2)
(2)
(2)
(5)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
1,3,4,5,6 5a
0.1 M R1
R2
GII Benzene 60 00.5Ph14 (6) (2)H
 
 
 
 
 
 
 
 
 
 
 
 
 109 
Stechiometric experiments 
 
 
 
 
Figure 1. 1H (up) and 31P (down) NMR of the reaction between 1.3 eq of 2 and 1 eq 
of GII in C6D6 recorded after 40 h at room temperature under nitrogen. 
Decomposition of the catalyst is between 5 and 6 %. 
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Figure 2. 1H NMR of the reaction between 1.2 eq of 1 and 1 eq of GII in C6D6 
recorded after 24 h at room temperature under nitrogen. 1 eq of naphthalene was used 
as internal standard (added at the end of the reaction, before NMR analysis). GII is 
almost completely decomposed. Formation of styrene (~ 0.9 eq) is observed. 
Unreacted 2 is still present. 
 
Styrene 
Starting  
diene 
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Figure 3. Determination of the NHC salt counterion (1H NMR). Reference 
SIMes.HCl and HBr (page before) and SIMes.HBr obtained from the reaction of 1 
with GII (below). 
 
Experimental section: synthesis of substrates. 
 
 
Br
Br
 
 
(Z)-1,2-Dibromo-2-butene (I): A mixture of trans-α-Bromocrotyl alcohol20 (1.50 g, 
9.93 mmol) and tetrabromocarbon (4.28 g, 12.91 mmol) in CH3CN (40 ml) was 
cooled to 0°C and then powdered triphenylphosphine (3.39 g, 12.91 mmol) was added 
portionwise. The transparent mixture obtained was stirred at room temperature until 
complete conversion was observed from TLC (Hexane - Et2O 10:1). The solvent was 
distilled off to give a viscous yellow oil to which hexane (3 ml) was added. The 
resulting suspension was sonicated for 5 minutes and then directly loaded on a silica 
gel filter (eluent: Hexane). Compound I was obtained in quantitative yield as a 
transparent oil (traces of CHBr3 were present from 1H-NMR analysis). IR (film): 
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1647, 1298, 1210, 943, 909, 673, 617 cm-1. 1H NMR (CDCl3, 400 MHz): δ 6.18 (m, 
1H), 4.32 (s, 2H), 1.76 (d, J = 7.2 Hz, 3H) 13C NMR (CDCl3, 100 MHz): δ 129.8, 
123.8, 39.1, 17.5 ppm. HRMS (ESI) calcd for C4H6Br2: 211.8836. Found 211.8836. 
 
Br
Br
 
 
1,2-Dibromo-3-methyl-2-butene (II): A solution of 2-bromo-3-methyl-buten-1-ol21 
(0.50 g, 3.00 mmol) in CH2Cl2 (20 ml) was cooled to -20°C and then powdered 
triphenylphosphine (0.94 g, 3.6 mmol) was added. To the resulting mixture was added 
solid N-bromo succinimide (0.59 g, 3.3 mmol) and the solution was stirred until from 
TLC (Hexane - Et2O 10:1) the reaction was complete (2h). Water was added (20 ml) 
and the organic layer was extracted with CH2Cl2 (2x50 ml).  After evaporation of the 
solvent the resulting yellow oil was subjected to silica gel chromatography (eluent: 
Hexane) to give the desired product (0.46 g, 67% yield). The analytical data were 
consistent with the one reported in literature.22 
 
Ph
Cl
Br
 
 
 
(Z)-(2-Chloro-3-bromopropenyl)benzene (III): A mixture of (Z)-2-bromo-3-
phenylprop-2-en-1-ol23 (1.10 g, 6.52 mmol) and tetrabromocarbon (2.60 g, 7.83 
mmol) in CH3CN (30 ml) was cooled to 0°C and then powdered triphenylphosphine 
(2.05 g, 7.83 mmol) was added portionwise. The resulting transparent mixture was 
stirred at room temperature until complete conversion was observed from TLC 
(eluent: Hexane-Et2O 10:1). After distillation of the solvent a yellow oil was obtained. 
Hexane (3 ml) was added and the resulting suspension was sonicated for 5 minutes 
and then directly loaded on a silica gel filter (eluent: Hexane).  Compound 3 was 
obtained in quantitative yield as a transparent oil. From NMR analysis traces of 
CHBr3 are present. They can be easily eliminated via distillation (35 °C, 0.01 mbar). 
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IR (film):  3055, 3025, 1631, 1597, 1574, 1491, 1447, 1242, 1345, 1288, 1208, 1286, 
1158, 1135, 1106, 1093, 1070, 1030, 919, 899, 863, 824, 752, 690, 656, 643, 621, 
613, 524, 480 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.65 (d, J = 7.8 Hz, 2H), 7.4 (m, 
3H), 6.87 (s, 1H), 4.32 (s, 2H). 13C NMR (CDCl3, 100 MHz): δ 134.0, 132.6, 129.5, 
129.2, 129.0, 128.5, 38.8. HRMS (EI) calcd for C9H8ClBr: 229.9498. Found 
229.9499. 
 
Ph
Br
Br  
 
(E)-(2,3-Dibromopropenyl)-benzene (IV): To a solution of (Z)-(2,3-dibromoprop-1-
enyl)benzene24 (1.00 g, 3.62 mmol) in 3 ml of CHCl3 was added a catalytic amount of 
I2. The obtained mixture was stirred until a light pink uniform solution is obtained and 
then it was exposed for 3 h to sunlight. After this time from TLC (eluent: Hexane) an 
almost 1:1 mixture of E and Z product was obtained. The solvent was distilled at 
room temperature and the obtained orange oil was loaded into a silica gel column 
(eluent: Hexane). Compound 4 (300 mg, 1.09 mmol, 30% yield) was obtained as 
transparent oil that rapidly solidifies at low temperature. From NMR analysis about 
5% of Z isomer is present. The starting material was recovered after purification (0.65 
g, 2.35 mmol). The obtained analytical data (IR and MS) were consistent with the one 
reported in literature.25 1H NMR (CDCl3, 400 MHz): δ 7.32 - 745 (m, 5H), 7.12 (s, 
1H), 4.40 (s, 2H). 13C NMR (CDCl3, 100 MHz): δ 137.0, 135.5, 129.1, 128.2 122.8, 
35.4. 
 
EtOOC
EtOOC
Br
 
 
Diethyl-2-(2-bromo-prop-2-enyl) malonate (2): Following the procedure described 
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for compound 5 and starting from diethyl-2-propyl malonate (1.00 g, 5.31 mmol), 
2,3-dibromopropene (1.27 g, 6.37 mmol), NaOEt (0.43 g, 6.37 mmol) and THF (40 
ml) the desired product was obtained after silica gel chromatography (eluent: Hexane 
- CH2Cl2 30:1) as a transparent oil (1.40 g, 86 % yield). IR (film): 2964, 2937, 1731, 
1625, 1465, 1446, 1367, 1281, 1257, 1219, 1193, 1146, 1126, 1096, 1042, 1027, 913, 
899, 856 cm-1. 1H NMR (CDCl3, 500 MHz): 5.63 (s, 1H), 5.57 (m, 1H), 4.18 (m, 4H), 
3.15 (s, 2H), 1.95 (m, 2H), 1.22 (m, 8H), 0.97 (t, J = 7.6 Hz, 3H). 13C NMR (CDCl3, 
100 MHz): δ 170.9, 127.8, 121.6, 61.7, 57.4, 43.1, 33.7, 17.6, 14.4, 14.2. HRMS 
(ESI) calcd for C13H21BrO4: 320.0623. Found 343.0524. 
 
EtOOC
EtOOC
Br
 
 
Diethyl-2-allyl-2’-(2-bromo-3-methyl-but-2-enyl) malonate (3): Following the 
procedure described for compound 5 and starting from diethyl-2-allyl malonate (0.35 
g, 1.76 mmol), II (0.40 g, 1.76 mmol), NaOEt (0.14 g, 2.11 mmol) and THF (25 ml), 
the desired product was obtained after silica gel chromatography (eluent: Hexane - 
CH2Cl2 1:1) as a transparent oil (0.55 g, 90 % yield). IR (film): 3075, 2983, 1731, 
1654, 1642, 1464, 1440, 1387, 1366, 1324, 1300, 1276, 1247, 1209, 1189, 1129, 
1095, 1051, 1039, 944, 858, 791, 691, 603 cm-1. 1H NMR (CDCl3, 500 MHz): 5.72 
(m, 1H), 5.05 (m, 2H), 4.15 (m, 4H), 3.28 (m, 2H), 2.72 (d, J = 7.0 Hz, 2H), 1.86 (s, 
3H), 1.76 (s, 3H), 1.24 (t, J = 7.0 Hz, 6H). 13C NMR (CDCl3, 100 MHz): δ 171.0, 
135.6, 133.2, 119.1, 115.5, 61.6, 58.1, 39.5, 36.8, 26.0, 21.7, 14.2. HRMS (ESI) calcd 
for C15H23BrO4: 346.0780. Found 369.0679. [M+Na]. 
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Diethyl-2-allyl-2’-((Z)-2-bromo-2-butenyl) malonate (4): Following the procedure 
described for compound 5 and starting from diethyl-2-allyl malonate (0.40 g, 2.00 
mmol), I (0.51 g, 2.4 mmol), NaOEt (0.15 g, 2.20 mmol) and THF (25 ml), the 
desired product was obtained after silica gel chromatography (eluent: Hexane - Et2O 
30:1) as a transparent oil (0.67 g, 95 % yield). IR (film): 3077, 2981, 2936, 1730, 
1654, 1642, 1464, 1441, 1389, 1366, 1326, 1300, 1276, 1247, 1211, 1187, 1130, 
1095, 1052, 1037, 944, 922, 858, 821, 791, 691, 603, 570 cm-1. 1H NMR (CDCl3, 400 
MHz): 5.85 (m, 1H), 5.77 (m, 1H), 5.10 (m, 2H), 4.18 (m, 4H), 3.15 (s, 2H), 2.72 (d, 
J = 7.3 Hz, 2H), 1.72 (d, J = 6.5 Hz, 3H), 1.25 (t, J = 7.1 Hz, 6H). 13C NMR (CDCl3, 
100 MHz): δ 170.6, 132.7, 129.1, 122.1, 119.4, 61.7, 57.5, 43.4, 36.3, 17.3, 14.2. 
HRMS (ESI) calcd for C14H21BrO4: 332.0623. Found 355.0514 [M+Na]. 
 
Br
Ph
EtOOC
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Diethyl-2-allyl-2’-((Z)-3-phenyl-2-bromo-2-propenyl) malonate (5): To a solution 
of diethyl allyl malonate (0.50 g, 2.50 mmol) in dry THF (5 ml) was added NaOEt 
(0.19 g, 2.75 mmol). The obtained mixture was stirred at room temperature until 
almost all the NaOEt was dissolved and then (Z)-(2,3-Dibromoprop-1-enyl)-benzene 
was added dropwise as a solution in THF (1 ml). From TLC analysis after 1 h at room 
temperature the reaction is complete.  A solution of HCl (5% in water) was added (20 
ml) and the organic layer was extracted with Et2O (3x20 ml). After evaporation of the 
solvent a yellow oil was obtained. This was subjected to silica gel chromatography 
purification (eluent: Hexane to Hexane - Et2O 30:1) to give the desired product 
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(transparent oil, 0.61 g, 62 % yield).  From NMR analysis about 5% of E isomer was 
detected. IR (film):  3079, 2980, 2936, 1730, 1640, 1492, 1464, 1445, 1389, 1366, 
1325, 1293, 1274, 1244, 1211, 1186, 1142, 1095, 1083, 1070, 1032, 999, 920, 860, 
794, 750, 695, 553 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.52 (m, 2H), 7.37-7.26 (m, 
3H), 6.85 (s, 1H), 5.74 (m, 1H), 5.17 (m, 2H), 4.22 (m, 4H), 3.35 (s, 2H), 2.84 (m, 
2H), 1.27 (t, J = 7.1 Hz, 6H). 13C NMR (CDCl3, 100 MHz): δ 170.5, 135.9, 132.9, 
132.6, 129.1, 128.3, 128.2, 120.3, 119.7, 61.8, 57.6, 45.0, 36.5, 14.3. HRMS (ESI) 
calcd for C19H23BrO4: 394.0780. Found 417.0672 [M+Na]. 
 
Br
Ph
EtOOC
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Diethyl-2-allyl-2’-((E)-3-phenyl-2-bromo-2-propenyl) malonate (6): Following 
the procedure described for compound 5 and starting from diethyl-2-allyl malonate 
(0.18 g, 0.88 mmol), IV (0.27 g, 0.98 mmol), NaOEt (0.07 g, 0.98 mmol) and THF 
(10 ml), the desired product was obtained after silica gel chromatography (eluent: 
CH2Cl2) as a transparent oil (0.33 g, 95 % yield). IR (film): 2983, 1728, 1642, 1625, 
1445, 1368, 1267, 1184, 1079, 1034, 913, 861, 754, 702, 554 cm-1. 1H NMR (CDCl3, 
500 MHz): δ 7.36 (m, 2H), 7.30-7.20 (m, 3H), 7.18 (s, 1H), 5.14 (m, 1H), 4.86 (m, 
1H), 4.75 (m, 1H), 4.12 (m, 4H), 3.50 (s, 2H), 2.67 (m, 2H), 1.20 (t, J = 7.2 Hz, 6H). 
13C NMR (CDCl3, 125 MHz): δ 170.5, 137.3, 136.1, 132.2, 128.9, 128.6, 127.8, 
123.5, 119.2, 62.0, 57.7, 37.3, 36.4, 14.1. HRMS (ESI) calcd for C19H23BrO4: 
394.0780. Found 417.0676  [M+Na]. 
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N-Allyl-N-((Z)-3-phenyl-2-bromo-2-propenyl)-p-toluensulfonamide (7): To a 
solution of N-allyl-p-toluenesulfonamide26 (0.50 g, 2.38 mmol) in dry DMF (10 ml) 
cooled to 0°C was added NaH  (55-65 % in mineral oil, 0.11 g, 2.85 mmol). The 
resulting white suspension was stirred for 15 min at this temperature and then (Z)-
(2,3-Dibromoprop-1-enyl)-benzene was added dropwise as a solution in dry DMF (5 
ml). The color changed rapidly to light yellow and the suspension vanished. From 
TLC analysis the reaction was completed after 30 min. The reaction mixture was 
quenched with a solution of NH4Cl (15 ml) and extracted with Et2O (2x30 ml).  After 
evaporation of the solvent and silica gel chromatography (eluent: Hexane - Et2O 7:1) 
the desired product was obtained as light yellow oil. To further purify the substrate 
crystallization from hot hexane was necessary. The product was then obtained as 
white needles (0.86 g, 90 % yield). From NMR analysis 5% of the E isomer was 
present. IR (film): 3083, 3055, 3025, 2980, 2921, 2858, 1639, 1597, 1492, 1445, 
1343, 1158, 1091, 991, 907, 863, 814, 749, 694, 663, 585, 547, 522 cm-1. 1H NMR 
(CDCl3, 400 MHz): δ 7.72 (d, J = 4.8 Hz, 2H), 7.50 (m, 2H), 7.35 – 7.26 (m, 5H), 
6.91 (s, 1H), 5.65 (m, 1H), 5.17 (m, 2H), 4.21 (s, 2H), 3.91 (d, J = 6.5 Hz, 2H), 2.40 
(s, 3H). 13C NMR (CDCl3, 100 MHz): δ 143.7, 137.6, 135.1, 132.6, 130.8, 129.9, 
129.2, 128.5, 128.4, 127.6, 120.8, 119.9, 56.0, 50.4, 21.7. HRMS (ESI) calcd for 
C19H20BrNO2S: 405.0398. Found 428.0875 [M+Na]. 
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N-Allyl-N-((Z)-3-phenyl-2-bromo-2-propenyl)-p-toluensulfonamide (8): To a 
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solution of chalcone (4.00 g, 19.20 mmol) in dry CH2Cl2 (50 ml) cooled to 0°C was 
added Br2  (3.69 g, 23.04 mmol) dropwise. The obtained orange solution was stirred 
for 1 h at room temperature and then quenched with a 1 M NH4Cl water solution (50 
ml). It was extracted with CH2Cl2 (2x30 ml), dried on MgSO4 and the solvent was 
removed under reduced pressure. The resulting solid was dissolved in CHCl3 (30 ml) 
and Et3N (3.30 g, 32.60 mmol) was added. The obtained mixture was stirred 
overnight at room temperature. At this point from TLC all the starting material was 
consumed. A 5 % HCl water solution was added (30 ml) and the solution was 
extracted with CH2Cl2. After column chromatography (eluent: Hexane - Et2O 10:1 to 
4:1) the desired product was obtained as a yellow oil (4.50 g, 82 % yield). All the 
analytical data obtained matched the ones previously reported in literature.27 This 
unsaturated ketone (1.00 g, 3.48 mmol) was dissolved in MeOH (30 ml) and 
CeCl3*7H2O (1.36 g, 3.66 mmol) was added at room temperature. After complete 
dissolution of the salt, NaBH4 (0.16 g, 4.18 mmol) was added portionwise (caution: 
gas is rapidly released from the reaction). From TLC all the starting material was 
consumed after 30 minutes. To the mixture was added a 5 % HCl solution in water 
(40 ml), it was extracted with Et2O, dried on MgSO4 and the solvent was evaporated 
under reduced pressure. The desired product was obtained after silica gel 
chromatography (eluent: Hexane – Et2O 9:1) as a clear oil (0.98 g, 97 % yield). All 
the analytical data obtained matched the ones previously reported in literature.28 This 
alcohol (0.28 g, 0.97 mmol) was dissolved in THF (10 ml) and to the obtained 
mixture, cooled to 0°C, were added PPh3 (0.25 g, 0.97 mmol) and N-allyl-p-
toluensulfonamide (0.17 g, 0.81 mmol). DIAD (0.20 g, 0.97 mmol) was then added 
dropwise dissolved in THF (5 ml). The reaction was stirred at room temperature until 
from TLC all the starting material was consumed (5 h). Water (20 ml) was then added 
and the obtained mixture was extracted with Et2O and dried on MgSO4. After 
evaporation of the solvent under reduced pressure the resulting yellow oil was 
purified by silica gel chromatography (eluent: Hexane - Et2O 9:1). The desired 
product was obtained as a transparent oil (0.30 g, 77 % yield). IR (film): 2921, 2866, 
1630, 1597, 1493, 1455, 1348, 1305, 1291, 1161, 1094, 1076, 1045, 870, 828, 814, 
754, 698, 669, 640, 604, 576, 546 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.77 (d, J = 
7.8 Hz, 2H), 7.45 (d, J = 8.0 Hz, 2H), 7.38 – 7.25 (m, 10H), 6.81 (s, 1H), 6.10 (s, 1H), 
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4.85 (m, 2H), 3.92 (m, 2H), 2.40 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 143.6, 
137.8, 136.6, 135.2, 134.9, 131.7, 129.7, 129.5, 129.3, 128.8, 128.5, 128.4, 128.3, 
127.9, 123.8, 117.5, 69.7, 49.2, 21.7. HRMS (ESI) calcd for C25H24BrNO2S: 
481.0711. Found 504.0611 [M+Na]. 
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Diethyl-2-allyl-2’-((Z)-3-phenyl-2-chloro-2-propenyl) malonate (9): Following 
the procedure described for compound 5 and starting from diethyl-2-allyl malonate 
(0.50 g, 2.52 mmol), III (0.61 g, 2.64 mmol), NaOEt (0.19 g, 2.77 mmol) and THF 
(25 ml), the desired product was obtained after silica gel chromatography (eluent: 
Hexane - Et2O 5:1) as a transparent oil (0.74 g, 84 % yield). IR (film): 2982, 2937, 
1732, 1640, 1491, 1445, 1367, 1296, 1244, 1212, 1187, 1143, 1095, 1073, 1032, 920, 
861, 752, 693, 648 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.53 (d, J = 7.6 Hz, 2H), 
7.38-7.26 (m, 3H), 6.56 (s, 1H), 5.72 (m, 1H), 5.15 (m, 2H), 4.22 (m, 4H), 3.29 (s, 
2H), 2.8 (d, J = 7.3 Hz, 2H), 1.27 (t, J = 7.2 Hz, 6H). 13C NMR (CDCl3, 100 MHz): δ 
170.6, 134.8, 132.6, 129.5, 129.3, 129.0, 128.4, 128.1, 119.7, 61.8, 57.3, 43.5, 36.5, 
14.3. HRMS (ESI) calcd for C19H23ClO4: 350.1285. Found 373.1180 [M+Na]. 
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Diethyl-2-(but-2-enyl)-2’-((Z)-3-phenyl-2-bromo-2-propenyl) malonate (10): 
Following the procedure described for compound 5 and starting from diethyl-2-(But-
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3-enyl) malonate29 (0.42 g, 1.96 mmol), (Z)-(2,3-Dibromoprop-1-enyl)-benzene (0.65 
g, 2.35 mmol), NaOEt (0.16 g, 2.35 mmol) and THF (15 ml), the desired product was 
obtained after silica gel chromatography (eluent: Hexane - Et2O 40:1) as a transparent 
oil (0.77 g, 97 % yield). IR (film): 3077, 2980, 2939, 1731, 1644, 1447, 1367, 1261, 
1203, 1184, 1091, 1032, 917, 861, 752, 696, 555 cm-1. 1H NMR (CDCl3, 400 MHz): δ 
7.51(m, 2H), 7.37-7.26 (m, 3H), 6.82 (s, 1H), 5.78 (m, 1H), 5.01 (m, 2H), 4.22 (m, 
4H), 3.37 (s, 2H), 2.1 (m, 4H), 1.27 (t, J = 7.1 Hz, 6H). 13C NMR (CDCl3, 100 MHz): 
δ 170.9, 137.5, 135.9, 132.7, 129.1, 128.3, 128.2, 120.5, 115.4, 61.8, 57.6, 44.9, 31.0, 
28.7, 14.3. HRMS (ESI) calcd for C20H25BrO4: 408.0936. Found 431.0626 [M+Na]. 
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1-Phenyl-1-((Z)-2-bromo-3-phenyl-but-3-enyl)-3-butene (11): Benzaldehyde (0.11 
g, 1,00 mmol), (Z)-2-bromo-3-phenylprop-2-en-1-ol24 (0.210 g, 1.00 mmol) and allyl-
trimethylsilane (0.14 g, 1.20 mmol) where charged in a 20 ml round bottom flask 
under nitrogen. To this mixture was added I2 (0.02 g, 0.10 mmol) and the obtained 
solution was stirred for 2 h at room temperature. It was then directly subjected to 
column chromatography purification (eluent: Hexane - CH2Cl2 3:1) to give the desired 
product as colorless oil (0.14 g, 40 % yield). IR (film): 3062, 3025, 2903, 2853, 1641, 
1491, 1446, 1352, 1306, 1288, 1263, 1101, 1077, 1026, 997, 916, 858, 751, 693, 612, 
593, 546, 515, 485, 425, 401 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.60 (m, 2H), 7.40-
7.25 (m, 8H), 6.95 (s, 1H), 5.83 (m, 1H), 5.05 (m, 2H), 4.42 (m, 1H), 4.22 (dd, J = 1.3 
- 13.8 Hz, 1H), 4.03 (dd, J = 1.0 - 13.8 Hz, 1H), 2.65 (m, 1H), 2.45 (m, 1H).  13C 
NMR (CDCl3, 100 MHz): δ 141.5, 135.4, 134.9, 129.3, 129.0, 128.7, 128.4, 128.3, 
128.1, 127.1, 122.7, 117.4, 81.5, 74.5, 42.8. HRMS (ESI) calcd for C19H19BrO: 
342.0619. Found 365.0509 [M+Na]. 
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N-(But-3-enyl)-N-((Z)-3-phenyl-2-bromo-2-propenyl) - p-toluensulfonamide (12): 
Following the procedure described for compound 7 and starting from N-(But-3-enyl)-
p-toluensulfonamide30 (0.30 g, 1.25 mmol), (Z)-(2,3-Dibromoprop-1-enyl)-benzene 
(0.29 g, 1.05 mmol), NaH (0.04 g, 1.05 mmol) and DMF (10 ml) the desired product 
was obtained after silica gel chromatography (eluent: Hexane - Et2O 9:1) as a white 
solid (0.24 g, 51 % yield). IR (film): 3063, 3024, 2977, 2922, 2867, 1640, 1597, 1492, 
1446, 1339, 1290, 1157, 1090, 1060, 997, 920, 889, 863, 813, 745, 694, 659, 587, 548 
cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.74 (m, 2H), 7.52 (m, 2H), 7.39 – 7.27 (m, 5H), 
6.96 (s, 1H), 5.72 (m, 1H), 5.07 (m, 2H), 4.24 (s, 2H), 3.32 (m, 2H), 2.42 (s, 3H), 
2.35 (m, 2H).  13C NMR (CDCl3, 100 MHz): δ 143.7, 137.4, 135.1, 134.8, 130.6, 
129.9, 129.2, 128.5, 128.4, 127.6, 121.1, 117.5, 57.6, 48.1, 33.2, 21.7. HRMS (EI) 
calcd for C20H22BrNO2S: 419.0555. Found 339.9800 [M-Br]. 
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N-(1-Phenyl-but-3-enyl)-N-((Z)-3-phenyl-2-bromo-2-propenyl) - p-toluensulfon-
amide (13). Following the procedure described for compound 7 and starting from N-
(1-Phenyl-but-3-enyl)-p-toluensulfonamide (0.19 g, 0.60 mmol), (Z)-(2,3-
Dibromoprop-1-enyl)-benzene (0.20 g, 0.72 mmol), NaH (0.03 g, 0.66 mmol) and 
DMF (5 ml), the desired product was obtained after silica gel chromatography (eluent: 
Hexane - Et2O 20:1) as a white solid (0.18 g, 59 % yield). IR (film): 3061, 3030, 
2920, 2853, 1658, 1596, 1494, 1450, 1350, 1332, 1160, 1095, 1069, 988, 970, 944, 
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915, 886, 814, 776, 756, 728, 697, 666, 642, 558 cm-1. 1H NMR (CDCl3, 400 MHz): δ 
7.78 (d, J = 8.0 Hz, 2H), 7.4-7.2 (m, 12H), 6.69 (s, 1H), 5.61 (m, 1H), 5.15 (m, 1H), 
4.98 (m, 2H), 4.23 (d, J =17.5 Hz, 1H), 3.96 (d, J = 17.5 Hz, 1H), 2.91 (m, 1H), 2.64 
(m, 1H), 2.42 (s, 3H).  13C NMR (CDCl3, 100 MHz): δ 143.7, 138.2, 137.1, 135.3, 
134.6, 130.1, 129.8, 129.10, 129.07, 128.7, 128.5, 128.2, 127.8, 122.2, 118.0, 61.39, 
53.9, 36.3, 21.7. HRMS (EI) calcd for C26H26BrNO2S: 495.0868. Found 518.07584 
[M+Na]. 
 
Cl
Ph
N
Ts
Ph
 
 
N-(1-Phenyl-but-3-enyl)-N-((Z)-3-phenyl-2-chloro-2-propenyl) - p-Toluensulfon-
amide (14): Following the procedure described for compound 7 and starting from N-
(1-Phenyl-but-3-enyl)-p-toluensulfonamide31 (0.20 g, 0.66 mmol), III (0.18 g, 0.80 
mmol), NaH (0.03 g, 0.73 mmol) and DMF (5 ml), the desired product was obtained 
after silica gel chromatography (eluent: Hexane - Et2O 10:1) as a white solid (0.22 g, 
75 % yield). IR (film): 3065, 3030, 2976, 2922, 1641, 1597, 1493, 1448, 1337, 1304, 
1184, 1158, 1119, 1090, 1059, 1016, 998, 954, 919, 895, 869, 813, 770, 754, 741, 
696, 661, 608, 561, 544 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.73 (d, J = 8.3 Hz, 2H), 
7.37 (d, J = 7.3 Hz, 2H), 7.30 – 7.20 (m, 10H), 6.39 (s, 1H), 5.58 (m, 1H), 5.15 (m, 
1H), 4.95 (m, 2H), 4.13 (d, J = 16.7 Hz, 1H), 3.79 (d, J = 16.7 Hz, 1H), 2.88 (m, 1H), 
2.62 (m, 1H), 2.41 (s, 3H).  13C NMR (CDCl3, 100 MHz): δ 143.5, 138.1, 136.9, 
134.5, 134.1, 129.6, 129.5, 129.10, 128.9, 128.5, 128.2, 128.1, 127.6, 127.2, 117.8, 
61.0, 51.9, 36.0, 21.6. HRMS (ESI) calcd for C26H26ClNO2S: 451.1373. Found 
474.1264 [M+Na]. 
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N-(1-Phenyl-3-methyl-but-3-enyl)-N-((Z)-3-phenyl-2-chloro-2-propenyl) - p-
toluensulfonamide (15): Following the procedure described for compound 7 and 
starting from N-(1-Phenyl-3-methyl-but-3-enyl)-p-toluensulfonamide (0.30 g, 0.95 
mmol), III (0.26 g, 1.14 mmol), NaH (0.05 g, 1.14 mmol) and DMF (10 ml), the 
desired product was obtained after silica gel chromatography (eluent: Hexane - Et2O 
9:1 to 5:1) as a white solid (0.21 g, 46 % yield). IR (film): 3065, 3030, 2976, 2922, 
1641, 1597, 1493, 1448, 1337, 1304, 1184, 1158, 1119, 1090, 1059, 1016, 998, 954, 
919, 895, 869, 813, 770, 754, 741, 696, 661, 608, 561, 544 cm-1. 1H NMR (CDCl3, 
400 MHz): δ 7.73 (d, J = 8.3 Hz, 2H), 7.37 (d, J = 7.3 Hz, 2H), 7.30 – 7.20 (m, 10H), 
6.39 (s, 1H), 5.58 (m, 1H), 5.15 (m, 1H), 4.95 (m, 2H), 4.13 (d, J = 16.7 Hz, 1H), 
3.79 (d, J = 16.7 Hz, 1H), 2.88 (m, 1H), 2.62 (m, 1H), 2.41 (s, 3H), 1.62 (3H). 13C 
NMR (CDCl3, 100 MHz): δ 143.5, 138.1, 136.9, 134.5, 134.1, 129.6, 129.5, 129.10, 
128.9, 128.5, 128.2, 128.1, 127.6, 127.2, 117.8, 61.0, 51.9, 36.0, 21.6. HRMS (ESI) 
calcd for C27H28ClNO2S: 465.1529. Found 488.1422 [M+Na]. 
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Diethyl-2-(3-methyl-but-3-enyl)-2’-((Z)-3-phenyl-2-chloro-2-propenyl) malonate 
(16): Following the procedure described for compound 7 and starting from diethyl-2-
(3-methyl-But-3-enyl) malonate32 (0.25 g, 1.09 mmol), III (0.30 g, 1.31 mmol), 
NaOEt (0.09 g, 1.01 mmol) and THF (10 ml) the desired product was obtained after 
silica gel chromatography (eluent: Hexane - CH2Cl2 1:1) as a transparent oil (0.40 g, 
96 % yield). IR (film): 2979, 1732, 1447, 1257, 1232, 1196, 1181, 1096, 1030, 891, 
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862, 752, 694 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.52 (d, J = 7.8 Hz, 2H), 7.38-7.24 
(m, 3H), 6.52 (s, 1H), 4.71 (s, 1H), 4.22 (m, 4H), 3.22 (s, 2H), 2.18 (m, 2H), 1.95 (m, 
2H), 1.71 (s, 3H), 1.26 (t, J = 7.1 Hz, 6H). 13C NMR (CDCl3, 100 MHz): δ 170.9, 
144.9, 134.8, 129.3, 129.2, 129.1, 128.4, 128.1, 110.9, 61.7, 57.3, 43.2, 32.6, 30.2, 
22.6, 14.3. HRMS (ESI) calcd for C21H27ClO4: 378.1598. Found 401.8795 [M+Na]. 
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N-(1-Phenyl-pent-4-enyl)-N-((Z)-3-phenyl-2-bromo-2-propenyl) - p-Toluensulfon-
amide (17): Following the procedure described for compound 7 and starting from N-
(1-Phenyl-pent-3-enyl)-p-toluensulfonamide33 (0.19 g, 0.60 mmol), (Z)-(2,3-
Dibromoprop-1-enyl)-benzene (0.20 g, 0.72 mmol), NaH (0.03 g, 0.66 mmol) and 
DMF (10 ml) the desired product was obtained after silica gel chromatography 
(eluent: Hexane - Et2O 20:1) as an oil (0.18 g, 59 % yield). IR (film): 3068, 3030, 
2863, 1660, 1594, 1495, 1450, 1332, 1160, 1097, 1064, 988, 972, 944, 915, 886, 814, 
778, 756, 731, 697, 667, 641, 559 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.75 (d, J = 
8.2 Hz, 2H), 7.37-7.15 (m, 12H), 6.69 (s, 1H), 5.72 (m, 1H), 5.07 (m, 1H), 4.92 (m, 
2H), 4.21 (d, J = 16.4 Hz, 1H), 3.95 (d, J = 16.4 Hz, 1H), 2.40 (s, 3H), 2.30-1.70 (m, 
4H).  13C NMR (CDCl3, 100 MHz): δ 137.4, 137.2, 135.4, 131.6, 129.9, 129.8, 129.7, 
129.5, 129.0, 128.9, 128.8, 128.6, 128.4, 128.3, 128.2, 127.9, 127.8, 122.4, 115.7, 
66.1, 61.0, 53.7, 31.1, 31.0, 21.7, 15.5. HRMS (ESI) calcd for C27H28BrNO2S: 
509.1024. Found 532.0922 [M+Na]. 
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N-(1-Phenyl-but-3-enyl)-N-((Z)-3-phenyl-2-chloro-2-propenyl) - p-toluensulfon-
amide (18): ): Following the procedure described for compound 14 and starting from 
N-(2,2’-diphenyl-pent-3-enyl)-p-toluensulfonamide34 (0.30 g, 0.76 mmol), 3 (0.21 g, 
0.91 mmol), NaH (0.03 g, 0.84 mmol) and DMF (10 ml), the desired product was 
obtained after silica gel chromatography (eluent: Hexane - Et2O 9:1) as a white foam 
(0.31 g, 74 % yield). IR (film): 3060, 3025, 2924, 1598, 1493, 1445, 1344, 1159, 
1089, 921, 813, 742, 699, 655, 551 cm-1. 1H NMR (CDCl3, 500 MHz): δ 7.70 (d, J = 
8.2 Hz, 2H), 7.35 – 7.18 (m, 17H), 6.12 (s, 1H), 5.58 (m, 1H), 4.90 (m, 2H), 4.22 (s, 
2H), 3.30 (s, 2H), 3.12 (d, J = 6.9 Hz, 2H), 2.38 (s, 3H).  13C NMR (CDCl3, 125 
MHz): δ 145.6, 143.6, 137.6, 134.7, 134.0, 129.7, 129.3, 129.0, 128.3, 128.2, 128.1, 
128.0, 127.9, 127.8, 126.8, 118.1, 57.0, 55.7, 51.2, 41.7, 21.7. HRMS (ESI) calcd for 
C33H32ClNO2S: 541.1842. Found 564.1731 [M+Na]. 
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N-(1-Phenyl-but-3-enyl)-N-((Z)-3-phenyl-2-bromo-2-propenyl) - p-toluensulfon-
amide (19). Following the procedure described for compound 14 and starting from N-
(2,2’-diphenyl-pent-3-enyl)-p-toluensulfonamide (0.30 g, 0.76 mmol), (Z)-(2,3-
Dibromoprop-1-enyl)-benzene (0.25 g, 0.91 mmol), NaH (0.04 g, 0.91 mmol) and 
DMF (10 ml), the desired product was obtained after silica gel chromatography 
(eluent: Hexane - Et2O 10:1) as a white foam (0.27 g, 60 % yield). IR (film): 3059, 
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3024, 2930, 1598, 1490, 1446, 1340, 1156, 913, 812, 736, 697, 656, 548 cm-1. 1H 
NMR (CDCl3, 500 MHz): δ 7.70 (d, J = 8.2 Hz, 2H), 7.35 – 7.18 (m, 17H), 6.44 (s, 
1H), 5.58 (m, 1H), 4.90 (m, 2H), 4.27 (s, 2H), 3.42 (s, 2H), 3.12 (d, J = 7.0 Hz, 2H), 
2.38 (s, 3H). 13C NMR (CDCl3, 125 MHz): δ 145.6, 143.7, 137.5, 135.0, 134.7, 130.2, 
129.8, 129.1, 128.2, 128.1, 127.9, 126.8, 120.3, 118.2, 57.4, 57.3, 51.2, 41.7, 21.7. 
HRMS (ESI) calcd for C33H32BrNO2S: 585.1337. Found 608.1209 [M+Na]. 
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N-(But-3-enyl)-N-((E)-3-phenyl-2-bromo-2-propenyl) - p-toluensulfonamide (20): 
Following the procedure described for compound 7 and starting from N-(But-3-enyl)-
p-toluensulfonamide (0.19 g, 0.84 mmol), IV (0.28 g, 1.01 mmol), NaH (0.04 g, 1.01 
mmol) and DMF (10 ml), the desired product was obtained after silica gel 
chromatography (eluent: Hexane - Et2O 10:1) as an oil (0.34 g, 97 % yield). IR (film): 
3059, 3026, 2976, 2924, 1641, 1597, 1494, 1445, 1341, 1304, 1158, 1090, 1032, 918, 
814, 748, 701, 670, 657, 591, 553 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.68 (m, 2H), 
7.40- 7.29 (m, 3H), 7.25 (m, 3H), 7.17 (m, 2H), 5.48 (m, 1H), 4.72 (m, 2H), 4.32 (s, 
2H), 3.12 (m, 2H), 2.41 (s, 3H), 1.98 (m, 2H). 13C NMR (CDCl3, 100 MHz): δ 143.5, 
137.6, 137.4, 135.6, 134.8, 129.7, 128.9, 128.6, 128.3, 127.7, 124.6, 117.1, 49.2, 46.5, 
32.5, 21.7. HRMS (EI) calcd for C20H22BrO4: 419.0555. Found 442.0456 [M+Na]. 
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Diethyl-2-(but-2-enyl)-2’-((E)-3-phenyl-2-bromo-2-propenyl) malonate (21): 
Following the procedure described for compound 5 and starting from diethyl-2-(But-
3-enyl) malonate (0.18 g, 0.84 mmol), IV (0.30 g, 1.09 mmol), NaOEt (0.07 g, 1.01 
mmol) and THF (10 ml), the desired product was obtained after silica gel 
chromatography (eluent: Hexane - Et2O 20:1) as a transparent oil (0.31 g, 91 % yield). 
IR (film): 2981, 1730, 1642, 1623, 1445, 1366, 1269, 1184, 1078, 1032, 913, 861, 
754, 700, 553 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.38 (m, 2H), 7.33-7.25 (m, 3H), 
7.20 (s, 1H), 5.56 (m, 1H), 4.85 (m, 1H), 4.77 (m, 1H), 4.22 (m, 4H), 3.54 (s, 2H), 
2.00 (m, 2H), 1.44 (m, 2H), 1.24 (t, J = 7.1 Hz, 6H). 13C NMR (CDCl3, 100 MHz): δ 
170.9, 137.5, 137.2, 136.1, 128.9, 128.5, 127.9, 126.5, 114.9, 61.7, 57.1, 37.1, 30.6, 
28.3, 14.11. HRMS (ESI) calcd for C19H23BrO4: 408.0936. Found 431.0826 [M+Na]. 
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N-(1-Phenyl-3-methyl-but-3-enyl)-N-((Z)-3-phenyl-2-bromo-2-propenyl) - p-
toluensulfonamide (22): Following the procedure described for compound 7 and 
starting from N-(1-Phenyl-3-methyl-but-3-enyl)-p-toluensulfonamide (0.30 g, 0.95 
mmol), (Z)-(2,3-Dibromoprop-1-enyl)-benzene (0.34 g, 1.23 mmol), NaH (0.05 g, 
1.23 mmol) and DMF (10 ml) the desired product was obtained after silica gel 
chromatography (eluent: Hexane - Et2O 20:1 to 10:1) as a white solid (0.18 g, 37 % 
yield). IR (film): 3061, 3030, 2975, 2924, 1649, 1597, 1493, 1446, 1338, 1304, 1157, 
1091, 1063, 1016, 920, 894, 813, 770, 740, 696, 660, 608, 572, 549 cm-1. 1H NMR 
(CDCl3, 400 MHz): δ 7.75 (d, J = 8.2 Hz, 2H), 7.33 – 7.19 (m, 12H), 6.65 (s, 1H), 
5.32 (m, 1H), 4.7 (s, 1H), 4.62 (s, 1H), 4.22 (d, J = 16.8 Hz, 1H), 4.00 (d, J = 16.8 Hz, 
1H), 2.95 (m, 1H), 2.50 (m, 1H), 2.41 (s, 3H), 1.61 (s, 3H). 13C NMR (CDCl3, 100 
MHz): δ 143.7, 141.4, 138.2, 137.1, 135.4, 129.9, 129.8, 129.1, 129.0, 128.6, 128.4, 
128.2, 128.1, 127.9, 127.7, 122.2, 114.0, 59.7, 53.8, 40.0, 22.7, 21.7. HRMS (ESI) 
calcd for C27H28BrNO2S: 509.1024. Found 532.0925 [M+Na]. 
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Experimental section: characterization of products 
 
General procedure for ring closing metathesis: 
 
A screw cap vial with septum was charged in a glove box with the catalyst. Solvent 
was then added and the mixture was stirred until complete dissolution. The vial was 
then closed and placed in an oil bath pre-heated to 65 degree outside of the box (It 
seems to be important from the collected data to pre-heat the catalyst solution before 
mixing it with the desired substrate). After 2 minutes a solution of the desired diene 
was added with a syringe. The mixture was stirred until from TLC and/or GC-MS 
analysis the reaction was complete. The vial was then cooled to room temperature and 
opened to the air for few minutes to completely decompose the catalyst. The resulting 
yellow-brown solution was directly charged on the top of a silica gel filter for 
purification. 
 
EtOOC
EtOOC Br
 
 
3-Bromo-1,1’-(dicarboxilic acid diethyl ester)-cyclopent-3-ene (5a): Following the 
general procedure and starting from 9 (0.063 g, 0.16 mmol), GII (0.0027 mg, 0.0032 
mmol), and benzene (1.6 ml), the desired product was obtained after silica gel 
chromatography (eluent: Hexane - Et2O 20:1) as a colorless oil (0.041 g, 87 % yield). 
IR (film): 2981, 2937, 1730, 1630, 1464, 1445, 1389, 1366, 1257, 1242, 1180, 1160, 
1096, 1073, 1058, 1034, 1013, 981, 861, 820 cm-1. 1H NMR (CDCl3, 400 MHz): δ 
5.71 (m, 1H), 4.20 (q, J = 7.1 Hz, 4H), 3.21 (m, 2H), 2.96 (m, 2H), 1.23 (t, J = 7.1 
Hz, 6H). 13C NMR (CDCl3, 100 MHz): δ 171.2, 128.3, 117.0, 62.2, 58.9, 46.7, 40.8, 
14.2. HRMS (EI) calcd for C11H13BrO4: 290.0154. Found 313.0048 [M+Na]. 
 
 
 130 
N
Ts
Br
 
 
1-Tosyl-2,5-dehydro-3-bromopyrrole (7a): Following the general procedure and 
starting from 7 (0.063 g, 0.16 mmol), GII (0.0027 g, 0.0032 mmol), and benzene (1.6 
ml), the desired product was obtained after silica gel chromatography (eluent: 
Toluene; with p-anisaldehyde the product gave yellow spots on TLC; the main 
impurity gave black spots) as a white crystalline solid (0.029 g, 64 % yield). From 
MS analysis the main impurity arises from cross metathesis of 7 with the styrene 
generated during the reaction.  IR (film): 2915, 2864, 1632, 1599, 1348, 1324, 1162, 
1102, 1048, 817, 667, 601, 545 cm-1.  1H NMR (CDCl3, 400 MHz): δ 7.71 (d, J = 8.1 
Hz, 2H), 7.34 (d, J = 8.1 Hz, 2H), 5.80 (m, 1H), 4.10 (m, 4H), 2.47 (s, 3H). 13C NMR 
(CDCl3, 100 MHz): δ 144.2, 134.0, 130.2, 127.7, 125.9, 114.1, 58.8, 55.4, 21.8. 
HRMS (ESI) calcd for C11H12BrNO2S: 300.9772. Found 323.9643 [M+Na]. 
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1-Tosyl-2,5-dehydro-2Phenyl-3-bromopyrrole (8a): Following the general 
procedure and starting from 8 (0.085 g, 0.18 mmol), GII (0.0027 g, 0.0032 mmol), 
and benzene (1.8 ml), the desired product was obtained after silica gel 
chromatography (eluent: Toluene) as a white crystalline solid (0.051 g, 76 % yield). 
From NMR and MS analysis the main impurity arise from cross metathesis of 8 with 
the styrene generated during the reaction. IR (film): 3030, 2920, 2871, 1630, 1598, 
1493, 1455, 1348, 1162, 1094, 1044, 827, 814, 755, 698, 670, 604, 576, 546 cm-1.  1H 
NMR (CDCl3, 400 MHz): δ 7.45 (d, J = 8.5 Hz, 2H), 7.32-7.21 (m, 5H), 6.02 (s, 1H), 
5.40 (m, 1H), 4.35 (m, 1H), 4.23 (m, 1H), 2.40 (s, 3H). 13C NMR (CDCl3, 100 MHz): 
δ 143.7, 138.3, 135.5, 129.7, 128.7, 128.6, 128.2, 127.5, 125.6, 119.9, 55.2, 21.7. 
HRMS (ESI) calcd for C17H16BrNO2S: 377.0085. Found 399.9984  [M+Na]. 
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3-Chloro-1,1’-(dicarboxilic acid diethyl ester)-cyclopent-3-ene (9a): Following the 
general procedure and starting from 9 (0.056 g, 0.16 mmol), GII (0.0027 mg, 0.0032 
mmol), and benzene (1.6 ml), the desired product was obtained after silica gel 
chromatography (eluent: Hexane - Et2O 20:1) as a colorless oil (0.038 g, 96 % yield). 
The analytical data matched the one previously reported in literature.35 
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3-Bromo-1,1’-(dicarboxilic acid diethyl ester)-cyclohex-3-ene (10a): Following the 
general procedure and starting from 10 (0.065 g, 0.16 mmol), GII (0.0027 g, 0.0032 
mmol), and benzene (1.6 ml), the desired product was obtained after silica gel 
chromatography (eluent: Hexane - Et2O 20:1) as a colorless oil (0.048 g, 96 % yield). 
IR (film): 2980, 2937, 2846, 1730, 1655, 1464, 1445, 1389, 1366, 1335, 1305, 1277, 
1246, 1230, 1214, 1175, 1135, 1086, 1069, 1053, 1016, 976, 949, 897, 859, 838, 768, 
733, 696 cm-1. 1H NMR (CDCl3, 400 MHz): δ 6.01 (m, 1H), 4.19 (q, J = 7.1 Hz, 4H), 
2.93 (s, 2H), 2.13 (m, 4H), 1.23 (t, J = 7.1 Hz, 6H). 13C NMR (CDCl3, 100 MHz): δ 
170.5, 127.8, 118.5, 61.9, 55.1, 39.5, 26.4, 24.6, 14.2. HRMS (ESI) calcd for 
C12H17BrO4: 304.0310. Found 327.0202 [M+Na]. 
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2-Phenyl-5-bromo-3,6-dihydro-pyran (11a): Following the general procedure and 
starting from 11 (0.055 g, 0.16 mmol), GII (0.0027 g, 0.0032 mmol), and benzene 
(1.6 ml), the desired product was obtained after silica gel chromatography (eluent: 
Hexane - CH2Cl2 7:1) as a colorless oil (0.036 g, 94 % yield). IR (film): 3062, 3031, 
2928, 2897, 2833, 1655, 1494, 1450, 1426, 1366, 1271, 1235, 1092, 1024, 1011, 982, 
960, 905, 876, 821, 756, 697, 532 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.71 (d, J = 
8.1 Hz, 2H), 7.34 (d, J = 8.1 Hz, 2H), 5.80 (m, 1H), 4.10 (m, 4H), 2.47 (s, 3H). 13C 
NMR (CDCl3, 100 MHz): δ 141.3, 128.7, 128.1, 126.2, 126.1, 119.6, 75.4, 70.9, 35.5. 
HRMS (EI) calcd for C11H11BrO: 237.9993. Found 237.9996. 
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1-Tosyl-1,2,3,6-tetrahydro-5-bromopyridine (12a): Following the general procedure 
and starting from 12 (0.085 g, 0.18 mmol), GII (0.0027 g, 0.0032 mmol), and 
benzene (1.6 ml), the desired product was obtained after silica gel chromatography 
(eluent: Hexane – Et2O 9:1) as a white crystalline solid (0.048 g, 96 % yield).  IR 
(film): 2923, 2846, 2359, 2340, 1336, 1165, 1098, 1010, 970, 945, 817, 731, 652, 
570, 548 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.68 (d, J = 8.2 Hz, 2H), 7.34 (d, J = 
8.2 Hz, 2H), 6.06 (m, 1H), 3.78 (s, 2H), 3.22 (t, J = 5.7 Hz, 2H), 2.44 (s, 3H), 2.25 
(m, 2H). 13C NMR (CDCl3, 100 MHz): δ 144.1, 133.8, 130.1, 127.8, 127.1, 115.9, 
51.0, 42.0, 27.4, 21.8. HRMS (EI) calcd for C12H14BrNO2S: 314.9929. Found 
337.9801[M+Na]. 
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1-Tosyl-1,2,5,6-tetrahydro-2-phenyl-5-bromopyridine (13a): Following the general 
procedure and starting from 13 (0.080 g, 0.16 mmol), GII (0.0027 g, 0.0032 mmol), 
 133 
and benzene (1.6 ml), the desired product was obtained after silica gel 
chromatography (eluent: Hexane – Et2O 6:1) as a colorless oil (0.060 g, 95 % yield). 
Due to the low solubility of 13 in benzene for this reaction it is important to heat the 
starting substrate solution to 60 °C before injecting it into the catalyst mixture. IR 
(film): 3061, 3030, 2920, 2853, 1658, 1598, 1494, 1450, 1439, 1350, 1332, 1159, 
1095, 1069, 988, 943, 886, 814, 776, 756, 727, 697, 666, 642, 575, 558 cm-1. 1H NMR 
(CDCl3, 400 MHz): δ 7.72 (d, J = 8.3 Hz, 2H), 7.30 (m, 7H), 6.05 (m, 1H), 5.28 (d, J 
= 5.5 Hz, 1H), 4.31 (d, J = 19.4 Hz, 1H), 3.49 (m, 1H), 2.60-2.30 (m, 5H). 13C NMR 
(CDCl3, 100 MHz): δ 143.9, 138.1, 137.5, 130.0, 128.8, 128.1, 127.5, 127.3, 125.6, 
117.01, 52.3, 46.7, 28.5, 21.8. HRMS (EI) calcd for C18H18BrNO2S: 391.0242. Found 
414.0136 [M+Na]. 
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1-Tosyl-1,2,5,6-tetrahydro-2-phenyl-5-bromopyridine (14a): Following the general 
procedure and starting from 14 (0.072 g, 0.16 mmol), GII (0.0027 g, 0.0032 mmol), 
and benzene (1.6 ml) the desired product was obtained after silica gel chromatography 
(eluent: Hexane - Et2O 9:1) as a colorless oil (0.054 g, 97 % yield). Due to the low 
solubility of 14 in benzene for this reaction it is important to heat the starting substrate 
solution to 60 °C before injecting it into the catalyst mixture. IR (film): 3062, 3032, 
2923, 2851, 1661, 1595, 1494, 1450, 1439, 1334, 1305, 1160, 1096, 1068, 1005, 974, 
948, 915, 888, 814, 784, 759, 734, 698, 671, 644, 584, 560, 539, 402 cm-1. 1H NMR 
(CDCl3, 400 MHz): δ 7.72 (d, J = 8.3 Hz, 2H), 7.30 (m, 7H), 5.81 (m, 1H), 5.25 (d, J 
= 5.5 Hz, 1H), 4.20 (d, J = 18.4 Hz, 1H), 3.40 (m, 1H), 2.60-2.30 (m, 5H). 13C NMR 
(CDCl3, 100 MHz): δ 143.6, 137.9, 137.2, 129.8, 128.6, 127.9, 127.3, 127.2, 127.0, 
121.3, 52.2, 44.9, 26.9, 21.6. HRMS (ESI) calcd for C18H18ClNO2S: 347.0747. Found 
370.0637 [M+Na]. 
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1-Tosyl-1,2,5,6-tetrahydro-2-phenyl-5-bromopyridine (15a): Following the general 
procedure and starting from 15 (0.075 g, 0.16 mmol), GII (0.0068 g, 0.008 mmol), 
and CH2Cl2 (1.6 ml), the desired product was obtained after silica gel chromatography 
(eluent: Hexane - Et2O 10:1 to Hexane - Et2O 4:1) as a colorless oil (0.047 g, 81 % 
yield). Due to the low solubility of 15 in benzene for this reaction it is important to 
heat the starting substrate solution to 60 °C before injecting it into the catalyst 
mixture. The same reaction performed using benzene as a solvent gave lower yield. 
IR (film): 2919, 2856, 1683, 1596, 1495, 1447, 1338, 1162, 1119, 1089, 1055, 812, 
772, 738, 690, 646, 558 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.70 (d, J = 8.3 Hz, 2H), 
7.30 (m, 7H), 5.24 (d, J = 4.3 Hz, 1H), 4.15 (d, J = 18 Hz, 1H), 3.40 (m, 1H), 2.40 (m, 
5H), 1.70 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 143.8, 138.4, 137.4, 129.8, 128.8, 
128.1, 127.4, 127.3, 127.1, 121.2, 53.5, 45.4, 32.8, 21.8, 19.4. HRMS (ESI) calcd for 
C19H20ClNO2S: 361.0903. Found 384.0796 [M+Na]. 
 
EtO2C
EtO2C
Cl
 
 
3-Chloro-4-methyl-1,1’-(dicarboxilic acid diethyl ester)-cyclohex-3-ene (16a): 
Following the general procedure and starting from 16 (0.054 g, 0.14 mmol), GII 
(0.006 g, 0.0071 mmol), and CH2Cl2 (1.4 ml), the desired product was obtained after 
silica gel chromatography (eluent: Hexane - Et2O 20:1) as a colorless oil (0.036 g, 92 
% yield). IR (film): 2979, 1730, 1443, 1367, 1295, 1252, 1240, 1178, 1114, 1091, 
1057, 1028, 861, 816 cm-1. 1H NMR (CDCl3, 400 MHz): δ 4.19 (q, J = 7.2 Hz, 4H), 
2.83 (s, 2H), 2.12 (s, 4H), 1.76 (s, 3H), 1.23 (t, J = 7.2 Hz, 6H). 13C NMR (CDCl3, 
100 MHz): δ 170.8, 128.6, 122.9, 61.8, 54.8, 38.1, 29.1, 27.7, 19.8, 14.2. HRMS 
(ESI) calcd for C19H13ClO4: 274.0972. Found 297.0781 [M+Na]. 
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1-Tosyl-2,3,4,7-tetrahydro-3,3-diphenyl-5-chloro-azepine (18a): Following the 
general procedure and starting from 18 (0.077 g, 0.141 mmol), GII (0.0060 g, 0.007 
mmol), and CH2Cl2 (14 ml), the desired product was obtained after silica gel 
chromatography (eluent: Toluene) as a white solid (0.046 g, 76 % yield). The same 
reaction performed using benzene as a solvent gave a slightly lower yield. IR (film): 
2920, 1597, 1495, 1444, 1669, 1160, 1091, 912, 813, 753, 700, 657, 565, 547 cm-1. 1H 
NMR (CDCl3, 400 MHz): δ 7.60 (d, J = 8.2 Hz, 2H), 7.32-7.20 (m, 12H), 5.87 (t, J = 
8.0 Hz, 1H), 4.30 (s, 2H), 3.97 (s, 2H), 3.05 (d, J = 6.8 Hz, 2H), 2.42 (s, 3H). 13C 
NMR (CDCl3, 100 MHz): δ 146.4, 144.0, 134.9, 130.1, 129.2, 128.6, 127.7, 127.4, 
126.8, 59.4, 55.3, 51.6, 36.5, 21.8. HRMS (ESI) calcd for C25H24ClNO2S: 437.1216. 
Found 460.1110 [M+Na]. 
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1-Tosyl-2,3,4,7-tetrahydro-3,3-diphenyl-5-bromo-azepine (19a): Following the 
general procedure and starting from 19 (0.083 g, 0.14 mmol), GII (0.0060 g, 0.007 
mmol), and CH2Cl2 (14 ml), the desired product was obtained after silica gel 
chromatography (eluent: Toluene) as a white foam (0.046 g, 67 % yield). IR (film): 
2921, 1597, 1494, 1445, 1669, 1159, 1092, 907, 813, 804, 784, 759, 733, 700, 659, 
565, 547 cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.58 (d, J = 8.2 Hz, 2H), 7.35-7.20 (m, 
12H), 6.10 (t, J = 8.0 Hz, 1H), 4.05 (m, 2H), 3.03 (d, J = 6.8 Hz, 2H), 2.42 (s, 3H). 
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13C NMR (CDCl3, 100 MHz): δ 146.4, 144.0, 134.9, 131.7, 130.0, 129.3, 128.9, 
128.5, 128.3, 127.7, 127.6, 26.8, 118.5, 59.3, 57.1, 51.6, 38.0, 21.8. HRMS (ESI) 
calcd for C25H24BrNO2S: 481.0711. Found 504.0583 [M+Na]. 
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